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A number of 3,3′-disubstituted binaphthol-modified allylboronates (2.42a-m) were prepared 
from the reaction between triallylborane and the corresponding 3,3′-disubstituted binaphthols. These 
chiral allylboronates could allylate carbonyl compounds to produce chiral homoallylic alcohols in 
high chemical and optical yields. Chiral ligands were readily recycled through simple acid-base 
extraction. Among all allylboronates tested, 3,3′-(CF3)2-BINOL-modified allylboronate (2.42b) is an 
especially effective reagent that allows for allylborations of both aldehydes and ketones in high 
enantioselectivities (up to 98% yield and >99% ee). Reagent 2.42b represents one of the best 
allylation reagents for carbonyl compounds developed thus far.  
Allylations of cyclic imines using 3,3′-disubstituted binaphthol-modified allylboronates 
(2.42a-j) were carried out at low temperature. 3,3′-Bis[3,5-(CF3)2-C6H3]-binaphthol-modified 
allylboronate (2.42j) gave the best enantioselectivities (91% ee to >99% ee) in the allylation of a 
variety of cyclic imines. This methodology represents the first successful enantioselective 
allylboration of cyclic imines. The versatility of the allylation products (chiral α-allyl cyclic amines) 
was demonstrated through efficient total syntheses of several naturally occurring alkaloids such as 
coniine, crispine A and corynantheidol. 
3,3′-Disubstituted binaphthol-modified alkynylboronates (4.47a-g) were synthesized according 
to a reported procedure. It was found that these chiral alkynylboronates add to N-acylaldimines in an 
enantioselective manner to produce chiral propargylamides in excellent yields and enantioselectivities. 
Up to >99% ee could be obtained with 3,3′-diphenyl binaphthol-modified alkynylboronates (4.47f). 
This represents the first direct asymmetric synthesis of chiral propargylamides. Using this 
 iv
methodology, an antitubulin agent (-)-N-acetylcolchinol (AstraZeneca® ZD6126 phenol) was 
synthesized in 4 steps from commercially available 3-hydroxybenzaldehyde. 
During a study of the asymmetric conjugate alkynylation of enones via chiral alkynylboronates, 
it was found that achiral dialkyl alkynylboronates could add to enones enantioselectively in the 
presence of catalytic amounts of chiral bidentate ligands (such as 3,3′-disubstituted binaphthols, 
diisopropyl tartrate and activated chiral amino acids). A catalytic cycle driven by “ligand-exchange” 
processes was proposed to rationalize this asymmetric induction. This is the first reported example of 
an asymmetric reaction that is promoted by a catalytic amount of an exchangeable chiral ligand on the 
boron reagent. More importantly, we have demonstrated a proof of principle that ligand exchange 
with boronates can be sufficiently fast that catalytic amounts of chiral ligands can be used to effect 
high levels of stereoselectivity. This catalytic protocol can potentially be applied to other asymmetric 
reactions providing the following three requirements are met: (1) the starting achiral boronate does 
not react with the electrophile (no background reaction); (2) the chiral boronate reacts with the 
electrophile and (3) ligand exchange or transesterification occurs under the reaction conditions. 
Potential applications of this principle include asymmetric allylboration, hydroboration, aldol reaction 
and reduction, just to name a few. 
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Chapter 1. Introduction 
 
1.1 C2 Symmetry and Binaphthols in Asymmetric Synthesis 
1.1.1 C2 Symmetry 
"C2 symmetry", by definition, means that 180o rotation about an axis through the molecule 
results in a geometry equivalent to the starting geometry. When compared to chiral reagents with other 
symmetries, the presence of a C2 symmetry axis within the auxiliary often offers unique advantages in 
achieving asymmetric induction for given chemical transformations. Indeed the primary benefit of a 
C2-symmetric auxiliary is that the number of competing diastereomeric transition states is greatly reduced, 
making system and protocol design more rational.1 For example, Yamada has reported the 
enantioselective alkylation of cyclohexanone enamines using proline esters as chiral auxiliaries giving 
alkylation products in low ee’s (10-30% ee),2-4 while Whitesell applied a C2-symmetrical 
2,5-dimethylpyrrolidine in the same reaction and achieved much higher enantioselectivities (80-90% 
ee, Scheme 1.1).5,6 It was reasoned that when an enamine (1.1) is formed from cyclohexanone and 
(S)-methyl proline, there are two possible distinct conformations (1.1a and 1.1b) which result in four 
possible diastereomeric transition states in the alkylation reaction and only one of them is disfavoured 
due to steric hindrance. The three favoured transition states then lead to the formation of the final 
product in both R and S forms and low enantioselectivities are observed accordingly. On the other 
hand, when 2,5-dimethylpyrrolidine is adopted, only two diastereomeric transition states are possible 
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and one of them is disfavoured. Therefore the only favoured diastereomeric transition state gives the 





































In the past few decades, C2-symmetric reagents have received increasing attention in 
asymmetric synthesis as a result of the generally high selectivities that are obtained with them. To 
date, a large number of molecules possessing C2 symmetry have been synthesized and utilized as 
chiral auxiliaries and catalysts in asymmetric synthesis. Some of the common ones are illustrated in 

















Figure 1.1 Examples of commonly used C2-symmetric reagents. 
 3
1.1.2 Binaphthols in Asymmetric Synthesis 
2,2′-Dihydroxy-1,1′-binaphthyl (BINOL), the two enantiomers of which are stable at high 
temperature and under various experimental conditions, is undoubtedly one of the most successful 
C2-symmetrical molecules that have been applied in asymmetric synthesis.  Although it was first 
synthesized in 1926, its application in asymmetric induction was only recognized in 1979 by Noyori 













up to 97% yield and >99% ee
R = Me, Et, Pr ...
 
Scheme 1.2 
Since Noyori’s discovery, BINOL has been applied in numerous metal catalyzed asymmetric 
reactions such as asymmetric aldol reactions, allylations, Diels-Alder reactions and epoxidations. In 
some rare cases, BINOL was also used as a chiral auxiliary. There is no need to describe those 
processes individually since a comprehensive review has been published concerning recent advances 
in asymmetric synthesis involving BINOL as chiral reagent or ligand.13 
Although great success in asymmetric synthesis has been achieved with BINOL, it does not 
always give satisfactory results. Thus there has been an increasing interest in modified BINOL’s. 
Substitution on BINOL-based metal complexes affects not only the steric environment around the 
metal center but also the electronic properties of the metal complexes, which may induce asymmetric 
reactions with enhanced stereoselectivities. For instance, in an enantioselective 1,3-dipolar 
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cycloaddition of nitrones 1.10 with ethyl vinyl ether (1.11), BINOL modified aluminum catalyst 
(Table 1.1, entry 1) gave poor conversion (11%) and enantioselectivity (24% ee for the exo product). 
However, introduction of bulkier substituents on BINOL led to remarkable increases in yield, 
exo/endo selectivity and enantioselectivity of the reaction (Table 1.1, entries 2 and 3).14  
















entry R conversion (%) exo/endo ee (%, for exo) 
1 H 11 85/15 24 
2 2-naphthyl 78 87/13 67 
3 2,5-(OMe)2-C6H3- 74 98/2 82 
During the last decade, a huge collection of modified binaphthols has been successfully 
prepared and applied to a wide range of asymmetric transformations. Some typical examples are 
shown in Figure 1.2. Details of preparations and applications of these modified BINOLs are presented 












X, Y = Cl, Br, I ...
OH
OH
R = Alkyl, Aryl, SiR3, Cl, Br, I 






















Figure 1.2 Examples of modified binaphthols. 
1.2 Boron in Asymmetric Synthesis 
Chirally modified boron reagents have proven to be effective in many asymmetric processes. In 
fact, the first non-enzymatic asymmetric synthesis with high enantioselectivity was the hydroboration 
of alkenes with (Ipc)2BH.16 Since then, many asymmetric reactions such as the reduction of ketones, 
aldol reactions, the allylation of carbonyls, and Diels-Alder reactions have been successfully 
conducted using chirally modified boron reagents. Several reviews have been published regarding the 
application of chiral boron reagents in asymmetric synthesis.17-22 
There are several factors that contribute to the popularity of chiral boron reagents. Firstly, the 
boron atom is small (atomic radius: 82 pm), which may result in strong interactions between adjacent 
groups and lead to highly stereoselective reactions (Figure 1.3). Secondly, due to the electron 
configuration of boron (1s22s22p1), only a maximum of four bonds can be formed around a boron 
atom (Scheme 1.3). The simplicity of the bond patterns around boron makes the stereochemistry of 
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boron-induced asymmetric reactions easily rationalized. Thirdly, the boron atom forms relatively 
strong covalent bonds with heteroatoms such as C, N, O and halogens. This allows one to modify 
chiral auxiliaries on boron easily, given that there are a huge number of carbon-, nitrogen- or oxygen- 
based chiral auxiliaries available. Some classical chiral controllers on boron are shown in Figure 
1.4.9,10,23-26 Finally, the low cost and low toxicity of boron allow for scaling up those methodologies in 














small radius (82 pm)
stay close
Major bonding styles for boron:
 































1.22 1.23 1.24  
Figure 1.4 Examples of chirally modified boron reagents. 
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1.3 Boron and Binaphthol 
In most boron-induced asymmetric reactions, the initial step involves the coordination of the 
boron atom and one of the reactants. For example, in a typical allylboration reaction, the oxygen on 
the aldehyde coordinates with the allylborane. The allyl group is then delivered to afford the final 
product (Scheme 1.3).10 Another example is chiral borane catalyzed Diels-Alder reaction, in which 



























Since the coordination step is crucial, increasing the Lewis acidity of the chiral boron reagent 
would lead to a stronger coordination between the boron and reactants, which may in turn enhance the 
reaction rate. In other words, electron deficient ligands could be excellent candidates for modifying 
chiral boron reagents.  
Given that BINOL and its derivatives are non-basic alcohols, they should be suitable chiral 
ligands for boron-induced asymmetric reactions. However, to our knowledge, there are only limited 
examples of asymmetric processes induced by binaphthol-modified boron reagents. For example, 


























Binaphthol-borane complexes such as 1.27 could also be used to catalyze Mannich reactions 


































R = H or Me






In addition, several “propeller-shaped” and spiro binaphthol-borane complexes (Figure 1.5) 
have also been applied in asymmetric inductions such as catalytic Diels-Alder reactions,31 Mannich 




















M = H, Ag, Cu
X = H or Br  
Figure 1.5 “Propeller-shaped” and spiro binaphthol-boron complexes. 
1.4 Purpose and Scope of the Thesis 
As was mentioned in previous sections, both boron reagents and binaphthols have been utilized 
successfully in asymmetric synthesis. However, asymmetric reactions that take advantage of both 
boron and binaphthols are rare. This thesis mainly focuses on the development of asymmetric 
inductions involving binaphthol-modified boron reagents.  
Several highly effective methodologies are presented in this thesis. These include the 
asymmetric allylboration of carbonyl compounds and cyclic imines, the enantioselective synthesis of 
propargylamides and the catalytic conjugate alkynylation of enones accelerated by “exchangeable” 
ligands on boron. These methodologies were applied to the synthesis of several naturally occurring 
alkaloids such as coniine, crispine A and corynantheidol as well as a pre-clinical antivascular agent 
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Chapter 2. Asymmetric Allylboration of Aldehydes and Ketones 
using 3,3′-Disubstituted Binaphthol-modified Boronates 
 
2.1 Introduction 
Asymmetric allylation of aldehydes and ketones has been one of the most useful reactions in organic 
chemistry not only because the chiral homoallylic alcohol products occur in many natural products, 
but also because these alcohols can be easily transformed into many other functionalities such as β- 
and γ-hydroxyaldehydes, γ- or δ-lactones, 1,3-diol and 1,3-aminoalcohols. Over the past two decades, 
efforts have been constantly made towards the development of new allylmetallic reagents that can 








M = Al, B, Si, Sn, Ti ...  
Scheme 2.1 
Many metal reagents such as Al-, B-, Cr-, Mg-, Sn-, Si-, Ti-based allylmetallics have been 
applied successfully in the allylation of carbonyls (Scheme 2.1).1 Among those, allylboron reagents 
have been extensively studied and utilized due to their high efficiency in inducing excellent 
stereoselectivities. The low cost and low toxicity of boron also makes allylboron reagents more 
popular.  
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One of the first studies in the allylboration of carbonyls was done by Hoffmann, who developed 
the first chiral allylboron reagents from camphor glycols in 1978.2,3 Upon treatment of aliphatic 
aldehydes with borolane 2.1, homoallylic alcohols were obtained in excellent yields with moderate 












R yield (%) ee (%) 
Me 92 65 
Et 91 77 
i-Pr 88 70 
t-Bu 85 45 
Scheme 2.2 
It was not until 1983 that H. C. Brown discovered the first practical allylboron reagent for the 
asymmetric allylation of aldehydes.4 Chiral B-allyldiisopinocampheylborane 2.2 can be easily 
prepared from naturally occurring (+) or (-)-α-pinene in both enantiomeric forms (Scheme 2.3). It 
allylates a variety of aldehydes (both aliphatic and aromatic ones) to furnish homoallylic alcohols in 







then NaOH, H2O2 R
OH









The allylboration is believed to proceed through a six-membered chair (Zimmerman-Traxler) 
transition state (Figure 2.1). Of the two possible transition states, B is disfavoured due to the repulsion 


















A (favoured) B (disfavoured)
H
 
Figure 2.1 Transition states for allylboration of aldehydes using (Ipc)2BAll. 
Crotylation using 2.3 also proceeded with excellent diastereo- and enantioselectivities 




then NaOH, H2O2 Me
OH








Later, Roush reported that good yields and enantioselectivities (up to 95% ee) could be 
obtained in reactions of tartrate-modified allylboronates with aldehydes.7 The auxiliary system was 
also applied to the (E) and (Z)-crotyl cases to give anti- or syn- allylboration products, respectively,  


















Interestingly, different from the allylborations developed by Brown or Hoffmann mentioned 
above, this asymmetric induction cannot be explained simply by steric interactions since the R group 
in the aldehyde is far too remote to interact with the tartrate ester. It has thus been proposed that the 
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stereoelectronic interaction may play an important role (Figure 2.2).8 Of the two possible chair 
transition states of the reaction, transition state A is favoured over transition state B, in which an n-n 
electronic repulsive interaction involving the aldehydic oxygen atom and the β-face ester group is the 
cause of destabilization.  





















Figure 2.2 Transition states for allylboration of aldehydes using tartrate modified allylboranes. 
In 1989, Corey developed another effective chiral boron reagent for aldehyde allylation using 
1,2-diamino-1,2-diphenylethane as the controller group (Scheme 2.6). Allylborane 2.5 exhibited 







X = H (2.5)
      Br (2.6)







R = Ph, (E)-PhCH=CH-, n-C5H11, c-C6H11  
Scheme 2.6 
In addition to unsubstituted borane 2.5, two special 2-haloallyl reagents 2.6 and 2.7 were also 
successfully prepared. Allylations of aldehydes using 2.6 and 2.7 also showed high stereoselectivity 
(79-99% ee). The synthetic utility of their allylboration products has been demonstrated through a 
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number of transformations (Scheme 2.7). The outstanding enantioselectivity and the versatility of the 


























As asymmetric allylboration of aldehydes became more and more popular, several other 
allylboron reagents have been synthesized and used for allylation of aldehydes in the past two 
decades. Some of them exhibited excellent stereoselectivities and were also utilized in natural product 




































Figure 2.3 Common chiral allylboranes for the allylation of aldehydes (All = allyl). 
It is generally accepted that the addition of an allylboronate onto an aldehyde occurs via 
six-membered ring transition states (Type I) where the aldehyde is activated by the internal boron 
atom (Scheme 2.8).1 Accordingly, it was believed that the addition of an external Lewis acid would 
not help to accelerate the reaction, and that the use of Lewis acids might change the closed 
six-membered ring transition state to an open chain transition state (Type II) and possibly change the 
reaction’s stereoselectivity. Therefore, there has been a perception that the allylboration of aldehydes 
is not suited to Lewis acid catalysis. In other words, it was believed that induction of asymmetric 
allylborations would always require a stoichiometric amount of “chiral source”. This has been the 
major drawback of allylboration over other methodologies such as allylsilations and allylstannations 













Type II  
Scheme 2.8 
However this perception was challenged in 2002 by Hall who discovered that under the 
catalysis of some metal salts, tetrasubstituted allylboronates 2.8 add to aldehydes at temperatures 
almost 100 oC lower than the corresponding uncatalyzed reactions (Scheme 2.9).15 It was proposed 
that the catalyzed reaction proceeds through a closed transition state similar to that of the uncatalyzed 
reaction. Since the allylboronates and metal salts he used were all racemic, there were no 
enantioselectivities involved in this allylboration reaction. However, his discovery raised the hope 
that one might be able to utilize only catalytic amounts of chiral Lewis acids to induce an asymmetric 
















M = Sc, Cu, Yb
R1, R2 =  Me, Et


















Later on, Hall also developed a practical aldehyde allylboration methodology based on the 
Sc(OTf)3-catalyzed reaction of camphor-based allylboronates (Scheme 2.10).16 Chiral allylboronate 
2.9 (R1, R2, R3 = H) reacted with both aliphatic and aromatic aldehydes to give excellent yields and 
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enantioselectivities (up to 98% ee). Crotylboration (R1 or R2 = Me) also gave comparably high levels 
of enantioselectivities (94-97% ee) and very high diastereoselectivities (>98% de). Unlike other chiral 
allylboron reagents, allylboronates 2.9 are “bench-stable” compounds which can be purified by 















R1, R2, R3 = H or Me






Almost at the same time as Hall found the Lewis acid catalyzed allylboration reactions, 
Ishiyama also realized that Lewis acids such as AlCl3 and Sc(OTf)3 can catalyze the addition of 
achiral allylboronates 2.10 to aldehydes.17 More importantly, enantioselective crotylborations 
catalyzed by (S)-binaphthol-modified Lewis acids were attempted and yielded the desired adducts in 
up to 51% ee. Although the stereoselectivities are not very high, this methodology is nevertheless the 
first asymmetric allylboration/crotylboration of aldehyde using only a catalytic amount of chiral 





R2 cat. (10 mol%)
PhMe/ -78 oC Ph
OH
R2 R32.10  
catalyst E-Crotylboration 
AlCl3/(S)-BINOL 92% yield, 39% ee, 98% de 
Et2AlCl/(S)-BINOL 92% yield, 39% ee, 98% de 
Sc(OTf)3/(S)-BINOL Trace 
 Z-Crotylboration 





Recently, our group discovered that 3,3′-disubstituted binaphthol-modified alkynylboronates 
2.11 could deliver alkynyl groups onto enones in a conjugate fashion with excellent yields (up to 99%) 
and enantioselectivities (up to >99% ee).18 The stereochemical result may be explained using a closed 














up to >99% ee
X = Ar, CF3, Halo...




Similar to the six-membered chair transition state for the allylboration of aldehyde (A), the 
six-membered chair transition state for the alkynylboration (B) also possesses one boron, one oxygen, 
four consecutive carbons and two double bonds (Figure 2.4). Since 3,3′-disubstituted binaphthols are 
able to take good control of the enantioselectivities in the alkynylboration reactions, we thought that 
they may also have potential for inducing good stereoselectivity in the allylboration of carbonyls. 



















2.3 Results and Discussions 
2.3.1 Preparation of 3,3′-Disubstituted Binaphthols 
(±)-BINOL (rac-2.12) was prepared via the oxidative coupling of 2-naphthol in aqueous 
Fe2(SO4)3 solution.22 A resolution of rac-2.12 using (8S, 9R)-(-)-N-benzylcinchonidinium chloride 













3,3′-Disubstituted BINOLs were then easily prepared from the MOM derivative of 2.12. Thus, 
protection of the two hydroxy groups of 2.12 using MOMCl and NaH gave 2.13 in quantitative yield. 
Ortho-lithiation of 2.13 using n-butyllithium followed by trapping the anion with the appropriate 













(R)-2.14 (E+ = BrCCl2CCl2Br, E = Br)
(R)-2.15 (E+ = I2, E = I)
(R)-2.16 (E+ = MeI, E = Me)
(R)-2.17 (E+ = TMSCl, E = TMS)  
Scheme 2.14 
 25
Dibromide 2.14 or diiodide 2.15 underwent Suzuki cross-coupling with various arylboronic 











2.18 (Ar = Ph)
2.19 (Ar = 4-CH3OC6H4)
2.20 (Ar = 3,5-(CH3)2C6H3)
2.21 (Ar = 3,5-(t-Bu)2C6H3)
2.22 (Ar = 3,5-(CF3)2C6H3)
2.23 (Ar = 2-naphthyl)
2.14 (X = Br)
or 
2.15 (X = I)
 
Scheme 2.15 
A trifluoromethyl derivative (2.25) was obtained in excellent yield through a Cu mediated 
cross-coupling reaction between diiodide 2.15 and methyl fluorosulfonyldifluoroacetate (2.24).26  
The reaction is believed to involve a [CuCF3] intermediate. Coincidently, a similar preparation of 
2.25 using CBr2F2/Cd/CuI was reported by Kobayashi after we developed this methodology. In 
comparison to Kobayashi’s method, this heavy metal free method is more practical in terms of both 


















The installation of neopentyl groups on the 3 and 3′ positions of BINOL was accomplished via 















Finally, the MOM derivatives were deprotected under mildly acidic conditions to afford the 
desired 3,3′-disubstituted BINOL (2.27~2.37) in nearly quantitative yields except for disilyl 











2.27 (X = Br) 
2.28 (X = I) 
2.29 (X = Me) 
2.30 (X = neopentyl) 
2.31 (X = CF3)
2.32 (X = Ph) 
2.33 (X = 4-CH3OC6H4) 
2.34 (X = 3,5-(CH3)2C6H3) 
2.35 (X = 3,5-(t-Bu)2C6H3) 
2.36 (X = 3,5-(CF3)2C6H3) 
2.37 (X = 2-naphthyl)  
Scheme 2.18 
In order to obtain 3,3′-disilyl BINOL, Yamamoto’s procedure was followed.27 Protection of the 
hydroxyl groups on dibromo BINOL 2.27 followed by an intramolecular 1,3-silyl rearrangement 

















2.38a: SiR3 = TMS
2.38b: SiR3 = TBDMS
2.39 (SiR3 = TMS)
2.40 (SiR3 = TBDMS)  
Scheme 2.19 
In 1989, Poirier and coworkers developed a mild method for the nitration of phenols using 
Fe(NO3)3.28 Following his procedure, treatment of 3,3′-(CF3)2-BINOL 2.31 with Fe(NO3)3 in hot 
chloroform led to the selective nitration of the molecule on the 6 and 6′ positions. This turned out to 


















2.3.2 Allylboration of Aldehydes using 3,3′-Disubstituted Binaphthyl-modified 
Allylboronates 
2.3.2.1 Optimization of Reaction Conditions 
With a variety of 3,3′-disubstituted BINOLs in hand, the preparation of binaphthol-modified 
allylboronates was pursued. It has been reported by several groups that treatment of triallylborane 
with bidentate ligands such as diols or some acidic diamines has led to the formation of allylboronates 
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in good yields.2,29 Therefore triallylborane was reacted with stoichiometric amounts of 
3,3′-disubstituted BINOLs in THF to afford 3,3′-disubstituted binaphthol-modified allylboronates. 
Allylboronates are very sensitive to moisture and were therefore used without further purification or 
characterization. In addition, since triallylborane is a pyrophoric liquid, it was prepared and stored 
















The allylboration of benzaldehyde using binaphthol-modified allylboronate (R)-2.42a (X = H) 
was first attempted. As expected, the reaction occurred readily at -78 oC to give the desired 
(R)-homoallylic alcohol. However the reaction gave highly variable yields and enantioselectivities 






toluene, -78 oC, 3 h
(R)-2.44a
50~86% yield
14~42% ee  
Scheme 2.22 
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This problem could be explained by proposing that allylboronate 2.42a can undergo 
disproportionation to give a thermodynamically stable compound 2.43, the formation of which has 
been documented by others (Scheme 2.23).31 Another byproduct of this process would be 


















In order to avoid this problem, all one needs to do is introduce substituents on the 3 and 3′ 
positions of the parent BINOL. The steric hindrance provided by those substituents appears to make 
the formation of the trimer 2.43 highly disfavoured. Therefore, another modified allylboronate 2.42b 
(X = CF3) was tested. In addition, the strongly electron-withdrawing CF3 groups on the BINOL rings 
should also make the allylboronate more electrophilic and hence more reactive toward carbonyl 
compounds. The allylboration of benzaldehyde using 2.42b was carried out in several solvents at low 
temperature. In all solvents tested, the allylation was complete in less than 5 minutes (indicated by 
TLC of the reaction mixture). The best result was obtained in THF at -78 oC with 90% yield and 95% 
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ee. Other solvents (toluene, methylene chloride, acetonitrile, diethyl ether, DME) gave respectable but 














Similar to other asymmetric allylborations, this allylboration chemistry also requires a 
stoichiometric amount of chiral ligand 3,3′-(CF3)2-BINOL (2.31). However, the 3,3′-(CF3)2-BINOL 
(2.31) is easily recovered from the reaction mixture with no detectable racemization by simple 
extraction with aqueous base (1 M NaOH). Actually, 2.31 seems to be extremely resistant to 
racemization even under strongly acidic (10% HCl, H2O/THF, reflux, 24 hours) or basic (0.1 M KOH, 
n-BuOH, 60 oC, 48 hours) conditions which cause complete racemization of the parent BINOL. 
Given the fact that THF provides the best result for the allylboration of benzaldehyde using 
boronate 2.42b, allylations of benzaldehyde with other boronates were examined in THF. The results 
were summarized in Table 2.2.  
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entry X yield (%) ee (%)a 
1 H (2.42a) 50 42 
2 CF3 (2.42b) 90 95 
3 Me (2.42c) 91 75 
4 neopentyl (2.42d) >95b 69 
5 I (2.42e) 91 74 
6 Ph (2.42f) 90 45 
7 4-CH3OC6H4 (2.42g) 89 62 
8 3,5-(CH3)2C6H3 (2.42h) 94 60 
9 3,5-(t-Bu)2C6H3 (2.42i) 92 66 
10 3,5-(CF3)2C6H3 (2.42j) 92 70 
11 2-naphthyl (2.42k) 90 50 
12 TMS (2.42l) >95 b 12 
13 TBDMS (2.42m) >95 b 0.3 
a Enantiomeric excesses were determined by chiral HPLC analysis on a 
Chiralcel OD column. The absolute configuration of the product was determined 
by the comparison of rotation value with reported value.32 b Conversion 
determined by 1H NMR. 
In all cases, allylboronates (R)-2.42 gave homoallylic alcohol 2.44a with R configuration. Upon 
comparison of the parent compound 2.42a (X = H, Table 2.2, entry 1), 2.42c (X = Me, Table 2.2, 
 32
entry 3) or 2.42d (X = neopentyl, Table 2.2, entry 4) gave much better enantioselectivities (Table 2.2, 
entries 3 and 4). It means that the size of 3 and 3′ substituents does have some effect on the 
enantioselectivity of this reaction. On the other hand, although a CF3 group is only slightly larger than 
a methyl group (based upon the A values of those two groups), CF3-reagent 2.42b (Table 2.2, entry 2) 
gave much better enantioselectivity than did CH3-reagent 2.42c (Table 2.2, entry 3). Also, 2.42e (X = 
I, Table 2.2, entry 5) and 2.42c (X = Me, Table 2.2, entry 3) gave comparable stereoselectivities (74% 
ee vs. 75% ee), even though an iodo group is much smaller than a methyl group (based on A values). 
This indicates that steric bulkiness of the 3 and 3′ substituents is not the only factor that affects the 
enantioselectivity in this reaction. Electronic effects must also play an important role; however this is 
not fully understood.  
Various 3,3′-diaryl BINOLs were also examined (Table 2.2, entries 6-11) because those ligands 
induced the best stereoselectivities in the alkynylations of enones. However, for the allylation of 
benzaldehyde, 3,3′-diaryl BINOLs  only gave enantiomeric excesses from 45% to 70% depending 
on the structures of the aryl groups. Increasing the size of the aryl groups resulted in a slight increase 
of selectivities. Again, 2.42j bearing four electron-withdrawing CF3 groups gave the best result (70% 
ee, Table 2.2, entry 10). 
The disilyl-BINOLs were also used for allylborations. It was thought that the bulkiness of silyl 
groups could have more of an impact on the transition state of the reaction and increase the 
stereoselectivity. However, for TMS-BINOL, only 12% ee was observed (Table 2.2, entry 12). On 
replacement of the TMS substituents with larger TBDMS groups, the enantioselectivity dropped to 
0.3% ee (Table 2.2, entry 13).  These results show that increasing the size of the 3 and 3′ substituents 
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does not always result in better stereoselectivity. Also the electron-donating nature of the silyl groups 
might be another reason for the low ee’s. 
In an effort to determine whether the electron-withdrawing nature of the substituents in 2.42b 
was the most important factor, nitro-substituted BINOL derivative 2.42n was applied to the 
allylboration of benzaldehyde. Provided that electron-withdrawing groups on the BINOL ring are 
good for enantioselectivities, allylboronate 2.42n which bears four electron-withdrawing groups was 
expected to give improved results. Surprisingly, the allylboration of benzaldehyde using 2.42n gave 
0% ee, the reason for which is not clear. One possible explanation is that the reaction might proceed 
through other types of mechanisms, such as an open chain transition state or a radical process, 
although no work has been done to elucidate the reasons for the formation of racemic product with 

















In summary, among all the 3,3′-disubstituted binaphthol-modified allylboronates tested, 2.42b 
(X = CF3) showed the best enantioselectivity. The capacity of 2.42b for inducing high 
enantioselectivity in the allylboration of benzaldehyde seems to be the result of a delicate 
combination of steric and electronic effects. 
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2.3.2.2 Allylboration of Aldehydes using 3,3′-(CF3)2-Binaphthol-modified Allylboronates 
(2.42b) 
In order to examine the scope and limitations of the allylboration reaction, several other 
aldehydes were subjected to the allylation with 2.42b (Table 2.3). In all cases, the reactions proceeded 
smoothly at -78 oC to give products in high yields. High enantioselectivities were obtained for all the 
aromatic aldehydes, regardless of substitution. In cases involving non-aromatic aldehydes (Table 2.3, 
entries 6 and 7), high yields but slightly lower selectivities were observed. Similar observations were 
reported by our group in the alkynylation of enones using 3,3′-disubstituted BINOL modified 
boronates where only enones bearing β-aryl groups gave high enantioselectivities.18  













entry R yield (%) ee (%)a 
1 Ph (2.45a) 90 95 
2 4-CH3OC6H4(2.45b) 93 94 
3 4-ClC6H4(2.45c) 93 94 
4 4-O2NC6H4(2.45d) 96 92 
5 4-CF3C6H4(2.45e) 94 94 
6 PhCH=CH(2.45f) 98 75 
7 c-C6H11(2.45g) 90 75 
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a Enantiomeric excesses were determined by chiral HPLC analysis on a 
Chiralcel OD column. The absolute configuration of the products was 
determined by the comparison of rotation values with reported values 
(see experimental section). 
2.3.2.3 Working Model for the Allylboration of Aldehydes  
Based on the observation that (R)-boronates 2.42 afforded (R)-homoallylic alcohols 2.44a, a 
six-membered chair transition state model similar to that of other allylborations was proposed to 
explain the sense of asymmetric induction. For the allylation of aromatic aldehydes, the aryl group on 
the aldehyde is forced into the equatorial position in order to prevent a repulsive n-π electron 







Figure 2.5 n-π Interaction between the lone pair on oxygen and the aromatic ring on the aldehyde. 
The 3 and 3′ substituents on the BINOL play an important role in destabilizing one of the two 
possible transition states (Scheme 2.26). In transition state A, there seems to be a strong interaction 
between a CF3 group and the aldehydic H. In addition, the other CF3 group has an interaction with 
one of the methylene proton on the allyl group. The accumulation of the two interactions appears to 




























In the cases of non-aromatic aldehydes, in comparison to aromatic aldehydes, the chance for the 
alkyl (or alkenyl) group occupying an axial position is slightly higher due to the lack of the n-π 
electron interaction with the boronate oxygen. This results in lower enantioselectivities although 
transition state B is still favoured. 
2.3.3 Allylboration of Ketones using 3,3′-(CF3)2-Binaphthol-modified Allylboronate 
(2.42b) 
According to the proposed model for the allylation of aldehydes discussed above, the 
interaction of one of the CF3 group with aldehydic proton contributes to the high enantioselectivities 
observed. It prompted us to expect that replacement of the aldehydic proton with a larger group would 
result in a stronger destabilization of transition state A (Scheme 2.26) and accordingly better 
enantioselectivity. In other words, the allylboration of ketones using 2.42b would be expected to also 
give high enantioselectivities based on the proposed model. In terms of the reactivity of the 
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allylboration of ketones, it is clear that the carbonyl group in a ketone is more hindered than the one 
in an aldehyde and the alkyl group on a ketone is more electron-donating than a proton to make the 
ketone carbonyl group less electrophilic. Accordingly, we expected that the allylboration of ketones 
would be more difficult than the allylboration of aldehydes. 
To our delight, allylboronate 2.42b did in fact react with ketones, albeit much more slowly than 
with aldehydes. As was mentioned above, 2.42b usually gave complete reactions with aldehydes in 
THF within 5 minutes at -78 oC. However, acetophenone was only partially consumed giving the 
corresponding adduct in 60% yield even after 6 hours at -78 oC (Table 2.4, entry 1). Despite the low 
yield, the enantioselectivity of the reaction was excellent (96% ee) as expected. Allowing the reaction 
to warm up to -40 oC gave a complete reaction. The ee of the product dropped slightly to 92% but was 
still acceptable (Table 2.4, entry 2). 
Other alkyl aryl ketones were examined under the same conditions. The desired adducts were 
obtained in excellent yields and enantioselectivities (Table 2.4, entries 3-5). It is worthwhile to point 
out that in the allylation of α-bromoacetophenone (Table 2.4, entry 3), an epoxide 2.47 could be 
obtained from the allylation product 2.46b in one pot by simply basifying the reaction mixture during 
workup (Table 2.4, Scheme 2.27). The resulting epoxide 2.47 is a potentially useful compound since 











2.46b 2.47  
Scheme 2.27 
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entry R R′ compd no. yield (%)c ee (%)d 
1 Ph CH3 2.46a 60b 96 
2 Ph CH3 2.46a 88 92 
3 Ph CH2Br 2.46b 87e 94 
4 4-CH3OC6H4 CH3 2.46c 95 98 
5 4-ClC6H4 CH3 2.46d 94 >99f 
6 PhCH=CH CH3 2.46e 91 75 
7 t-Bu CH3 2.46f 75 90g 
8 PhCH2CH2 CH3 2.46g 98 50 
9 HC≡C CH3 2.46h 71 10g 
a Reactions were run in toluene at -78 to -40 oC, 48 h. b The reaction was performed at 
-78 oC for 6 h. c Isolated yields of chromatographed products. d Determined by HPLC 
analysis with a Chiralcel OD column. e Isolated yield of 1-phenyl-1- (2-propenyl)oxirane 
2.47 after workup with 1 M NaOH. f The minor enantiomer was not detected by HPLC 
analysis. g Determined by the 1H NMR analysis in the presence of Eu(hfc)3. 
Similar to aldehyde allylations, allylboration of a non-aromatic α,β-unsaturated ketone, 
benzalacetone, gave lower but still respectable enantioselectivity (Table 2.4, entry 6). Allylboration of 
a dialkyl ketone, pinacolone, also gave decent enantioselectivity (90% ee, Table 2.4, entry 7). 
However, low enantioselectivity was observed for the allylation of a ketone bearing two sterically 
similar alkyl groups (Table 2.4, entry 8). Even lower enantioselectivity (10% ee) was obtained in the 
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allylation of an alkynyl methyl ketone (Table 2.4, entry 9) and the absolute configuration of the 
allylation product 2.46h was not determined. 
Asymmetric allylboration of ketones in general has been a very difficult reaction. To our 
knowledge, there had been only one example for the allylboration of acetophenone using Brown’s 
Ipc2BCH2CH=CH2 to gave adduct 2.46a in only 5% ee.32 The high enantioselectivities obtained with 
2.42b are also comparable with other methods for the asymmetric allylation of ketones (such as 
allylstannations and allylsilations).1,34-36 In fact, 2.42b is one of the best enantioselective allylation 
reagents for alkyl aryl ketones thus far developed. 
During the course of this work, Shibasaki reported the first catalytic asymmetric allylboration 
of ketones with allylB(pin) catalyzed by CuF2/i-Pr-DuPHOS/La(Oi-Pr)3. However, this allylboration 
chemistry seems to work only for ketones (no corresponding aldehyde allylation was reported) and 







(R, R)-i-Pr-DuPHOS (6 mol%)
La(Oi-Pr)3 (4.5 mol%)









(R, R)-i-Pr-DuPHOS  
Scheme 2.28 
Also, very recently, Soderquist reported another aldehyde/ketone allylboration using chiral 
boranes derived from 9-BBN. R-(-)-2.48a exhibited high enantioselectivities in the allylboration of 
aldehydes while R-(-)-2.48b worked well specifically for ketone allylations. It is particularly 
noteworthy that R-(-)-2.48b induced high levels of enantioselectivity even in some very demanding 
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R = Ar, Me, Et, vinyl ...
R = Ar, Me, Et, vinyl ...
R' = Me, Et  
Scheme 2.29 
The new concept of a “chiral pocket” was proposed to explain the sense of enantioselectivities 
in this allylation. The allyl group and the 10-substituent clearly define a chiral pocket which controls 
the facial discrimination during the allylation (Figure 2.6). The size of the pocket could be adjusted 












Figure 2.6 “Chiral pocket” model.  
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2.4 Summary and Future Work 
In summary, we have shown that 3,3′-disubstituted-BINOL modified allylboronates can be used 
to allylate carbonyl compounds. The easily prepared 3,3′-(CF3)2-BINOL (2.31) (4 steps from BINOL) 
was the best ligand among all the ligands tested. It is highly effective in inducing the asymmetric 
allylboration of both aldehydes and ketones in high enantioselectivities (Scheme 2.30). Also it is 
readily recycled and reused without loss of enantiomeric purity. Some part of this work has been 
published in Organic Letters (Wu, T. R.; Shen, L.; Chong, J. M. Org. Lett. 2004, 6, 2701-2704).40 
Considering all the merits mentioned above, we anticipate that other applications of ligand 2.31 as 













 up to 95% ee for aldehydes
 up to >99% ee for ketones  
Scheme 2.30 
Since 3,3′-(CF3)2-binaphthol-modified allylboronate 2.42b induces excellent 
enantioselectivities in the allylboration of carbonyls, crotylboration of carbonyls using crotylboronate 
2.49 (Z or E) which proceeds through the same closed six-membered transition state as that of the 
allylboration might give the same level of enantioselectivity as well as good diastereoselectivity 



























However, some possible problems need to be taken into consideration. Brown and coworkers 
have reported that a diastereomerically pure (Z) or (E)-B-crotyl borane 2.50 isomerizes quickly to the 
other diastereomer via a simple borotropic rearrangement (Scheme 2.32). The rate of the 
isomerization of B-crotyl boranes varies greatly with the nature of other groups on boron: 









(E)-2.50 (Z)-2.50  
Scheme 2.32 
According to this study, it is impossible to prepare diastereomerically pure chiral crotylboronate 



























Diastereomerically pure 3,3′-(CF3)2-binaphthol-modified crotylboronate 2.49 may be 
synthesized using Roush’s route8 or a method similar to the preparation of binaphthol-modified 



























A potential application of the asymmetric allylboration of ketones would be the total synthesis 
of antifungal agents Sch56592 and Sch51048 which have shown promising activities against a variety 















Sch 56592, X = OH
Sch 51048, X = H
 
Figure 2.7 Structures of antifungal agents Sch56592 and Sch51048. 
Sch56592 and Sch51048 might be synthesized from a common intermediate 2.51. The chiral 
tetrahydrofuran core of 2.51 could be obtained through an intramolecular epoxide ring opening 

























2.51 2.52  
Scheme 2.35 
The epoxide 2.52 might be prepared using a known strategy44 from a homoallylic alcohol 2.53 































2.5.1 General Experimental 
IR spectra were recorded on a Bomem MB-100 infrared spectrophotometer. 1H (250 and 300 
MHz), 13C (63 and 75 MHz), and 19F (188 and 282 MHz) NMR spectra were recorded on Bruker 
AM250 or AVANCE 300 spectrometers unless otherwise noted. Chemical shifts are given in parts 
per million (ppm) downfield from tetramethylsilane (TMS). The 1H NMR samples were run in 
deuteriochloroform containing ca. 0.01% TMS as an internal standard (δ = 0.0). The spectral 
reference for 13C NMR spectra was CDCl3 (δ = 77.0). The spectral reference for 19F NMR spectra was 
CF3COOH (δ = 76.53 upfield of CFCl3). Elemental analyses were conducted by M-H-W 
Laboratories, Phoenix, Arizona. Mass spectra were recorded on a GC-MS (Hewlett Packard G 1800A 
GCD System) or a Kratos MA890 mass spectrometer using electron impact (EI, 70 eV) ionization if 
the mass was over 430. Optical rotations were recorded in cells with 10 cm path length on a 
Perkin-Elmer 241 digital polarimeter. 
All reactions involving air or moisture sensitive reagents were performed under an argon or 
nitrogen atmosphere on the bench using standard Schlenk techniques. Solvents were dried prior to 
use. Tetrahydrofuran (THF) and diethyl ether (Et2O) were dried by distillation from 
sodium/benzophenone. Dichloromethane (CH2Cl2), DMF, HMPA and n-pentane were dried by 
distillation from calcium hydride. Chloromethyl methyl ether was prepared according to the 
literature.45 BrCl2CCCl2Br was prepared in 85% yield from the reaction of tetrachloroethene and 
bromine in dichloromethane under reflux condition for 3 days, followed by the removal of organic 
solvent.25 Triallylborane was prepared as reported by Brown and was distilled prior to use.30 BINOL 
 46
(2.12) was prepared following a literature procedure22 and was resolved using the Merck method.24,46 
Methyl fluorosulfonyldifluoroacetate was purchased from SynQuest Laboratories, Alachua, FL and 
used without further purification. Unless otherwise noted, other chemicals were purchased from 
Aldrich Chemical Company. 




The preparation followed literature procedures47 with some modifications. NaH (2.92 g, 60% in 
oil, 73.0 mmol) was mixed in dry THF (150 mL) in a 500 mL round bottom flask at 0 oC under an 
argon atmosphere. To the mixture with stirring, was added a solution of (±)-2,2′-dihydroxy- 
1,1′-binaphthyl (2.12) (9.50 g, 33.2 mmol) in THF (50 mL) in a dropping funnel. After the addition, 
the mixture was stirred at 0 oC for 1 hour, then allowed to warm up to room temperature for 15 
minutes. After the mixture was re-cooled to 0 oC, chloromethyl methyl ether (5.54 mL, 73.0 mmol) 
was slowly added from the dropping funnel. After the addition, the reaction mixture was warmed to 
room temperature and stirred for 4.5 hours. Saturated aqueous NH4Cl (50 mL) was added to the flask, 
and then the solvent was removed in vacuo. The residue was extracted with CH2Cl2 (50 mL x 3). The 
organic layers were combined, washed with brine (50 mL), dried over Na2SO4, and concentrated. The 
crude product was purified by column chromatography (EtOAc/hexanes: 1/10) and crystallized from 
CH2Cl2/hexanes to give a white crystalline product (±)-2.13 in quantitative yield. mp 89-92 oC (lit.5 
mp 88-91 oC); IR (KBr): υ(max) 1236, 1144, 1028 cm-1; 1H NMR (CDCl3): δ 7.88-8.14 (HAr, 2H, m), 
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7.76-7.84 (HAr, 2H, m), 7.10-7.62 (HAr, 8H, m), 4.97 (OCH2O, 2H, d, J = 8.5 Hz), 5.08 (OCH2O, 2H, 
d, J = 8.5 Hz), 3.10 (OCH3, 6H, s); 13C NMR (CDCl3): δ 152.6 (CAr), 130.0 (CAr), 129.9 (CAr), 129.3 
(CAr), 127.8 (CAr), 126.3 (CAr), 125.5 (CAr), 124.0 (CAr), 121.3 (CAr), 117.3 (CAr), 95.2 (OCH2O), 55.7 
(OCH3); MS m/e (relative intensity): 374 (M+, 100), 298 (90), 270 (71), 239 (23); Anal. Calcd for 
C24H22O4: C, 76.99; H, 5.92. Found: C, 77.02; H, 5.94. (R)-2,2′-Dihydroxy-1,1′-binaphthyl was used 
to afford (R)-2.13 in quantitative yield. mp 98-100 oC. The sample showed [α]D25 +95.0 (c = 1.0, 
THF). 
2.5.3 General Procedure A: Preparation of 
3,3′-Disubstituted-2,2′-bis(methoxymethoxy) -1,1′-binaphthyls 2.14-2.17 
The preparation of 3,3′-disubstituted binaphthyl compounds followed literature procedures47 
with some modifications. (±)- or (R)-2,2′-Bis(methoxymethoxy)-1,1′-binaphthyl (2.13) (1.0 equiv.) 
was dissolved in dry Et2O (17 mL/1 mmol of 2.13) in a round bottom flask under an argon 
atmosphere. To the mixture with stirring, was added n-BuLi (3.0 equiv.) at room temperature by 
syringe injection. After the reaction mixture was stirred for 3 hours, THF (11 mL/1 mmol of 2.13) 
was injected into the flask and then the mixture was stirred for 1 hour. After the flask was cooled in 
an ice water bath for 5 minutes, the appropriate electrophile (3.0 equiv.) was added quickly in one 
portion. The reaction mixture was stirred for 15 minutes, quenched with saturated aqueous NH4Cl and 
diluted with water. The two phases were separated. The aqueous layer was extracted with Et2O twice. 
All organic solutions were combined, washed with brine, dried over Na2SO4 and concentrated. 
Subsequent work-up gave the product. 
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(±)-2,2′-Bis(methoxymethoxy)-1,1′-binaphthyl (2.13) (8.80 g, 23.5 mmol) was treated with 
n-BuLi (44.10 mL of a 1.6 M solution in hexane, 70.5 mmol) at room temperature and the resulting 
mixture was quenched with dibromotetrachloroethane (23.0 g, 70.5 mmol). The crude product was 
purified by column chromatography (EtOAc/hexanes: 1/10) and crystallized from Et2O/hexanes to 
give a white crystalline product (±)-2.14 (10.60 g) in 85% yield. mp 125-126 oC (lit.47 mp 124-126 
oC); IR (KBr): υ(max) 1235, 1157, 1026 cm-1; 1H NMR (CDCl3): δ 8.25-8.30 (HAr, 2H, m), 7.78-7.82 
(HAr, 2H, m), 7.18-7.48 (HAr, 6H, m), 4.81 (OCH2O, 2H, d, J = 6.0 Hz), 4.82 (OCH2O, 2H, d, J = 6.0 
Hz), 2.56 (OCH3, 6H, s); Anal. Calcd for C24H20Br2O4: C, 54.16; H, 3.79. Found: C, 54.10; H, 3.87. 
(R)-2,2′-Bis(methoxymethoxy)-1,1′- binaphthyl was used to afford (R)-2.14 in 84% yield. mp 
123-124 oC. The sample showed [α]D25 +28.3 (c = 1.0, THF). 
 





(±)-2,2′-Bis(methoxymethoxy)-1,1′-binaphthyl (2.13) (6.50 g, 17.3 mmol) was treated with 
n-BuLi (33.0 mL of a 1.6 M solution in hexane, 52.8 mmol) at room temperature and the resulting 
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mixture was quenched with iodine (13.2 g, 52.0 mmol). The crude product was purified by column 
chromatography (EtOAc/hexanes: 1/10) and crystallized from CH2Cl2/hexanes to give a white 
crystalline product (2.15) (9.60 g) in 88% yield. mp 45-47 oC.; IR (KBr): υ (max) 1232, 1156, 1026 
cm-1; 1H NMR (CDCl3): δ 8.50-8.62 (HAr, 2H, m), 7.70-7.85 (HAr, 2H, m), 7.10-7.54 (HAr, 6H, m), 
4.81 (OCH2O, 2H, d, J = 5.7 Hz), 4.69 (OCH2O, 2H, d, J = 5.7 Hz), 2.59 (OCH3, 6H, s); MS m/e 
(relative intensity): 626 (M+, 35), 550 (20), 549 (100), 422 (60), 268 (45), 239 (46), 237 (28), 226 
(37), 224 (45); Anal. Calcd for C24H20I2O4: C, 46.03; H, 3.22. Found: C, 46.05; H, 3.20. The R 
enantiomer showed [α]D25 -5.3 (c = 1.0, THF). 





(R)-2,2′-Bis(methoxymethoxy)-1,1′-binaphthyl [(R)-2.13] (2.0 g, 5.34 mmol) was treated with 
n-BuLi (10.0 mL of a 1.6 M solution in hexane, 16.0 mmol) at room temperature and the resulting 
mixture was quenched with iodomethane (1.0 mL, 16.0 mmol). The crude product was purified by 
column chromatography (EtOAc/hexanes: 1/10) and crystallized from CH2Cl2/hexanes to give a white 
crystalline product (R)-2.16 (2.1 g) in 96% yield. mp 91-92 oC (lit.47 (S)-2.16 mp 90.5-91.5 oC); IR 
(KBr): υ (max) 1238, 1155, 1035 cm-1; 1H NMR (CDCl3): δ 7.72-7.80 (HAr, 4H, m), 7.26-7.38 (HAr, 
2H, m), 7.14-7.20 (HAr, 4H, m), 4.46 (OCH2O, 2H, d, J = 5.8 Hz), 4.58 (OCH2O, 2H, d, J = 5.8 Hz), 
2.83 (OCH3, 6H, s), 2.57 (ArCH3, 6H, s); 13C NMR (CDCl3): δ 153.1 (CAr), 133.0 (CAr), 131.6 (CAr), 
131.0 (CAr), 129.6 (CAr), 127.1 (CAr), 126.1 (CAr), 125.5 (CAr), 125.4 (CAr), 124.7 (CAr), 98.5 
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(OCH2O), 56.4 (OCH3), 17.8 (ArCH3); MS m/e (relative intensity): 402 (M+, 30), 327 (29), 326 (100), 
309 (26), 298 (36), 297 (50), 296 (45), 283 (29), 252 (20), 239 (30), 119 (27), 111 (25); Anal. Calcd 
for C26H26O4: C, 77.59; H, 6.51. Found: C, 77.55; H, 6.47. The sample showed [α]D25 -86.6 (c = 1.0, 
THF). 





(R)-2,2′-Bis(methoxymethoxy)-1,1′-binaphthyl [(R)-2.13] (2.07 g, 5.53 mmol) was treated with 
n-BuLi (10.5 mL of a 1.6 M solution in hexane, 16.6 mmol) at room temperature and the resulting 
mixture was quenched with chlorotrimethylsilane (1.8 g, 16.6 mmol). The crude product was purified 
by column chromatography (EtOAc/hexanes: 1/20) and crystallized from CH2Cl2/hexanes to give an 
off-white foamy product (R)-2.17 (2.80 g) in 98% yield. 1H NMR (CDCl3): δ 8.04 (HAr, 2H, s), 7.85 
(HAr, 2H, d, J = 8.1 Hz,), 7.36 (HAr, 2H, m), 7.18-7.26 (HAr, 4H, m), 4.43 (OCH2O, 2H, d, J = 4.4 Hz), 
4.08 (OCH2O, 2H, d, J = 4.4 Hz), 2.90 (OCH3, 6H, s), 0.40 (SiMe3, 18H, s). 
2.5.4 General Procedure B: Preparation of 3,3′-Diaryl-2,2′-bis(methoxymethoxy)- 
1,1′-binaphthyls 2.18-2.23 
The preparation of 3,3′-disubstituted binaphthyl compounds followed literature procedures47 
with some modifications. (R)-3,3′-Dibromo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.14) or 
(R)-3,3′-diiodo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.15) (1.0 equiv.) and Pd(PPh3)4 (10 
mol%) were mixed in THF or DME in a round bottom flask at room temperature under an argon 
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atmosphere. To the mixture, with stirring, were added arylboronic acid (2.5-3.5 equiv.) and 1-2 M 
aqueous degassed K2CO3 (or Na2CO3) solution. The resulting mixture was stirred and heated to reflux 
for 24-48 hours, cooled to room temperature, and passed through a pad of Celite. The organic solution 
was evaporated to give a residue. The residue was dissolved in CH2Cl2, washed with saturated 
aqueous NH4Cl, water, brine, dried over Na2SO4, and concentrated to give a crude product. 
Subsequent purification gave the product. 





Following General Procedure B, (R)-3,3′-diiodo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl 
(2.15) (4.70 g, 7.5 mmol) was treated with Pd(PPh3)4 (0.87 g, 0.75 mmol), phenylboronic acid (2.31 
g, 18.8 mmol) and 1 M aqueous K2CO3 solution (38 mL) in THF (75 mL). Purification was carried 
out by column chromatography (EtOAc/hexanes: 1/10) to give a foamy product (R)-2.18 (3.55 g) in 
90% yield. The product was directly used for the deprotection of MOM group with only 1H NMR and 
13C NMR being examined. 1H NMR (CDCl3): δ 7.65-8.05 (HAr, 8H, m), 7.22-7.55 (HAr, 12H, m), 4.40 
(OCH2O, 2H, d, J = 5.8 Hz), 4.37 (OCH2O, 2H, d, J = 5.8 Hz), 2.34 (OCH3, 6H, s); 13C NMR 
(CDCl3): δ 139.0 (CAr), 135.5 (CAr), 133.6 (CAr), 130.9 (CAr), 130.6 (CAr), 129.6 (CAr), 128.3 (CAr), 
127.9 (CAr), 127.3 (CAr), 126.5 (CAr), 126.4 (CAr), 126.3 (CAr), 125.2 (CAr), 98.5 (OCH2O), 55.8 
(OCH3).  
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Following General Procedure B, (±)-3,3′-diiodo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl 
(2.15) (3.13 g, 5 mmol) was treated with Pd(PPh3)4 (0.58 g, 0.5 mmol), 4-methoxyphenylboronic acid 
(1.90 g, 12.5 mmol) and 1 M aqueous K2CO3 solution (25 mL) in THF (50 mL). Purification was 
carried out by column chromatography (EtOAc/hexanes: 1/10) (2.19) (2.73 g) in 93% yield; IR 
(KBr): υ (max) 1608, 1513, 1247 cm-1; 1H NMR (CDCl3): δ 7.82-7.96 (HAr, 4H, m), 7.63-7.78 (HAr, 
4H, m), 7.18-7.47 (HAr, 6H, m), 6.90-7.08 (HAr, 4H, m), 4.42 (OCH2O, 2H, d, J = 5.7 Hz), 4.37 
(OCH2O, 2H, d, J = 5.7 Hz), 3.87 (OCH3, 6H, s), 2.35 (OCH3, 6H, s); 13C NMR (CDCl3): δ 159.0 
(CAr), 151.3 (CAr), 135.0 (CAr), 133.4 (CAr), 131.4 (CAr), 130.9 (CAr), 130.7 (CAr), 130.2 (CAr), 127.7 
(CAr), 126.6 (CAr), 126.4 (CAr), 126.1 (CAr), 125.1 (CAr), 113.8 (CAr), 98.3 (OCH2O), 55.9 (OCH3), 
55.3 (OCH3); Anal. Calcd for C38H34O6: C, 77.80; H, 5.84. Found: C, 77.68; H, 5.78. 
(R)-3,3′-Dibromo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl was used to afford (R)-2.19. mp 68-70 
oC. The sample showed [α]57825 -109.6 (c = 1.0, THF). 
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Following General Procedure B, (±)-3,3′-dibromo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl 
(2.20) (2.0 g, 3.76 mmol) was treated with Pd(PPh3)4 (0.43 g, 0.372 mmol), 
3,5-dimethylphenylboronic acid (2.0 g, 13.34 mmol) and 2 M aqueous Na2CO3 solution (10 mL) in 
DME (40 mL) in a 100 mL round bottom flask. Purification was carried out by column 
chromatography (CH2Cl2/hexanes: 1/1) and crystallization from CH2Cl2/hexanes to give colorless 
crystals (2.20) (2.25 g) in 93% yield. mp 84-85 oC; IR (KBr): υ (max) 1600, 1389, 1233, 1157 cm-1; 
1H NMR (CDCl3): δ 7.80-7.97 (HAr, 4H, m), 7.18-7.48 (HAr, 10H, m), 7.02-7.08 (HAr, 2H, m), 4.69 
(OCH2O, 2H, d, J = 5.8 Hz), 4.44 (OCH2O, 2H, d, J = 5.8 Hz), 2.40 (ArCH3, 12H, s), 2.36 (OCH3, 
6H, s); 13C NMR (CDCl3): δ 151.4 (CAr), 139.0 (CAr), 137.7 (CAr), 135.7 (CAr), 133.6 (CAr), 130.8 
(CAr), 130.5 (CAr), 128.9 (CAr), 127.7 (CAr), 127.4 (CAr), 126.4 (CAr), 126.1 (CAr), 125.0 (CAr), 98.5 
(OCH2O), 55.8 (OCH3), 21.4 (ArCH3); MS m/e (relative intensity): 582 (M+, 35), 518 (12), 507 (41), 
506 (100), 478 (28); Anal. Calcd for C40H38O4: C, 82.44; H, 6.57. Found: C, 82.55; H, 6.50. 
(R)-3,3′-Dibromo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl was used to afford (R)-2.20. mp 81-83 
oC. The sample showed [α]57825 -36.8 (c = 1.1, THF). 
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Following general procedure B, (R)-3,3'-dibromo-2,2'-bis(methoxymethoxy-1,1'-binaphthyl 
(2.14) (2.50 g, 4.70 mmol) was treated with Pd(PPh3)4 (0.54 g, 0.470 mmol), 
3,5-di(tert-butyl)phenylboronic acid (3.85 g, 16.40 mmol) and 2 M aqueous Na2CO3 solution (12.5 
mL) in DME (50 mL) in a 100 mL round bottom flask. Purification was carried out by column 
chromatography (CH2Cl2/hexanes: 1/1) and crystallization from CH2Cl2/hexanes to give colorless 
crystals (2.21) (3.5 g) in 99% yield. mp 97-99 oC; IR (KBr): υ (max) 1595, 1390, 1244, 1157 cm-1; 1H 
NMR (CDCl3): δ 7.84-8.02 (HAr, 4H, m), 7.54-7.64 (HAr, 4H, m), 7.20-7.50 (HAr, 8H, m), 4.42 
(OCH2O, 2H, d, J = 5.7 Hz), 4.40 (OCH2O, 2H, d, J = 5.7 Hz), 2.37 (OCH3, 6H, s), 1.39 (CMe3, 18H, 
s); 13C NMR (CDCl3): δ 151.6 (CAr), 150.6 (CAr), 138.2 (CAr), 136.4 (CAr), 133.5 (CAr), 130.8 (CAr), 
130.2 (CAr), 127.8 (CAr), 126.5 (CAr), 126.4 (CAr), 126.0 (CAr), 124.9 (CAr), 123.9 (CAr), 121.0 (CAr), 
98.3 (OCH2O), 55.7 (OCH3), 34.9 (CMe3), 31.5 (CMe3); Anal. Calcd for C52H62O4: C, 83.16; H, 8.32. 










Following General Procedure B, (R)-3,3′-dibromo-2,2′-bis(methoxymethoxy-1,1′-binaphthyl 
(2.14) (2.36 g, 4.43 mmol) was treated with Pd(PPh3)4 (0.512 g, 0.443 mmol), 
3,5-bis(trifluoromethyl)phenylboronic acid (4.0 g, 15.5 mmol) and 2 M aqueous Na2CO3 solution 
(11.7 mL) in DME (50 mL) in a 100 mL round bottom flask. Purification was carried out by column 
chromatography (CH2Cl2/hexanes: 2/3) and crystallization from CH2Cl2/hexanes to give slightly 
yellow crystals (R)-2.22 (3.0 g) in 85% yield. mp 69-71 oC; IR (KBr): υ (max) 1621, 1377, 1281, 
1153 cm-1; 1H NMR (CDCl3): δ 8.20-8.32 (HAr, 4H, m), 7.86-8.08 (HAr, 6H, m), 7.20-7.56 (HAr, 6H, 
m), 4.43 (OCH2O, 2H, d, J = 6.0 Hz), 4.37 (OCH2O, 2H, d, J = 6.0 Hz), 2.50 (OCH3, 6H, s); 13C 
NMR (CDCl3): δ 151.3 (CAr), 141.2(CAr), 134.2(CAr), 132.8(CAr), 132.0(CAr), 131.5(CAr), 131.1(CAr), 
130.7(CAr), 130.0(CAr), 128.3(CAr), 127.5(CAr), 126.4(CAr), 126.3(CAr), 125.9(CAr), 125.6(CAr), 
121.1(CF3), 99.2 (OCH2O), 56.2 (OCH3); 19F NMR (CDCl3): δ -63.43; Anal. Calcd for C40H26F12O4: 
C, 60.16; H, 3.28. Found: C, 60.35; H, 3.17. The sample showed [α]57825 -83.6 (c = 1.1, THF). 
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Following General Procedure B, (±)-3,3′-dibromo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl 
(2.14) (1.2 g, 2.25 mmol) was treated with Pd(PPh3)4 (0.26 g, 0.225 mmol), 2-naphthylboronic acid 
(2.02 g, 11.76 mmol) and 2 M aqueous Na2CO3 solution (5.9 mL) in DME (25 mL) in a 100 mL 
round bottom flask. Purification was carried out by column chromatography (CH2Cl2/hexanes: 1/1) 
and crystallization from CH2Cl2/hexanes to give colorless crystals (2.14) (1.4 g) in 85% yield. mp 
103-104 oC; IR (KBr): υ (max) 1597, 1154 cm-1; 1H NMR (CDCl3): δ 8.14-8.28 (HAr, 2H, m), 
8.01-8.10 (HAr, 2H, m), 7.70-8.01 (HAr, 10H, m), 7.22-7.66 (HAr, 10H, m), 4.45 (OCH2O, 2H, d, J = 
5.9 Hz), 4.44 (OCH2O, 2H, d, J = 5.9 Hz), 2.32 (OCH3, 6H, s); 13C NMR (CDCl3): δ 151.5 (CAr), 
136.7 (CAr), 135.3 (CAr), 133.7 (CAr), 133.5 (CAr), 132.5 (CAr), 130.9 (CAr), 128.1 (CAr), 128.0 (CAr), 
127.9 (CAr), 127.7 (CAr), 127.6 (CAr), 126.6 (CAr), 126.5 (CAr), 126.4 (CAr), 126.1 (CAr), 126.0 (CAr), 
125.2 (CAr), 98.6 (OCH2O), 55.9 (OCH3); MS m/e (relative intensity): 627 (M+, 1), 271 (22), 270 
(100), 269 (30), 268 (15), 239 (22); Anal. Calcd for C44H34O4: C, 84.32; H, 5.47. Found: C, 84.23; H, 
5.38. (R)-3,3′-Dibromo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl was used to afford (R)-2.14 as a 
yellowish syrup. The sample showed [α]57825 -110 (c = 1.1, THF). 
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A mixture of FSO2CF2CO2Me (1.63 mL, 12.78 mmol), CuI (1.46 g, 7.67 mmol), HMPA (2.22 
mL, 12.78 mmol) and (R)-3,3′-diiodo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.15) (2.0 g, 3.19 
mmol) in DMF (40 mL) was stirred under argon atmosphere for 6 hours at 70 oC. The reaction 
mixture was then cooled to room temperature. It was diluted with CH2Cl2 (400 mL), the solution 
washed with water (3 x 200 mL), dried over Na2SO4, and concentrated to afford a syrup. Purification 
was done by column chromatography (EtOAc/hexanes: 1/20) to give 1.51 g of pure product 2.25 
(93%). mp 43-45 oC; IR (KBr): υ (max) 1230, 1165, 1035 cm-1; 1H NMR (CDCl3): δ 8.22-8.32 (HAr, 
2H, m), 7.85-7.98 (HAr, 2H, m), 7.25-7.55 (HAr, 4H, m), 7.08-7.25 (HAr, 2H, m), 4.68 (OCH2O, 2H, d, 
J = 5.5 Hz), 4.44 (OCH2O, 2H, d, J = 5.5 Hz), 2.63 (OCH3, 6H, s); 13C NMR (CDCl3): δ 150.8 (CAr), 
140.3 (CAr), 135.6 (CAr), 129.2 (CAr), 129.1 (CAr), 129.0 (CAr), 128.9 (CAr), 126.9 (CAr), 126.2 (CAr), 
126.0 (CAr), 123.9 (CF3-CAr, q, J = 30.4 Hz), 123.6 (CF3, q, 272.7 Hz), 99.7 (OCH2O), 56.2 (OCH3); 
19F NMR (CDCl3): δ -61.7; Anal. Calcd for C26H20F6O4: C, 61.18; H, 3.95, F, 22.33. Found: C, 61.10; 
H, 3.76; F, 22.43. The sample showed [α]D25 –57.0 (c = 1.0, THF). 
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Neopentyl iodide (3.67 g, 18.53 mmol, 11.6 equiv.) was added via syringe over 2 hours to Mg 
turnings (0.26 g, 10.9 mmol, 6.8 equiv.) in 20 mL refluxing diethyl ether. After the addition, the 
mixture was stirred at room temperature for 1.5 hours. The resulting solution was transferred via 
cannula into a mixture of NiCl2(dppe) (6.1 mg) and (R)-3,3′-diiodo-2,2′-bis(methoxy 
methoxy)-1,1′-binaphthyl 2.15 ( 1.0 g, 1.6 mmol, 1.0 equiv.) in 20 mL ether at 0 oC. The reaction 
mixture was allowed to reflux for 20 hours then cool to room temperature before quenching with 
saturated aqueous NH4Cl. The organic layer was separated and the aqueous layer was extracted with 
Et2O twice. The combined organic phases were washed with sodium thiosulfate and brine. The 
ethereal solution was dried over Na2SO4 and concentrated and the crude product was purified by 
column chromatography (EtOAc/hexanes: 1/30) to give a white foamy product (0.583 g) in 86% 
yield.  1H NMR (CDCl3): δ 7.81 (HAr, 2H, d, J = 8.1 Hz), 7.72 (HAr, 2H, s), 7.03-7.36 (HAr, 6 H, m), 
4.30 (OCH2O, 2H, d, J = 5.9 Hz), 4.41 (OCH2O, 2H, d, J = 5.9 Hz), 3.03 (CH2t-Bu, 2H, d, J = 12.8 
Hz), 3.01 (OCH3, 6 H, s), 2.66 (CH2t-Bu, 2H, d, J = 12.8 Hz), 0.99 (-CH3, 18H, s). 
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2.5.7 General Procedure C: Preparation of 3,3′-Disubstituted-2,2′-dihydroxy-1,1′- 
binaphthyls 2.27-2.37 
A mixture of 3,3′-disubstituted-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.0 mmol) and 
Amberlyst 15 resin (1.0 g) in THF/MeOH (1:1) was stirred and heated to reflux under an argon 
atmosphere for 15 hours, then cooled to room temperature. The resin was removed by filtration and 
the filtrate was concentrated by rotary evaporation. Subsequent purification gave the product. 





(R)-3,3′-Dibromo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.14) (2.0 g, 3.76 mmol) was 
treated with Amberlyst 15 (2.0 g) in THF/MeOH (100 mL, 1:1) as described in general procedure C. 
Purification was carried out by crystallization (CH2Cl2/hexanes) to afford 1.6 g of a white crystalline 
product (R)-2.27 (96%). mp 256-257 oC (lit.48 mp 243-244 oC); IR (KBr): υ (max) 3479, 1616, 1577, 
1499, 1448, 1421, 1382, 1359, 1255, 1195, 1138 cm-1; 1H NMR (CDCl3): δ 8.20-8.35 (HAr, 2H, m), 
7.74-7.88 (HAr, 2H, m), 7.05-7.50 (HAr, 6H, m), 5.53 (OH, 2 H, s); 13C NMR (CDCl3): δ 148.1, 132.8, 
129.8, 127.6, 127.4, 124.9, 124.6, 114.7, 112.3; Anal. Calcd for C20H12Br2O2: C, 54.09; H, 2.72. 
Found: C, 54.05; H, 2.68. The sample showed [α]D 25 +104.7 (c = 1.0, THF); lit.48 [α]D25 +43 (c = 
0.22, CHCl3) 
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(R)-3,3′-Diiodo-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.15) (3.7 g, 5.91 mmol) was 
treated with Amberlyst 15 (3.0 g) in THF/MeOH (160 mL, 1:1) as described in general procedure C. 
Purification was carried out by column chromatography (EtOAc/hexanes: 1:10), and by 
crystallization (EtOAc/hexanes) to afford 3.0 g of a light yellow crystalline product (R)-2.28 (94%). 
mp 312-314 oC; IR (KBr): υ (max) 3483, 1565, 1355, 1177, 1141 cm-1; 1H NMR (CDCl3): δ 8.40-8.60 
(HAr, 2H, m), 7.70-7.90 (HAr, 2H, m), 7.02-7.50 (HAr, 6H, m), 5.41 (OH, 2H, s); 13C NMR (CDCl3): δ 
152.0, 140.4, 133.4, 130.7, 128.0, 127.3, 126.8, 125.2, 124.8, 124.4; Anal. Calcd for C20H12I2O2: C, 
44.64; H, 2.25. Found: C, 44.58; H, 2.27. The sample showed [α]D25 +102.7 (c = 1.0, THF). 





(R)-3,3′-Dimethyl-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.16) (1.80 g, 4.47 mmol) was 
treated with Amberlyst 15 (2.5 g) in THF/MeOH (80 mL, 1:1) as described in general procedure C. 
Purification was carried out by column chromatography (EtOAc/hexanes: 1:10), and by 
crystallization (CH2Cl2/hexanes) to afford 1.40 g of a slightly yellow crystalline product (R)-2.29 
(100%). mp 201-202 oC [lit.49 for (S)-2.29, mp 200-202 oC]; IR, 1H NMR, and 13C NMR were 
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identical with that of (±)-2.29.49 Anal. Calcd for C22H18O2: C, 84.05; H, 5.77. Found: C, 84.01; H, 
5.78. The sample showed [α]58925 +43.4 (c = 1.0, THF). 





A mixture of (R)-2.26 (2.2 g, 5.16 mmol) and Amberlyst-15 resin (2.58 g) in THF/MeOH (110 
mL, 1:1) was heated to reflux under an argon atmosphere for 47 hours. The resin was removed by 
filtration through Celite and the filtrate was concentrated to dryness. Purification was carried out by 
column chromatography with silica gel (CH2Cl2/hexanes = 1:10) to afford at yellow foam 
(quantitative yield). 1H NMR (CDCl3): δ 7.84 (HAr, 2H, d, J = 8.1 Hz), 7.76 (HAr, 2H, s), 7.05-7.35 
(HAr, 6H, m), 5.36 (OH, 2H, s), 2.88 (CH2, d, J = 12.8 Hz), 2.77 (CH2, d, J = 12.8 Hz), 1.01 (-CH3, 
18H, s).13C NMR (CDCl3): δ 152.5 (CAr), 132.8 (CAr), 132.4 (CAr), 129.1 (CAr), 128.8 (CAr), 128.0 
(CAr), 126.6 (CAr), 124.0 (CAr), 123.9 (CAr), 110.8 (CAr), 43.2 (CH2t-Bu), 32.9 (CMe3), 29.6 (CH3)  
MS m/e (relative intensity): 627 (M+, 1), 271 (22), 270 (100), 269 (30), 268 (15), 239 (22);. The 
sample showed [α]57825 -110 (c = 1.1, THF). 






(R)-3,3′-Bis(trifluoromethyl)-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.25) (1.60 g, 3.13 
mmol) was treated with Amberlyst 15 (1.6 g) in THF/MeOH (80 mL, 1:1) as described in General 
Procedure C. Purification was carried out by column chromatography (EtOAc/hexanes: 1:10), and by 
crystallization (CH2Cl2/hexanes) to afford 1.30 g of a white crystalline product (R)-2.31 (98%). mp 
240-242 oC; IR (KBr): υ (max) 3490, 1545, 1365, 1179 cm-1; 1H NMR (CDCl3): δ 8.30-8.48 (HAr, 2H, 
m), 7.90-8.10 (HAr, 2H, m), 7.00-7.62 (HAr, 6H, m), 5.30 (OH, 2H, s); 13C NMR (CDCl3): δ 149.4, 
134.6, 130.4 (q, J = 5.5 Hz), 130.0, 129.7, 127.9, 125.5, 123.9, 123.3 (CF3, q, J = 272.2 Hz), 118.9 (q, 
J = 30.9 Hz), 112.2; 19F NMR (CDCl3): δ -63.38; Anal. Calcd for C22H12F6O2: C, 62.57; H, 2.86; F, 
26.99. Found: C, 62.50; H, 2.82; F, 26.88. MS m/e (relative intensity): 426 (M+, 100), 411 (M+-CH3, 
8), 369 (M+-t-Bu); The sample showed [α]58925 +100.3 (c = 1.0, THF). 





(±)-3,3′-Diphenyl-2,2′-bis(methoxymethoxy)-1,1′-binaphthol (2.18) (6.4 g, 12.15 mmol) was 
treated with Amberlyst 15 (6.0 g) in THF/MeOH (200 mL, 1:1) ) as described in general procedure C. 
Purification was carried out by column chromatography (EtOAc/hexanes: 1:10), followed by 
crystallization (CH2Cl2/hexanes) to afford 4.70 g of a white crystalline product (±)-2.32 (89%). mp 
209-210 oC [lit.49 mp 210-211 oC]; IR, 1H NMR, 13C NMR were identical to that of (±)-(2.32) in the 
literature8; Anal. Calcd for C32H22O2: C, 87.65; H, 5.06. Found C, 87.55; H, 4.99. 
(R)-3,3′-Diphenyl-2,2'-bis(methoxymethoxy)-1,1'-binaphthyl (2.18) was used to afford (R)-2.32. mp 
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200-202 oC [lit.50 mp 197-198 oC]; The sample showed [α]D25 +135.0 (c = 1.0, THF) [lit.50 [α]25546 
+132.4o (c = 1.0, THF)]. 





(±)-3,3′-Bis(4-methoxyphenyl)-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.19) (1.50 g, 2.56 
mmol) was treated with Amberlyst 15 (1.3 g) in THF/MeOH (80 mL, 1:1) as described in general 
procedure C. Purification was carried out by crystallization (EtOAc/hexanes) to afford 1.15 g of a 
light yellow crystalline product (±)-2.33 (90%). mp 224-225 oC; IR (KBr): υ (max) 3480, 1606, 1512, 
1244, 1177 cm-1; 1H NMR (CDCl3): δ 7.80-8.10 (HAr, 4H, m), 7.56-7.75 (HAr, 4H, m), 7.12-7.45 (HAr, 
6H, m), 6.90-7.06 (HAr, 4H, m), 5.36 (OH, 2H, s), 3.83 (OCH3, 6H, s); 13C NMR (CDCl3): δ 159.3 
(CAr), 150.2 (CAr), 132.7 (CAr), 130.9 (CAr), 130.7 (CAr), 130.3 (CAr), 129.8 (CAr), 129.5 (CAr), 128.3 
(CAr), 127.1 (CAr), 124.2 (CAr), 113.9 (CAr), 112.4 (CAr), 55.3 (OCH3); Anal. Calcd for C34H26O4: C, 
81.91; H, 5.26. Found: C, 82.02; H, 5.16. (R)-3,3′-Bis(4-methoxyphenyl)- 
2,2′-bis(methoxymethoxy)-1,1′-binaphthyl was used to afford (R)-2.33 mp 109-111 oC. The sample 
showed [α]57825 +50.1 (c = 1.0, THF). 
 64







(±)-3,3′-Bis(3,5-dimethylphenyl)-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.20) (2.20 g, 
3.78 mmol) was treated with Amberlyst 15 (2.0 g) in THF/MeOH (100 mL, 1:1) as described in 
general procedure C. Purification was carried out by crystallization (THF/hexanes) to afford 1.74 g of 
a light yellow crystalline product (±)-2.34 (93%). mp 299-301 oC; IR (KBr): υ (max) 3476, 1600, 
1497, 1411, 1252, 1211 cm-1; 1H NMR (CDCl3): δ 7.82-8.08 (HAr, 4H, m), 7.18-7.48 (HAr, 10H, m), 
6.98-7.15 (HAr, 2H, m), 5.39 (OH, 2H, s), 2.40 (CH3, 12H, s); 13C NMR (CDCl3): δ 150.0 (CAr), 138.1 
(CAr), 137.3 (CAr), 133.0 (CAr), 130.9 (CAr), 129.5 (CAr), 129.4 (CAr), 128.3 (CAr), 127.3 (CAr), 127.1 
(CAr), 124.4 (CAr), 124.1 (CAr), 112.8 (CAr), 21.4 (CH3); Anal. Calcd for C36H30O2: C, 87.42; H, 6.11. 
Found: C, 87.35; H, 5.98. (R)-3,3′-Bis(3,5-dimethylphenyl)-2,2′-bis(methoxymethoxy)- 
1,1′-binaphthyl was used to afford (R)-2.34. mp 124-125 oC. The sample showed [α]57825 +53.2 (c = 
1.1, THF). 
 65







(R)-3,3′-Bis[3,5-di(tert-butyl)phenyl]-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.21) (3.0 g, 
3.76 mmol) was treated with Amberlyst 15 (2.0 g) in THF/MeOH (100 mL, 1:1) as described in 
General Procedure C. Purification was carried out by column chromatography (EtOAc/hexanes: 
1:10), and by crystallization (EtOAc/hexanes) to afford 2.60 g of a white crystalline product (R)-2.35 
(98%). mp 142-144 oC; IR (KBr): υ (max) 3490, 1601, 1360, 1209 cm-1; 1H NMR (CDCl3): δ 
7.85-8.05 (HAr, 4H, m), 7.15-7.62 (HAr, 12H, m), 5.47 (OH, 2 H, s), 1.38 (C(CH3)3, 18H, s); 13C NMR 
(CDCl3): δ 151.0 (CAr), 150.1 (CAr), 136.5 (CAr), 133.0 (CAr), 131.6 (CAr), 130.9 (CAr), 129.4 (CAr), 
128.3 (CAr), 127.0 (CAr), 124.5 (CAr), 124.1 (CAr), 123.9 (CAr), 121.9 (CAr), 113.0 (CAr), 35.0 (CMe3), 
31.5 (CMe3); Anal. Calcd for C48H54O2: C, 86.96; H, 8.21. Found: C, 86.86; H, 8.17. The sample 
showed [α]D25 +27.5 (c = 1.0, THF). 
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(3.0 g, 3.76 mmol) was treated with Amberlyst 15 (2.0 g) in THF/MeOH (100 mL, 1:1) as described 
in general procedure C. Purification was carried out by column chromatography (EtOAc/hexanes: 
1:10), and by crystallization (EtOAc/hexanes) to afford 2.60 g of a light yellow crystalline product 
(R)-2.36 (97%). mp 97-99 oC; IR (KBr): υ (max) 3477, 1603, 1385, 1203, 1165 cm-1; 1H NMR 
(CDCl3): δ 7.80-8.35 (HAr, 10H, m), 7.10-7.60 (HAr, 6H, m), 5.37 (OH, 2H, s); 13C NMR (CDCl3): δ 
150.0 (CAr), 139.7 (CAr), 133.4 (CAr), 132.4 (CAr), 131.7 (CAr, q, J = 33.9 Hz), 129.9 (CAr), 129.6 (CAr), 
128.9 (CAr), 128.6 (CAr), 127.9 (CF3, q, J = 275.5 Hz), 125.2 (CAr), 124.1 (CAr), 121.3 (CAr), 112.0 
(CAr); 19F NMR (CDCl3): δ -63.49; Anal. Calcd for C36H18O2F12: C, 60.86; H, 2.55; F, 32.09. Found: 
C, 60.80; H, 2.48; F, 31.99. The sample showed [α]D25 -11.9 (c = 1.1, THF). 
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(±)-3,3′-Bis(2-naphthyl)-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl (2.23) (1.35 g, 2.15 mmol) 
was treated with Amberlyst 15 (1.1 g) in THF/MeOH (80 mL, 1:1) as described in general procedure 
C. Purification was carried out by column chromatography (CH2Cl2/hexanes: 1:1), then by 
crystallization (CH2Cl2/hexanes) to afford 1.05 g of a light yellow crystalline product (±)-2.37 (91%). 
mp 184-185 oC; IR (KBr): υ (max) 3478, 1615, 1501, 1384, 1226, 1169, 1118 cm-1; 1H NMR 
(CDCl3): δ 7.70-8.40 (HAr, 14H, m), 7.15-7.60 (HAr, 10H, m), 5.46 (OH, 2H, s); 13C NMR (CDCl3): δ 
150.3, 135.0 (CAr), 133.5 (CAr), 133.0 (CAr), 132.8 (CAr), 131.7 (CAr), 130.6 (CAr), 129.6 (CAr), 128.5 
(CAr), 128.2 (CAr), 127.9 (CAr), 127.7 (CAr), 127.4 (CAr), 126.3 (CAr), 124.4 (CAr), 124.3 (CAr), 112.5 
(CAr); Anal. Calcd for C40H26O2: C, 89.19; H, 4.86. Found: C, 88.98; H, 5.05. 
(R)-3,3′-Bis(2-naphthyl)-2,2′-bis(methoxymethoxy)-1,1′-binaphthyl was used to afford (R)-2.37: mp 
217-218 oC (dec.). The sample showed [α]57825 -32.9 (c = 1.0, THF). 
 






(R)-2.27 (1.50 g, 3.38 mmol,) and imidazole (0.70 g, 10.30 mmol, 3.05 equiv.) was dissolved in 
23 mL of DMF. Chlorotrimethylsilane (0.93 g, 8.58 mmol, 2.5 equiv.) was syringed into the reaction 
flask at room temperature and the reaction mixture was stirred overnight. Ether (50 mL) was added to 
the reaction flask, and the reaction was quenched with 50 mL of 5% sodium bicarbonate solution. The 
aqueous layer was extracted and washed three times with diethyl ether. The combined organic layers 
were washed five times with water and dried over sodium sulfate. The desired product (1.20 g, 60% 
yield) was obtained after flash column chromatography on silca gel (1:15 EtOAc/hexanes). 1H NMR 
(CDCl3): δ 8.19 (HAr, 2H, s), 7.75 (HAr, 2H, d, J = 8.1 Hz), 7.18-7.36 (HAr, 4H, m), 7.01 (HAr, 2H, d, J 
= 8.1 Hz), -0.24 (TMS, 18H, s). 





(R)-2.27 (3.00 g, 6.75 mmol) and imidazole (1.86 g, 27.3 mmol, 4.05 equiv.) was dissolved in 
50 mL of DMF. tert-Butylchlorodimethylsilane (4.07 g, 27.0 mmol, 4.0 equiv.) was syringed into the 
reaction flask at room temperature. The reaction was stirred at that temperature 70 hours. Ether (100 
mL) was added to the reaction flask, and the reaction was quenched with 50 mL of 5% sodium 
bicarbonate solution. The aqueous layer was extracted and washed three times with diethyl ether. The 
combined organic layers were washed with water and brine and dried over sodium sulfate. The 
organic layers were dried over sodium sulfate and concentrated to dryness. The crude product (4.11g) 
was obtained in 91% yield which was used in the next step without further purification. 1H NMR 
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(CDCl3): δ 8.19 (HAr, 2H, s), 7.72 (HAr, 2H, d, J = 8.1 Hz), 7.19-7.34 (HAr, 4H, m), 7.07 (HAr, 2H, d, J 
= 8.1 Hz), 0.80 (Me2SiCMe3, 18H, s), -0.03 (Me2SiCMe3, 12H, s). 
 





(R)-2.38a (0.87 g, 1.48 mmol) was dissolved in 30 mL of dry THF. The solution was cooled to 
0 oC and tert-butyllithium (6.19 mL, 1.43 M solution in pentane, 8.86 mmol, 6.0 equiv.) was added 
dropwise. After the addition, the reaction was warmed to room temperature and stirred overnight. The 
reaction was quenched by pouring the reaction mixture into 20 mL of saturated aqueous NH4Cl. The 
aqueous layer was extracted and washed three times with dichloromethane. Organic layers were 
combined and dried over sodium sulfate. Crude product was purified by column chromatography 
(EtOAc/hexanes: 1/20) to give a foam (0.379 g) in 60% yield. 1H NMR (CDCl3): δ 8.06 (HAr, 2H, s), 
7.87 (HAr, 2H, d, J = 8.1 Hz), 7.27-7.38 (HAr, 4H, m), 7.07 (HAr 2H, d, J = 8.1 Hz), 5.28 (OH, 2H, s) 
0.40 (TMS, 18H, s). 






(R)-2.38b (0.50 g, 0.74 mmol) was dissolved in 20 mL of dry THF. tert-Butyllithium (3.1 mL, 
1.43 M solution in pentane, 4.46 mmol, 6.0 equiv.) was added dropwise at 0 oC. After the addition, 
the reaction warmed to room temperature and stirred overnight. The reaction mixture was poured into 
20 mL of saturated aqueous NH4Cl. The aqueous layer was extracted and washed three times with 
dichloromethane. The combined organic layers were dried over sodium sulfate and concentrated to 
dryness. The crude product was purified by column chromatography (EtOAc/hexanes: 1/10) to give a 
white foam (0.362g) in 95% yield. . 1H NMR (CDCl3): δ 8.06 (HAr, 2 H, s), 7.87 (HAr, 2 H, d, J = 7.8 
Hz), 7.21-7.35 (HAr, 4H, m), 7.07 (HAr, 2H, d, J = 7.8 Hz), 5.34 (OH, 2H, s), 0.93 (Me2SiCMe3, 18H, 
s), 0.41 (Me2SiCMe3, 12H,s).  
 
2.5.12 Preparation of (R)-3,3′-Bis(trifluoromethyl)- 2,2′-dihydroxy-6,6′-dinitro-1,1′ 







To a solution of (R)-3,3′-bis(trifluoromethyl)-2,2′-dihydroxy-1,1′-binaphthyl 2.31 (0.65g, 
1.54mmol) in 27 mL of 2:1 THF/CHCl3 was added Fe(NO3)3·9H2O (3.08 g, 7.70 mmol, 5.0 equiv.). 
The resulting brown suspension was heated to reflux for 3 hours. The reaction was quenched with 1 
M HCl and was diluted with ether. The organic phase was separated and the aqueous phase was 
extracted with ether three times. The combined organic layers were then washed with brine and dried 
over Na2SO4. Purification was done by flash column chromatography on silica gel (1:5 
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EtOAc/hexanes) yielding the desired product as pale yellow powder (0.66 g, 71%). 1H NMR (CDCl3): 
δ 8.96 (HAr, 2H, d, J = 1.9 Hz), 8.58 (HAr, 2H, s), 8.20 (HAr, 2H, dd, J = 1.9 Hz, 9.2Hz), 7.15 (HAr, 2H, 
d, J = 9.2 Hz), 5.90 (OH, 2H, s); 13C NMR (CDCl3 with a few drops of DMSO, CF3 signal was not 
found): δ 154.6 (CAr), 143.2 (CAr), 138.2 (CAr), 131.0 (CAr, q, J = 5.6 Hz), 125.8 (CAr), 125.1 (CAr), 
124.6 (CAr), 121.4 (CAr), 121.3 (CAr, q, J = 30.3 Hz), 114.3 (CAr); 19F NMR (CDCl3 with a few drops 
of DMSO): δ -62.8; MS m/e (relative intensity): 512 (M+, 100), 493 (M+-F, 8); HRMS m/z Calcd for 
C22H10F6N2O6 (M+): 512.0443. Found: 512.0440. This sample showed [α]D25 -1.4 (c = 0.94, 
THF). 
2.5.13 General Procedure D: Allylboration of Aldehydes and Ketones using 
Binaphthol-modified Allylboronates 2.42b  
To a solution of triallylborane (0.75 mmol, 1.5 equiv.) in dry THF (4 mL) under argon was 
added the 3,3′-disubstituted BINOL (0.9 mmol, 1.8 equiv.). This mixture was stirred at room 
temperature for 2 hours and then was heated at reflux for 1 hour. The solution was cooled to -78 oC 
(in ketone cases, THF was evaporated, and 5 mL toluene was added). The aldehyde (or ketone) (0.5 
mmol) was dissolved in 1 mL of dry THF (toluene for ketones) and added dropwise to the solution. 
Upon completion of the addition, the solution was stirred at –78 oC for 1 hour (-78 oC - -40 oC for 48 
hours for ketones). The reaction was quenched cold with 1 M NaOH and allowed to warm to room 
temperature. The mixture was diluted with CH2Cl2 (20 mL) and the organic layer washed with 0.1 M 
NaOH then brine, dried with sodium sulfate. The ligand was recovered by neutralizing the aqueous 
layer with 1 M HCl and extracting with Et2O. The organic layer was evaporated under reduced 
pressure to afford a clear colorless oil, which was purified via flash column chromatography (10:1 
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hexanes/EtOAc) to provide the expected homoallylic alcohol in the yields reported in Tables 2.2, 2.3, 
and 2.4. The enantiomeric excesses of most alcohols were determined by HPLC (4.6 x 250 mm 
Chiralcel OD) using racemic mixtures prepared with triallylborane as standards. While excess 
binaphthol was typically used to ensure that no free triallylborane remained, control experiments 
using 1.0:1.0 binaphthol:triallylborane gave essentially identical enantioselectivities. 
2.5.13.1 (R)-1-Phenyl-3-buten-1-ol (2.44a) 
OH
 
[α]D25 = +43.6 (c 1.24, benzene, 86% ee), lit.32 for S enantiomer: [α]D25 = -44.92 (c 7.38, 
benzene, 96% ee); 1H NMR (300 MHz, CDCl3): δ 7.26-7.60 (HAr, 5H, m), 5.72-5.86 (CH=CH2, 1H, 
m), 5.11-5.17 (CH=CH2, 2H, m), 4.70 (PhCH, 1H, dd, J = 11.6 Hz, 7.0 Hz), 2.34-2.57 (CH2, 2H, m), 
2.06 (OH, 1H, br, s); The enantiomeric excess of the product was determined by HPLC 
(hexanes/i-PrOH = 98/2, flow rate = 1 mL/min), tR = 15.87 min (R), tR = 18.90 min (S). 
2.5.13.2 (R)-1-(4-Methoxyphenyl)-3-buten-1-ol (2.44b) 
OH
MeO  
[α]D25 = +62.4 (c 0.75, CHCl3, 93% ee), lit.51: [α]D25 = +30.5 (c 1.0, benzene, 95% ee); 1H NMR 
(300 MHz, CDCl3): δ 7.20 (HAr, 2H, d, J = 8.7 Hz), 6.82 (HAr, 2H, d, J = 8.7 Hz), 5.53-5.93 (CH=CH2, 
1H, m), 5.08-5.13 (CH=CH2, 2H, m), 4.59 (ArCH, 1H, d, J = 6.6 Hz, 6.6 Hz), 3.74 (OCH3, 3H, s), 
2.48 (CH2, 2H, t, J = 6.6 Hz), 2.06 (OH, 1H, br, s); The enantiomeric excess of the product was 
 73
determined by HPLC (hexanes/i-PrOH = 98/2, flow rate = 1 mL/min), tR = 21.09 min (R), tR = 26.12 
min (S). 
2.5.13.3 (R)-1-(4-Chlorophenyl)-3-buten-1-ol (2.44c) 
OH
Cl  
[α]D25 = +61.4 (c 1.17, CHCl3, 94% ee), lit.52: [α]D25 = +26.4 (c 0.38, C6H6, 98% ee); 1H NMR 
(300 MHz, CDCl3): δ 7.19-7.31 (HAr, 4H, m), 5.68-5.83 (CH=CH2, 1H, m), 5.12-5.17 (CH=CH2, 2H, 
m), 4.68 (ArCH, 1H, dd, J = 7.5 Hz, 5.2 Hz), 2.37-2.53 (CH2, 2H, m), 2.02 (OH, 1H, br, s); The 
enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 98/2, flow rate = 0.6 
mL/min), tR = 23.19 min (S), tR = 25.29 min (R). 
2.5.13.4 (R)-1-(4-Nitrophenyl)-3-buten-1-ol (2.44d) 
OH
O2N  
[α]D25 = +58.6 (c 0.5, CHCl3, 91% ee), lit.53: [α]D25 = +40.1 (c 1.4, CHCl3, 89% ee); 1H NMR 
(300 MHz, CDCl3): δ 8.05 (HAr, 2H, d, J = 8.4 Hz), 7.52 (HAr, 2H, d, J = 8.4 Hz), 5.70-5.84 (CH=CH2, 
1H, m), 5.14-5.20 (CH=CH2, 2H, m), 4.85 (ArCH, 1H, dd, J = 4.8 Hz, 7.6 Hz), 2.38-2.60 (CH2, 2H, 
m), 2.22 (OH, 1H, br, s); The enantiomeric excess of the product was determined by 19F NMR of its 
corresponding R-Mosher esters (282 MHz, CDCl3): δ -70.83 (for RR diastereomer), -70.96 (for SR 
diastereomer). 
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2.5.13.5 (R)-1-(4-Trifluoromethylphenyl)-3-buten-1-ol (2.44e) 
OH
F3C  
[α]D25 = +53.2 (c 0.82, CHCl3, 93% ee), lit.53: [α]D25 = +43.1 (c 1.24, CHCl3, 96% ee); 1H NMR 
(300 MHz, CDCl3): δ 7.58 (HAr, d, J = 8.1 Hz), 7.44 (HAr, 2H, d, J = 8.1 Hz), 5.70-5.83 (CH=CH2, 
1H, m), 5.13-5.17 (CH=CH2, 2H, m), 4.74-4.76 (ArCH, 1H, m), 2.40-2.53 (CH2, 2H, m), 2.37 (OH, 
1H, br, s); The enantiomeric excess of the product was determined by 19F NMR of its corresponding 
R-Mosher esters (282 MHz, CDCl3): δ -70.89 (for RR diastereomer), -71.06 (for SR diastereomer). 
2.5.13.6 (R)-1-Phenyl-1,5-hexadien-3-ol (2.44f) 
OH
 
[α]D25 = -6.3 (c 0.8, Et2O, 75% ee), lit.51: [α]D25 = -12.3 (c 1.0, Et2O, 87% ee); 1H NMR (300 
MHz, CDCl3): δ 7.21-7.40 (HAr, 5H, m), 6.60 (PhCH=CH, 1H, J = 16.0 Hz), 6.25 (PhCH=CH,1H, dd, 
J = 6.0 Hz, 16.0 Hz), 5.81-5.87 (CH=CH2, 1H, m), 5.15-5.21 (CH=CH2, 2H, m), 4.34-4.38 
(PhCH=CH-CH, 1H, m), 2.32-2.49 (CH2, 2H, m), 1.90 (OH, 1H, br, s); The enantiomeric excess of 
the product was determined by 19F NMR of its corresponding R-Mosher ester (282 MHz, CDCl3): δ 
-71.04 (for RR diastereomer), -71.15 (for SR diastereomer).  




[α]D25 = +1.1 (c 0.53, CHCl3, 75% ee), lit.51: [α]D25 = +13.7 (c 1.0, Ethanol, 93 %ee); 1H NMR 
(300 MHz, CDCl3): δ 5.74-5.88 (CH2=CH, 1H, m), 5.08-5.13 (CH2=CH, 2H, m), 3.33-3.39 
(R2CHOH, 1H, m), 2.06-2.27 (OH and CH2=CHCH2, 3H, m), 0.95-1.85 (HCy, 11H, m),; The 
enantiomeric excess of the product was determined by HPLC analysis (hexanes/i-PrOH = 99.9/0.1, 
flow rate = 1 mL/min) of its corresponding benzoate ester, tR = 7.62 min (R), tR = 8.65 min (S). 
2.5.13.8 (R)-2-Phenyl-4-penten-2-ol (2.46a) 
HO
 
[α]D25 = +61.7 (c 0.36, CHCl3, 91% ee), lit.54: [α]D = +36.3 (c 0.84, CHCl3, 61% ee); 1H NMR 
(300 MHz, CDCl3): δ 7.20-2.44 (HAr, 5H, m), 5.54-5.68 (CH2=CH, 1H, m), 5.10-5.15 (CH2=CH, 2H, 
m), 2.68 (CH2, 1H, dd, ABX, J = 13.7 Hz, 6.9 Hz), 2.49 (CH2, 1H, dd, ABX, J = 8.4 Hz, 13.7 Hz), 
1.99 (OH, 1H, br, s), 1.54 (CH3, 3H, s); The enantiomeric excess of the product was determined by 




(R)-1-Phenyl-1-(2-propenyl)-oxirane was obtained from the allylboration of 
α-bromoacetophenone after workup with 1 M NaOH. [α]D25 = -29.8 (c 0.84 , CHCl3, 93% ee); 1H 
NMR (300 MHz, CDCl3): δ 7.25-7.38 (HAr, 5H, m), 5.70-5.84 (CH2=CH, 1H, m), 5.06-5.14 
(CH2=CH, 2H, m), 2.99 (OCH2, 1H, d, J = 5.2 Hz), 2.88 (CH2=CHCH2, 1H, dd, ABX, J = 6.3 Hz, 
15.0 Hz), 2.75 (OCH2, 1H, d, AB, J = 5.2 Hz), 2.64 (CH2=CHCH2, 1H, dd, ABX, J = 7.8 Hz, 15.0 
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Hz); The enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 99.5/0.5, 
flow rate = 1 mL/min) , tR = 6.54 min (R), tR = 7.93 min (S).  This compound has not been previously 
reported in enantiomerically enriched form; the absolute configuration has been assigned based on 
correlation with results for acetophenone and the assumption that –CH2Br (A value = 1.79 kcal 
mol-1)56 and -CH3 (A value = 1.74) behave similarly in the allylation.  
2.5.13.10 (R)-2-(4′-Methoxyphenyl)-4-penten-2-ol (2.46c).36 
HO
MeO  
[α]D25 = +65.2 (c 0.71 , CHCl3, 98% ee); 1H NMR (300 MHz, CDCl3): δ 7.40 (HAr, 2H, d, J = 
8.4 Hz), 6.85 (HAr, 2H, d, J = 8.4 Hz), 5.54-5.68 (CH2=CH, 1H, m), 5.07-5.13 (CH2=CH, 2H, m), 
3.78 (OMe, 3H, s), 2.64 (CH2=CHCH2, 1H, dd, ABX, J = 6.0 Hz, 13.1 Hz), 2.46 (CH2=CHCH2, 1H, 
dd, ABX, J = 8.1 Hz, 13.1 Hz), 2.02 (OH, 1H, br, s), 1.51 (R3C-CH3, 3H, s); The enantiomeric excess 
of the product was determined by HPLC (hexanes/i-PrOH = 99.5/0.5, flow rate = 0.6 mL/min) , tR = 
34.0 min (R), tR = 38.0 min (S). 
2.5.13.11 (R)-2-(4′-Chlorophenyl)-4-penten-2-ol (2.46d)36 
HO
Cl  
[α]D25 = +63.1 (c 0.58, CHCl3, > 98% ee); 1H NMR (300 MHz, CDCl3): δ 7.27-7.36 (HAr, 4H, 
m), 5.49-5.65 (CH2=CH, 1H, m), 5.09-5.13 (CH2=CH, 2H, m), 2.63 (CH2=CHCH2, 1H, dd, ABX, J = 
7.8 Hz, 13.2 Hz), 2.46 (CH2=CHCH2, 1H, dd, ABX, J = 6.0 Hz, 13.2 Hz), 2.08 (OH, 1H, br, s), 1.50 
(CH3, 3H, s); The enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 
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99.5/0.5, flow rate = 0.6 mL/min) , tR = 33.49 min (S), tR = 35.03 min (R). The minor (S) isomer was 
not detected but its retention time was determined using authentic racemate. 
2.5.13.12 (R)-1-Phenyl-3-hydroxy-3-methyl-1,5-hexandiene (2.46e)36 
HO
 
[α]D25 = +65.8 (c 1.1, CHCl3, 75% ee); 1H NMR (300 MHz, CDCl3): δ 7.21-7.38 ( HAr, 5H, m), 
6.59 (ArCH=CH, 1H, d, J = 15.9 Hz), 6.29 (ArCH=CH, 1H, d, J = 15.9 Hz), 5.69-5.90 (CH2=CH, 
1H, m), 5.12-5.18 (CH2=CH, 2H, m), 2.31-2.47 (CH2=CHCH2, 2H, m), 1.78 (OH, 1H, br, s), 1.38 
(CH3, 3H, s); The enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 
95/5, flow rate = 1.0 mL/min) , tR = 11.58 min (R), tR = 13.78 min (S). 
2.5.13.13 (R)-2,2,3-Trimethyl- 5-hexen-3-ol (2.46f)57 
HO
 
1H NMR (300 MHz, C6D6): δ 5.87-6.00 (CH2=CH, 1H, m), 5.02-5.13 (CH2=CH, 2H, m), 2.32 
(CH2, 1H, dd, ABX, J = 6.9 Hz, 13.5Hz), 2.06 (CH2, 1H, dd, ABX, J = 7.8 Hz, 13.5 Hz), 1.19 (OH, 
1H, br, s), 1.03 (Me, 3H, s), 0.97 (CMe3, 9H, s); The enantiomeric excess of the product was 
determined by 1H NMR (300 MHz, CDCl3) in the presence of chiral shift reagent, Eu(hfc)3. The 
optical rotation was not taken due to the volatility of the sample 











[α]D25 = +6.0 (c 1.1, CHCl3, 51% ee), literature value for the S enantiomer58: [α]D25 = -58.0 (c 
1.0, CHCl3, 92% ee); 1H NMR (300 MHz, C6D6): δ 7.16-7.23 (HAr, 5H, m), 5.75-5.90 (He, 1H, m), 
5.02-5.10 (Hf, 2H, m), 2.66-2.70 (Ha, 2H, m), 2.12-2.14 (Hd, 2H, m), 1.64-1.70 (Hb, 2H, m), 1.07 (Hg, 
3H, s), 0.97 (OH, 1H, br, s); The enantiomeric excess of the product was determined by HPLC 
(hexanes/i-PrOH = 95/5, flow rate = 0.6 mL/min) , tR = 16.18 min (S), tR = 17.35 min (R). 
2.5.13.15 3-Methylhex-5-en-1-yn-3-ol (2.46h)32 
OH
 
1H NMR (300 MHz, CDCl3): δ 5.87-6.02 (CH2=CH, 1H, m), 5.15-5.23 (CH2=CH, 2H, m), 2.48 
(CH2, 1H, dd, ABX, J = 6.6 Hz, 13.5 Hz), 2.36 (CH2, 1H, dd, ABX, J = 8.1 Hz, 13.5 Hz), 2.10 (OH, 
1H, s, br), 1.49 (CH3, 3H, s); The enantiomeric excess of the product was determined by 1H NMR 
(300 MHz, CDCl3) in the presence of chiral shift reagent, Eu(hfc)3 and the absolute configuration of 






(1)  Denmark, S. E.; Fu, J. P. Chem. Rev. 2003, 103, 2763-2793. 
(2)  Hoffmann, R. W.; Herold, T. Chem. Ber. 1981, 114, 375-383. 
(3)  Herold, T.; Hoffmann, R. W. Angew. Chem. Int. Ed. 1978, 17, 768-769. 
(4)  Brown, H. C.; Jadhav, P. K. J. Am. Chem. Soc. 1983, 105, 2092-2093. 
(5)  Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 1986, 108, 5919-5923. 
(6)  Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 1986, 108, 293-294. 
(7)  Roush, W. R.; Walts, A. E.; Hoong, L. K. J. Am. Chem. Soc. 1985, 107, 8186-8190. 
(8)  Roush, W. R.; Halterman, R. L. J. Am. Chem. Soc. 1986, 108, 294-296. 
(9)  Brown, H. C.; Jadhav, P. K. J. Org. Chem. 1984, 49, 4089-4091. 
(10)  Brown, H. C.; Randad, R. S.; Bhat, K. S.; Zaidlewicz, M.; Racherla, U. S. J. Am. Chem. Soc. 
1990, 112, 2389-2392. 
(11)  Garcia, J.; Kim, B. M.; Masamune, S. J. Org. Chem. 1987, 52, 4831-4832. 
(12)  Reetz, M. T.; Zierke, T. Chem. Ind. 1988, 663-664. 
(13)  Roush, W. R.; Banfi, L. J. Am. Chem. Soc. 1988, 110, 3979-3982. 
(14)  Short, R. P.; Masamune, S. J. Am. Chem. Soc. 1989, 111, 1892-1894. 
(15)  Kennedy, J. W. J.; Hall, D. G. J. Am. Chem. Soc. 2002, 124, 11586-11587. 
(16)  Lachance, H.; Lu, X. S.; Gravel, M.; Hall, D. G. J. Am. Chem. Soc. 2003, 125, 10160-10161. 
(17)  Ishiyama, T.; Ahiko, T.; Miyaura, N. J. Am. Chem. Soc. 2002, 124, 12414-12415. 
(18)  Chong, J. M.; Shen, L.; Taylor, N. J. J. Am. Chem. Soc. 2000, 122, 1822-1823. 
(19)  Brown, H. C.; Racherla, U. S.; Pellechia, P. J. J. Org. Chem. 1990, 55, 1868-1874. 
(20)  Ballinger, P.; Long, F. A. J. Am. Chem. Soc. 1960, 82, 795-798. 
(21)  Timberlake, C. F. J. Chem. Soc. 1957, 4987-4993. 
(22)  Ding, K. L.; Wang, Y.; Zhang, L. J.; Wu, Y. J.; Matsuura, T. Tetrahedron 1996, 52, 
1005-1010. 
(23)  Cai, D. W.; Hughes, D. L.; Verhoeven, T. R.; Reider, P. J. In Organic Syntheses, Vol 76 - 1999; 
John Wiley & Sons Inc: New York, 1999; Vol. 76, p 1-5. 
 80
(24)  Cai, D. W.; Hughes, D. L.; Verhoeven, T. R.; Reider, P. J. Tetrahedron Lett. 1995, 36, 
7991-7994. 
(25)  Shen, L. Ph. D. Thesis, University of Waterloo, 2000. 
(26)  Qing, F. L.; Fan, J. F.; Sun, H. B.; Yue, X. J. J. Chem. Soc. Perkin Trans. 1 1997, 3053-3057. 
(27)  Maruoka, K.; Itoh, T.; Araki, Y.; Shirasaka, T.; Yamamoto, H. Bull. Chem. Soc. Jpn. 1988, 61, 
2975-2976. 
(28)  Poirier, J. M.; Vottero, C. Tetrahedron 1989, 45, 1415-1422. 
(29)  Corey, E. J.; Yu, C. M.; Kim, S. S. J. Am. Chem. Soc. 1989, 111, 5495-5496. 
(30)  Brown, H. C.; Racherla, U. S. J. Org. Chem. 1986, 51, 427-432. 
(31)  Thormeier, S.; Carboni, B.; Kaufmann, D. E. J. Organomet. Chem. 2002, 657, 136-145. 
(32)  Jadhav, P. K.; Bhat, K. S.; Perumal, P. T.; Brown, H. C. J. Org. Chem. 1986, 51, 432-439. 
(33)  Noyori, R.; Tomino, I.; Tanimoto, Y.; Nishizawa, M. J. Am. Chem. Soc. 1984, 106, 6709-6716. 
(34)  Kii, S.; Maruoka, K. Chirality 2003, 15, 68-70. 
(35)  Waltz, K. M.; Gavenonis, J.; Walsh, P. J. Angew. Chem. Int. Ed. 2002, 41, 3697-3699. 
(36)  Casolari, S.; D'Addario, D.; Tagliavini, E. Org. Lett. 1999, 1, 1061-1063. 
(37)  Wada, R.; Oisaki, K.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2004, 126, 8910-8911. 
(38)  Canales, E.; Prasad, K. G.; Soderquist, J. A. J. Am. Chem. Soc. 2005, 127, 11572-11573. 
(39)  Burgos, C. H.; Canales, E.; Matos, K.; Soderquist, J. A. J. Am. Chem. Soc. 2005, 127, 
8044-8049. 
(40)  Wu, T. R.; Shen, L. X.; Chong, J. M. Org. Lett. 2004, 6, 2701-2704. 
(41)  Allendoerfer, R.; Loebenberg, D.; Rinaldi, M. G.; Graybill, J. R. Antimicrob. Agents 
Chemother. 1995, 39, 1345-1348. 
(42)  Saksena, A. K.; Girijavallabhan, V. M.; Lovey, R. G.; Pike, R. E.; Wang, H. Y.; Ganguly, A. 
K.; Morgan, B.; Zaks, A.; Puar, M. S. Tetrahedron Lett. 1995, 36, 1787-1790. 
(43)  Saksena, A. K.; Girijavallabhan, V. M.; Lovey, R. G.; Desai, J. A.; Pike, R. E.; Jao, E.; Wang, 
H. Y.; Ganguly, A. K.; Loebenberg, D.; Hare, R. S.; Cacciapuoti, A.; Parmegiani, R. M. Bioorg. Med. 
Chem. Lett. 1995, 5, 127-132. 
 81
(44)  Bartlett, P. A.; Meadows, J. D.; Brown, E. G.; Morimoto, A.; Jernstedt, K. K. J. Org. Chem. 
1982, 47, 4013-4018. 
(45)  Chong, J. M.; Shen, L. X. Synth. Commun. 1998, 28, 2801-2806. 
(46)  Cai, D. W.; Hughes, D. L.; Verhoeven, T. R.; Reider, P. J. In Organic Syntheses; John Wiley & 
Sons Inc: New York, 1999; Vol. 76, p 1-5. 
(47)  Cox, P. J.; Wang, W.; Snieckus, V. Tetrahedron Lett. 1992, 33, 2253-2256. 
(48)  Chow, H. F.; Wan, C. W.; Ng, M. K. J. Org. Chem. 1996, 61, 8712-8714. 
(49)  Cram, D. J.; Helgeson, R. C.; Peacock, S. C.; Kaplan, L. J.; Domeier, L. A.; Moreau, P.; Koga, 
K.; Mayer, J. M.; Chao, Y.; Siegel, M. G.; Hoffman, D. H.; Sogah, G. D. Y. J. Org. Chem. 1978, 43, 
1930-1946. 
(50)  Lingenfelter, D. S.; Helgeson, R. C.; Cram, D. J. J. Org. Chem. 1981, 46, 393-406. 
(51)  Wadamoto, M.; Ozasa, N.; Yanagisawa, A.; Yamamoto, H. J. Org. Chem. 2003, 68, 
5593-5601. 
(52)  Sugimoto, K.; Aoyagi, S.; Kibayashi, C. J. Org. Chem. 1997, 62, 2322-2323. 
(53)  Malkov, A. V.; Dufkova, L.; Farrugia, L.; Kocovsky, P. Angew. Chem. Int. Ed. 2003, 42, 
3674-3677. 
(54)  Yamasaki, S.; Fujii, K.; Wada, R.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2002, 124, 
6536-6537. 
(55)  Pribar, I.; Pearlman, P. S.; Stille, J. K. J. Org. Chem. 1983, 48, 4629-4634. 
(56)  Eliel, E. L.; Wilen, S. H. Stereochemistry of Organic Compounds, Wiley, New York, 1994, 
Page 647. 
(57)  Zhang, M. F.; Jia, Y.; Zhou, J. Y.; Wu, S. H. Heteroatom Chem. 1998, 9, 475-478. 




Chapter 3. Asymmetric Allylboration of Cyclic Imines and 
Applications to Alkaloid Syntheses 
 
3.1 Introduction: Enantioselective Allylation of Imino Compounds 
Since Hoffmann reported the first enantioselective allylboration of aldehydes almost thirty 
years ago,1 a large number of chiral allylmetallic reagents have been developed for the 
enantioselective allylation of carbonyl compounds.2,3 However, an analogous reaction to the allylation 
of carbonyls, namely the enantioselective allylation of imino compounds (compounds that contain 
C=N double bonds), has received much less attention. This may be partially due to the lower 
reactivity of C=N double bonds. Nevertheless, such a reaction is of great synthetic value because the 
products are optically active homoallylic amines, compounds which are versatile intermediates in 
total syntheses and are key structural features in many bioactive natural products such as 






















cryptophycin 337  
Figure 3.1 Natural products containing homoallylic amine moieties. 
Owing to increasing demands for chiral nitrogen-containing compounds from the 
pharmaceutical industry, the number of methods for the enantioselective allylation of imino 
compounds has been increasing dramatically in the last few years. Various chiral allylmetallic agents 
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such as B-, In-, Pd-, Si-, Sn- and Zn-based reagents have been successfully adopted in this type of 
transformation. Some examples regarding these enantioselective additions of chiral allylmetallics to 
imino compounds are discussed in the following section. 
3.1.1 Boron-based Allylation of Imino Compounds 
Chiral allylboron reagents have been one of the most popular reagents for the asymmetric 
allylation of carbonyl compounds in the past two decades. However, these reagents are in general not 
very reactive toward imino compounds. In 1995, after surveying the reactivities of various imines 
toward triallylborane, Itsuno found that N-trimethylsilylimine 3.1 was relatively reactive toward 








up to 90% yield





X = p-MeOC6H4 (55%)
      Tr (N.R.)
      MeO (36%)
      SPh (55%)
      Ac (N.R.)
      Ts (Decomp.)
      P(O)Ph2 (N.R.)
Rn Rn
Rn = o-Cl, p-Cl, o-OMe, p-OMe ...  
Scheme 3.1 
Imine 3.1 was then subjected to the asymmetric allylation with chiral allylboranes. It was found 
that allyl oxazaborolidine 3.3 gave the highest enantioselectivity (92% ee) among a variety of chirally 
modified reagents including Roush’s and Brown’s reagents which produced only 32% and 73% ee, 










90% yield, 92% ee
(S)-3.2





83% yield, 32% ee
B)2






However, a low-temperature 11B NMR study conducted by Brown and coworkers revealed that 
Brown’s chiral borane 3.5 did not react with N-TMS imine 3.1 even at room temperature, which is 
inconsistent with the results obtained by Itsuno (70% yield and 73% ee). Instead, they found that a 
fast allylboration took place during the aqueous work-up to produce homoallylic amine (S)-3.2. 
Consequently, they repeated the reaction with dropwise addition of a molar equivalent of water in 
THF to the solution of imine 3.1 and chiral borane 3.5 at -78 oC. A highly reactive aldimine 
intermediate 3.6 was released which reacted immediately with borane 3.5 to give the product amine 
3.2 in 92% ee and 90% yield, which is considerably better than the 73% ee and 70% yield realized by 



















Villiéras and coworkers discovered that chiral β-functionalized allylboronate 3.7 could also 
allylate N-silyl and N-alkylimines in excellent chemical and optical yields.9 The resultant chiral 
amines 3.8 could be converted to α-methylene-γ-lactams 3.9 readily. However, these allylation 
reactions need to be carried out at room temperature for 1-2 weeks which is not very practical 






















In addition, Itsuno also reported the asymmetric allylboration of N-metalloimines 3.10 prepared 
in situ from the corresponding cyano compounds 3.11. 10,11 However, enantioselectivities and yields 












36-90% ee  
Scheme 3.5 
Recently, Kobayashi developed the first three-component synthesis of homoallylic amines 

















74% yield, 34% ee
 
Scheme 3.6 
3.1.2 Indium-based Allylation of Imino Compounds 
Over the past decade, allylindium complexes have become popular as mild reagents for the 
allylation of carbonyl compounds.13-17 However, the application of chiral ligands to indium-mediated 
allylation of C=N double bonds has been a challenge due to the low heterophilicity of organoindium 
reagents and the low reactivity of imino compounds. Nevertheless, several examples of the 
enantioselective allylation of imino compounds utilizing allylindium and chiral inducers have been 
reported recently.  
Cinchona alkaloids, which induce good enantioselectivities in the indium-mediated allylation to 
aldehydes, were applied to the analogous allylation of imines 3.12. Although the yields of these 





















Very recently, another enantioselective allylation of C=N double bonds was reported by Cook 
and coworkers.19 (R)-3,3′-Bis(trifluoromethyl)-binaphthol 2.31, which was introduced by our group, 
was used as chiral additive to induce high enantioselectivity in the allylation of hydrazones 3.14. 
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When stoichiometric amounts of chiral ligand 2.31 were applied, excellent enantioselectivities were 
obtained with aromatic, alkenyl and aliphatic substrates (84-97% ee). A catalytic amount (10 mol%) 
of ligand could be used but gave reduced enantioselectivities. Selected results are listed in Table 3.1.  


















100 mol% 2.31 10 mol% 2.31 
entry R 
yield (%) ee (%) yield (%) ee (%) 
1 Ph 72 84 77 70 
2 4-MeO-C6H4 68 92 74 77 
3 4-Cl-C6H4 61 93 78 82 
4 2-Cl-C6H4 50 97 67 91 
5 PhCH=CH 76 90 79 34 
6 PhCH2CH2 61 92 73 34 
3.1.3 Si/Sn-based Allylation of Imino Compounds 
Allylsilanes and allylstannanes, which have been widely used in the catalytic asymmetric 
allylation of carbonyl compounds, can be applied to the asymmetric allylation of imino compounds as 
well.3 In general, allylsilane/stannane-induced asymmetric allylations are divided into four types: (1) 
chiral allylsilane/stannane-induced allylation; (2) chiral Lewis acid-activated allylation; (3) chiral 
Lewis base-activated allylation and (4) palladium catalyzed allylation.  
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3.1.3.1 Chiral Allylsilane/stannane-induced Allylations 
In 1999, Yamaguchi and coworkers reported the first chiral allylsilane-induced enantioselective 
allylation of N-acyliminium ions 3.17 (Scheme 3.8). 20 Activated cyclic N-acyliminium ions 3.17 
could be allylated by an α-chiral allylsilane (3.18) to produce chiral cyclic homoallylic amides in 






















R = H, Br, COOMe 73-95% ee  
Scheme 3.8 
A similar transformation using chiral allylstannanes was reported by Marshall in 2000, in which 
N-acyliminium ions 3.20 were treated with chiral γ-alkoxy allylstannanes 3.21 to form chiral 















OR265-91%> 95% ee and de
R1 = C6H13, i-Bu, 
        c-C6H11, 2-furyl
R2 =  TBS, MOM
 
Scheme 3.9 
In these cases, since α-chirality on the allylsilane or allylstannane is required for the 
asymmetric induction, transferring an unsubstituted allyl group is impossible.  
A general chiral allylsilane-induced allylation of imino compounds was realized by Leighton 
and coworkers.22,23 They found that allylsilane 3.23 bearing a chiral bidentate ligand is a suitable 
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reagent for the asymmetric allylation of aldehyde-derived hydrazones 3.24. The same chiral 
allylsilane was also applied to the allylation of ketone-derived hydrazones to produce chiral tertiary 



















R = Ar, t-Bu





1 = Ar, c-Hex, PhCH2CH2 ... 
R2 = Me, Et, i-Pr, COOMe ...
85-97% ee  
Scheme 3.10 
3.1.3.2 Chiral Lewis Acid-activated Allylations 
Under the catalysis of chiral Lewis acids, allylsilanes and allylstannanes can transfer an allyl 
group to imino electrophiles in an enantioselective manner. Several chiral-modified metal catalysts 
were found to be effective for this type of transformation. For instance, a copper salt (CuPF6) 
modified with chiral phosphine ligand 3.26 could induce the allylation of N-tosyl iminoester 3.27 in 
moderate enantioselectivity. Allylsilanes could be used in the same reaction but exhibited much lower 
yields.24 However, in the presence of another copper salt (CuClO4), allylsilanes allylate imine 3.27 



















R1 = H, Me
R2 = H, Ph ...
R1
up to 91% yield and 94% ee
 
Scheme 3.11 
Chiral zirconium reagents also proved efficient in catalyzing the addition of allylstannanes to 
imines.  Kobayashi has developed a very effective procedure to synthesize substituted homoallylic 
amines 3.31 from imines 3.29 catalyzed by chiral BINOL-modified zirconium reagents 3.28. High 


























X = Br or ClR1 = Ar R
2 = H or CH2OH
R3 = H or Me
 up to 99% ee
 
Scheme 3.12 
Chiral Lewis acid-catalyzed reactions are sometimes very sensitive to moisture. For example, in 
a copper(I) catalyzed asymmetric allylation of N-tosylimino ester 3.27, high enantioselectivities could 
be obtained only if molecular sieves are present.27 Nevertheless, a water tolerant asymmetric 
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allylation of hydrazones was reported by Kobayashi and coworkers. In the presence of a chiral 
1,2-diamine 3.32 and ZnF2, allyltrimethoxysilanes add to hydrazones 3.33 to give the desired chiral 
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        2-MeOC6H4  
Scheme 3.12 
3.1.3.3 Chiral Lewis Base-activated Allylations 
Recently, Denmark disclosed that electron-pair donors (Lewis bases) have a counter-intuitive 
ability of enhancing the electrophilic character of the electron-pair acceptors (Lewis acids, Scheme 
3.13). This novel concept was soon applied to asymmetric syntheses such as Lewis base catalyzed 







































The first Lewis base-activated allylsilane addition to imino compounds was realized by 
Kobayashi and coworkers.30 Chiral methyl tolyl sulfoxide 3.34 offered good stereocontrol in the 
addition of allyltrichlorosilane to various benzoylhydrazones, including those derived from aliphatic 
aldehydes (Scheme 3.14). Asymmetric crotylations with (Z)- and (E)-crotyltrichlorosilanes also 












R = Me, n-C7H15, i-Pr




Similar additions activated by other chiral bases such as a ferrocene-based chiral sulfoxide 3.35 










Figure 3.2 Chiral catalysts for allyltrichlorosilane additions to hydrazones. 
3.1.3.4 Palladium Catalyzed Allylations 
Yamamoto and co-workers developed chiral bis-π-allylpalladium complexes as catalysts for the 
asymmetric allylation of imines.34-37 A π-allyl complex 3.37 derived from β-(-)-pinene proved to be an 
effective catalyst for the palladium catalyzed asymmetric allyltributylstannane addition to imines. For 
the allylation of a wide range of substrates, up to 91% ee was obtained in the presence of a 
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stoichiometric amount of water. The role of water is crucial in this reaction as lower 














up to 91% ee
R1 = Ar, c-Hex ...
R2 = Me, Bn ...
 
Scheme 3.15 
The asymmetric induction is believed to proceed through a transmetalation between the 
palladium catalyst 3.37 and the allylstannane followed by a nucleophilic addition of the resulting 
allylpalladium species to imines. A six-membered chair-like transition state model for the addition of 
the allylpalladium intermediate to imines was proposed to explain the sense of enantioselectivity 










TSA (Favoured) TSB (Disfavoured)  
Figure 3.3 Transition state model for palladium catalyzed allylation of imines. 
The same palladium catalyst 3.37 could also induce an asymmetric addition of tetraallylsilane 















up to 94% eeR1 = Ar, c-Hex ...




3.1.4 Zn-based Allylations  
In 1996, Hanessian developed an effective method for the enantioselective allylation of 
ketoester oximes 3.38 with phenyl substituted chiral bis(oxazoline)allylzinc reagents 3.39. This 
method provides an expedient access to enantiomerically enriched derivatives of allylglycine 













R1 = H or Me







R3 = H or Me
R4 = H, Me, Ph, COOt-Bu  
Scheme 3.17 
Almost at the same time, Nakamura reported an allylation of cyclic imines using a similar 
chiral allylzinc reagent 3.40. Various chiral cyclic homoallylic amines were synthesized in excellent 
ee’s using this method (Scheme 3.18).39 This also represents the only general method for the 














2) E+ (H, COCF3, or Ts) R
1 R2
R3
3.40a: R1 = R2 = R3 = H; 3.40b: R1 = R2 = H, R3 = Me



























In the previous chapter, we have shown that substituted binaphthol-modified allylboronate 
2.42b is an excellent reagent for the allylation of carbonyl compounds in terms of both chemical and 
optical yields (up to 98% yield and >99% ee). Since it was also found that 2.42b is one of the most 
reactive chiral allylboron reagents toward carbonyls (complete reaction in less than 5 minutes at -78 
oC for aldehydes), we then turned our interest to the more challenging allylboration of imines, an area 
in which limited success has been achieved. Thus, chiral allylboronates (R)-2.42b and (R)-2.42j were 
treated with benzaldimine 3.42 at low temperature. To our delight, the reactions proceeded smoothly 
in both cases to afford the desired homoallylic amine in excellent yields with S configuration. 











2.42b: X = CF3
2.42j: X = 3,5-(CF3)2-C6H3
toluene, -40 oC, 16 h
90% yield, 56% ee for 2.42b







To rationalize this observation, the six-membered transition state model for this imine allylation 
was evaluated. As is illustrated in Figure 3.4, the phenyl ring of the imine adopts an axial position in 
each of the two possible transition states. In transition state A, a clear repulsion between the 
3-substituent on BINOL ring and the bulky phenyl group of imine 3.42 is present. In transition state B, 
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the interaction between the 3-substituent on BINOL and the methylene protons α to the imine 
nitrogen is the major destabilizing factor. Therefore, both transition states are severely destabilized 































Figure 3.4 Transition state model for the allylboration of acyclic imine 3.42. 
Based on the model above, it was thought that improved enantioselectivity could be obtained if 
either of the two destabilizing interactions could be removed. For instance, if Ph groups in both 
transition states are moved to the equatorial position, the repulsion between the 3-substituent on 
BINOL ring and the Ph group in transition state A would be diminished while transition state B 
would not be affected. Consequently, this may result in good enantioselectivities. In other words, the 
allylboration of cyclic (Z) imines would be expected to give better results than acyclic (E) imines 
since the bigger substituent on the cyclic imine would be “locked” in an equatorial position in the 














Racyclic imine cyclic imine
(E) double bond (Z) double bond
 
Figure 3.5 Comparison of the allylation of acyclic imine and cyclic imine. 
The asymmetric allylation of cyclic imines is potentially of great value because the products, 
chiral cyclic homoallylic amines, are found in a number of natural products such as angustifoline and 






















Figure 3.6 Chiral cyclic homoallylic amines in the total synthesis of natural products. 
As previously mentioned, the enantioselective allylation of acyclic imino compounds has 
become one of the most important methods for the preparation of homoallylic amines, and many 
efficient methodologies have been developed in the past few years. However, the analogous 
enantioselective allylation of cyclic imines is very rare. To the best of our knowledge, there have been 
only a few successful enantioselective allylation of cyclic imines using chiral allylzinc39 or allylsilane 
reagents20 (Scheme 3.8 and Scheme 3.18) and there has been no analogous asymmetric allylboration 
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process known for cyclic imines. In the following section, the asymmetric allylboration of cyclic 
imines using substituted binaphthol-modified allylboronates is discussed. 
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3.3 Results and Discussions 
3.3.1 Preparation of Substrates 
Three types of cyclic imines are of particular interest to us since their allylation products are 










n = 0, 1-pyrroline  
n = 1, ∆1-piperideine  
Figure 3.7 Structures of typical cyclic imines. 
Unsubstituted 3,4-dihydroisoquinoline (3.49a) was synthesized from commercially available 












3,4-Dihydroisoquinolines bearing electron-donating groups (3.49b and 3.49c) were synthesized 
via a Bischler-Napieralski reaction (Scheme 3.21).45  
NH2
CHO 1) CH3NO2, AcOH
    NH4OAc (cat.)







3.44b: R1 = R2 = OMe
3.44c: R1, R2 = -OCH2O-
3.44d: R1 = R2 = Cl
3.46b: R1 = R2 = OMe
3.46c: R1, R2 = -OCH2O-
3.46d: R1 = R2 = Cl
3.49b: R1 = R2 = OMe




For 3,4-dihydroisoquinolines bearing electron-withdrawing groups, Bischler-Napieralski 
reactions could not produce the desired cyclic imine products. Other synthetic strategies were applied. 
For instance, 3,4-dichlorophenethylamine 3.46d was successfully converted to a cyclic 
trifluoroacetamide 3.51 using a modified Pictet-Spengler procedure46 developed by Stokker. Removal 
of the trifluoroacetyl group followed by oxidation using NBS gave the desired cyclic imine 3.49d in 













1) 3 N KOH, MeOH






Nitration of 1,2,3,4-tetrahydroisoquinoline (3.48a) using Grunewald’s method gave 
7-nitro-1,2,3,4-tetrahydroisoquinoline (3.48e) along with regioisomers.47,48 Amine 3.48e was then 
purified by the recrystallization of its HCl salt. Finally, the oxidation of 3.48e using NBS afforded the 











3,4-Dihydro-β-carboline (3.53) was prepared in a similar manner to the preparation of 3.49b 
and 3.49c.49 The acidic indolic amine could be further protected using TsCl/NaH to give imine 3.54.50 
The electron-withdrawing nature of the tosyl group also helps to stabilize the oxygen-sensitive indolic 

















An unsubstituted cyclic imine, namely 1-pyrroline (3.57) was synthesized by the oxidation of 
pyrrolidine with iodosobenzene.51 It has been reported that simple cyclic imines such as 3.57 undergo 
trimerization at room temperature. Indeed, we found imine 3.57 readily trimerized in CH2Cl2, which 
was indicated by the gradual disappearance of signals of imine 3.57 in 1H NMR. Therefore, imine 
3.57 has to be freshly prepared prior to use (Scheme 3.25).   
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The same method was attempted to prepare the six-membered cyclic imine ∆1-piperideine 
(3.60). However, complicated mixtures were obtained under various conditions. The desired product 
3.60 was finally obtained using Scully’s method. 52  It was observed that imine 3.60 also trimerized 

















3.3.2 Allylboration of 3,4-Dihydroisoquinoline (3.49a): Condition Optimizations 
With a variety of cyclic imine substrates in hand, we were able to take a look at the asymmetric 
allylboration itself. Thus chiral allylboronate (S)-2.42b was prepared by heating a mixture of one 
equivalent of (S)-BINOL 2.31 and one equivalent of triallylborane in THF. Volatiles were removed 
under high vacuum, and the crude boronate (S)-2.42b was dissolved in toluene (a small amount of 
THF was added to help dissolving the allylboronate) followed by the treatment of 0.66 equivalents of 
imine 3.49a at low temperature (-78 oC - rt). The desired product 3.61a with an R absolute 
configuration (based on the optical rotation39) was obtained in excellent yield and enantioselectivity 

















It was also observed that an excess of ligand 2.31 caused (such as 1.2 equivalents, the amount 
typically used in the allylboration of aldehydes) incomplete reaction and diminished 
enantioselectivity as well. The problem became even worse when 3.49a was replaced by an 
electron-rich imine 3.49b. This is probably due to the coordination between the basic imine nitrogen 
and the proton on the free diol which prevents the allylboronate from coordinating with the imine and 










    3.49a: Rn = H




Allylborations of 3,4-dihydroisoquinoline 3.49a were also conducted using other 
3,3′-disubstituted BINOL-modified allylboronates. The results were summarized in Table 3.2.  The 
unsubstituted parent binaphthol (2.42a) exhibited essentially no stereoselectivity (Table 3.2, entry 1) 
while all of the 3,3′-disubstituted systems (Table 3.2, entries 2-10) examined gave reasonable to 
excellent enantioselectivities. For example, the best reagent for the allylboration of carbonyls, namely 
2.42b, gave 84% ee. 3,3′-Diphenyl reagent 2.42f also gave comparable enantioselectivities (87% ee) 
in this reaction (Table 3.2, entry 6). An electron-rich 3,3′-diaryl reagent 2.42g was tested giving 
essentially the same enantioselectivity as 2.42f (Table 3.2, entry 7). Slightly increasing the bulkiness 
of the aryl groups on the 3 and 3′ positions did not effect on the enantioselectivity of the reaction 
(Table 3.2, entry 8) while a remarkable decrease in enantioselectivity was observed when a much 
bulkier reagent 2.42i was introduced (Table 3.2, entry 10). It was finally found that reagent 2.42j 
which bears 3,5-(CF3)2-C6H3 groups on the 3 and 3′ positions gave an outstanding enantioselectivity 
of 95% ee (Table 3.2, entry 9). The rationale for reagent 2.42j giving better results than other 
3,3′-diaryl reagents is not clear yet, but it is believed to be a combinational result of both steric and 
electronic effects.  
It is worthwhile to point out that the chiral amine product could be isolated by a simple 
acid-base extraction and the chiral ligands were recycled from the organic phases without detectable 
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loss of enantiomeric purities. Thus, although stoichiometric amounts of reagents are employed, these 
reactions are quite practicable. Since 2.42j gave the best enantioselectivity among all chiral 
allylboronates tested, it was chosen for further studies. 







NHPhMe/THF, -78 oC - rt
2.42
3.49a 3.61a  
entry X (compd no.) yield (%)a ee (%)b 
1 H (2.42a) <50 10 
2 CH3 (2.42c) 94 75 
3 CH2t-Bu (2.42d) 81 52 
4 I (2.42e) 87 77 
5 CF3 (2.42b) 83 84 
6 Ph (2.42f) 90 87 
7 4-MeO-C6H4 (2.42g) 94 88 
8 3,5-(Me)2-C6H4 (2.42h) 88 87 
9 3,5-(CF3)2-C6H4 (2.42j) 92 95 
10 3,5-(t-Bu)2-C6H4(2.42i) 86 66 
a Isolated yields after acid-base extraction. b Determined by chiral HPLC analysis of 
the trifluoroacetamide on a Chiralcel OD column. Absolute configuration based on 
rotation.  
3.3.3 Allylboration of Cyclic Imines using Chiral Allylboronate 2.42j 
A variety of substituted dihydroisoquinolines (Table 3.3, entries 1-5) were subjected to the 
allylboration using 2.42j. Reactions of electron rich substrates (Table 3.3, entries 2 and 3) were much 
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slower than those of electron poor substrates (Table 3.3, entries 4 and 5) and longer reaction times 
were required to obtain satisfactory yields. Nonetheless, good yields could be obtained in all cases 
and selectivities observed were uniformly excellent (95% to 99% ee). 3,4-Dihydro-β-carboline (3.53) 
could be allylated using 2.42j without protecting the acidic indole functionality (Table 3.3, entry 6), 
and N-protected 3,4-dihydro-β-carboline 3.54 gave a similar result, indicating that the 
enantioselectivity of the reaction is not affected by the steric or electronic nature of the indole ring 
(Table 3.3, entry 7). 
Aliphatic cyclic imines 1-pyrroline (3.57) and ∆1-piperideine (3.60) were also subjected to the 
allylboration. Although imines 3.57 and 3.60 are enolizable, the allylation reactions were not affected 
and the desired chiral cyclic pyrrolidine and piperidine were obtained with high ee’s (92% and 91% 
ee, respectively, Table 3.3, entries 8 and 9). Slightly lower yields were obtained in both cases, likely 
due to the propensity of the starting imines to undergo rapid trimerization. In these cases, products 
were isolated as Boc or tosyl derivatives to avoid possible problems with volatility or water solubility. 
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1 3.49a (R1 =R2 = H) 3.61a 92b 95 
2 3.49b (R1 = R2 = OMe) 3.61b 78 98 
3 3.49c (R1, R2 = OCH2O) 3.61c 86 98 
4 3.49d (R1 = R2 = Cl) 3.61d 88 95d 










6 3.53  (R = H) 3.61f 80 94 
7 3.54 (R = Ts) 3.61g 84 94 
8 N
NTs
3.57 3.62  65 91e 
9 
N NBoc 3.633.60  71 92e 
a Isolated yields after flash column chromatography on silica gel. b Isolated yields after acid-base extraction. c 
Determined by chiral HPLC analysis of trifluoroacetamides. d Determined by 19F NMR of its R-MTPA amide. e 
The reaction was quenched using TsCl/pyridine/DMAP or (Boc)2O/Et3N/DMAP, and the ee of the product was 
determined by chiral HPLC analysis.  
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The allylboration of a cyclic ketimine 3.64 with allylboronate 2.42j was tested. However, no 
reaction was observed even after 24 hours at room temperature (Scheme 3.29). Compared to 
aldimines, the low reactivity of ketimine 3.64 may be caused by the steric hindrance provided by the 

















In addition, isoquinoline (3.65) was treated with chiral allylboronate 2.42j. A large amount of 
“double-allylation” product 3.66 was isolated along with the desired allylation product 3.67 (Scheme 
3.33). A possible explanation is that the allylation product 3.67 was allylated again during the 
aqueous work-up by allylboronic acid which is the hydrolysis product of the extra chiral allylboronate 























3.3.4 Transition State Model for Allylboration using Chiral Allylboronate 2.42 
The sense of asymmetric induction observed may be explained using a six-membered chair 
transition-state model (Figure 3.8). The repulsion between one of the substituents on the BINOL and 
the methylene protons α to the imine nitrogen is the major destabilizing interaction in transition state 






















Figure 3.8 Transition state model for the allylboration of cyclic imines using allylboronates 2.42. 
3.3.5 Application 1: Total Synthesis of (R)-(-)-Coniine 
NH
(R)-(-)-coniine  
Figure 3.9 Structure of (R)-(-)-coniine. 
As was previously mentioned, allylation products can serve as building blocks for the synthesis 
of natural products. For instance, (R)-(-)-coniine, an alkaloid which has been the target of 
innumerable demonstrations of synthetic methodologies,54-59 could be obtained in one pot from cyclic 
imine 3.57 (Scheme 3.31). 
N
1) 2.42j, PhMe/THF
    -78 oC - rt
2) Pd/C, H2 then HCl/Et2O
NH.HCl
3.57 (R)-(-)-coniine•HCl81% yield
91% ee  
Scheme 3.31 
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(+)-crispine A  
Figure 3.10 Structure of (+)-crispine A. 
(+)-Crispine A is a novel isoquinoline alkaloid that was isolated from Carduus crispus Linn. 
(welted thistle) by Zhao and coworkers. Important cytotoxic activity against SKOV3, KB and HeLa 
human cancer lines has been detected for crispine A according to their report.60  
A retrosynthetic analysis indicated that the five-membered ring of crispine A may be 













crispine A 3.61b  
Scheme 3.32 
However, treatment of 3.61b with mercury(II) salts such as Hg(OAc)2 led only to the formation 
of a pyrrolo[2,1-a]-isoquinoline 3.68 and no desired product was detected. This could be rationalized 
through the formation of intermediate organomecury species 3.69, followed by a rapid β-hydride 
elimination to give an enamine 3.70 which could then be converted to the more stable aromatic 


























Since the one-pot aminomercuration-reduction strategy did not work as intended, a two-step 
hydroboration route was proposed. Thus the allylboration product 3.61b was treated with 9-BBN in 
THF followed by an oxidation with H2O2/NaOH to produce the desired amino alcohol 3.71 in decent 
yield. Unlike common hydroboration/oxidation reactions, the oxidation step in this case only 
proceeds at elevated temperature due to the coordination between boron and the internal amino group. 
An intramolecular Mitsunobu reaction of 3.71 with PPh3/DEAD furnished the desired product 
(+)-crispine A. Alternatively, PPh3/CBr4 could be used instead of PPh3/DEAD to give cleaner and 























       [α]25 +96.9 (c 1.1, CHCl3) 

















Figure 3.11 Structure of emetine. 
Emetine (Figure 3.9) is the principal alkaloid found in “ipecac root” which has been used for 
centuries for the treatment of amebiasis and as an emetic, and was subsequently found to be of greater 
importance for its antiamebic activity.62 
The transformation of an advanced intermediate 3.72 to emetine has been described by others.63 
Amine 3.72 could be accessed from amide 3.73, which is the product of an intramolecular Michael 
addition of enoate 3.74. It was our contention that allylboration product 3.61b could be converted to 




































Accordingly, homoallylic amine 3.61b was treated with butyryl chloride to afford amide 3.75. 
However, the ozonolysis of 3.75 under various conditions proved unfruitful. This problem was likely 
















3.61b 3.75quant.  
Scheme 3.36 
Amide 3.75 was finally converted to the desired aldehyde 3.76 using a 
dihydroxylation-oxidation method developed by Jin and coworkers.64 A Wittig reaction with aldehyde 
3.76 then smoothly generated an α,β-unsaturated ester 3.77. We were hoping that the 3.77 could be 
deprotonated at the α-postion of the amide functionality by bases and undergo an intramolecular 
Michael addition. However, several attempts using bases (such as LDA, LiHMDS, KH etc.) failed to 
give the cyclized product 3.73. Either unreacted starting material or polymers were observed. 3.77 
was also subjected to several Lewis acids [Ti(Oi-Pr)4, TiCl4, BF3·OEt2] but gave no positive result 
(Scheme 3.37). These results indicated that deprotonation at the α-postion of the amide functionality 

































It is known that α-halogenated carbonyl compounds could be converted to enolates under 
various mild conditions. Therefore, a bromine atom was placed at the α-position of the amide as 












Br 1) OsO4, NaIO4
     2,6-lutidine









3.78 3.79a: R = Me
3.79b: R = Et 







The resulting bromoamide 3.79b was treated with radical initiators such as Bu3SnH/AIBN and 
Bu3SnH/BEt3/O2. The desired cyclized product did form but with a large quantity of protonated side 
product 3.80. Reformatsky conditions (CuCN/Zn, ZnEt2) were also attempted but produced mostly 
3.80 and polymers. Later, it was found that SmI2 could induce the desired intramolecular Michael 
addition without producing side product 3.80. However, 1H NMR indicated the formation of 1:1 


























Finally, it was realized that treatment of 3.79a-c with 1.2 equivalents of n-BuLi at low 
temperature resulted in the formation of 3.73a-c in high yield and moderate diastereoselectivities. The 
stereochemistry of the major diastereomer of lactam 3.73b was determined by NOE experiments and 
H-H coupling patterns (Figure 3.12). Disappointingly, we found that it was not the desired 







3.79a-c 3.73a: R = Me, dr = 4:1
3.73b: R = Et, dr = 3.5:1


































JHc-Ha  =  JHc-Hb  = JHc-Hd  =  12.6 Hz  
Figure 3.12 Selected NOE effects and H-H coupling constants for 3.73b. 
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The proposed stereochemistry for 3.73b was further supported by the 1H NMR of the reduction 






















Although the attempt in synthesizing emetine was not fully successful, the novel all-cis 
trisubstituted δ-lactam formation induced by n-BuLi may become a useful tool for the synthesis of 
other natural products. 







Figure 3.13 Structure of corynantheidol. 
The alkaloid corynantheidol was isolated from leaves of Mitragyna parvifolia (Roxb.) Korth 
(Figure 3.11).65 Several total syntheses of corynantheidol have been realized,66,67 while only two 
approaches, by Meyers68 and by Cook,69 were enantioselective. Meyers and coworkers accomplished 
their synthesis from chiral β-carboline 3.82 in 10 steps with 15.4% overall yield (Scheme 3.42), while 
Cook’s route took 12 steps from a natural amino acid D-tryptophan (3.89) in an overall yield of 








a) MeLi, -78 oC
b) ClCH2CN, KH
c) N2H4, H+



































a) 3 N HCl

























































































2) ClCO2i-Bu, NMM, CHCl3;
3) 2-mercaptopyridine N-oxide,





























As was previously mentioned, during a study toward the synthesis of emetine, we found that an 
all-cis trisubstituted δ-lactam could be formed from an n-BuLi induced intramolecular Michael 
addition. We figured that this methodology may be applied to the synthesis of corynantheidol 































Thus allylboration product 3.61g was treated with racemic 2-bromobutyric acid and DCC to 
afford α-bromoamide 3.98 in quantitative yield. Amide 3.98 was then converted to α,β-unsaturated 
ester 3.99 uneventfully. Treatment of 3.99 with n-BuLi at low temperature gave the desired all-cis 
trisubstituted δ-lactam 3.100 in good yield (3.5:1 diastereomers, Scheme 3.45). The stereochemistry 

















1) OsO4 (cat.), NaIO4
     2,6-lutidine (2eq)


















3.61g (94% ee) 3.98
3.99 3.100




Finally, the total synthesis of ent-corynantheidol was accomplished by a “global” reduction 
using LAH which reduced the amide, ester and N-tosylamide all in once (Scheme 3.46). The product 
ent-corynantheidol exhibits an optical rotation value of [α]D25 +93.2 (c 0.65, pyridine) which is the 
opposite to the reported value for corynantheidol ([α]D20 -93.0 (c 0.52, pyridine)) and its spectroscopic 














[α]D25 +93.2 (c 0.65, pyridine) 
lit. for corynantheidol: 
[α]D20 -93.0 (c 0.52, pyridine)
 
Scheme 3.46 
In summary, the total synthesis of ent-corynantheidol was furnished in 6 steps from a readily 
accessible material N-tosyl-3,4-dihydro-β-carboline (3.54) with an overall yield of 34% (Scheme 
3.47). This enantioselective route compares very favourably with the two aforementioned syntheses 
















1) OsO4 (cat.), NaIO4
     2,6-lutidine (2 equiv.)

















3.61g (84% yield, 94% ee)
3.98
3.99 3.100




















3.4 Summary  
A general methodology for the enantioselective allylation of cyclic imines has been developed. 
Addition of 3,3'-disubstituted binaphthol-modified allylboronate 2.42j to cyclic imines proceeded 
smoothly at low temperature to afford α-chiral cyclic homoallylic amines in excellent yields and 
enantioselectivities. The versatility of the allylation products has been demonstrated through efficient 
total syntheses of several alkaloids including (-)-coniine, (+)-crispine A and ent-corynantheidol 
(Scheme 3.48). Results from this chapter have been published in Journal of the American Chemical 

































3.5.1 General Experimental 
All reactions were performed using flame-dried glassware under an argon atmosphere. 
Dichloromethane was freshly distilled from calcium hydride. Tetrahydrofuran, diethyl ether, and 
toluene were freshly distilled from sodium/benzophenone. Chiral 3,3′-disubstituted binaphthols were 
synthesized using procedures from Chapter 2. 1H, 13C and 19F NMR spectra were recorded in CDCl3 
at 300 MHz, 75 MHz and 282 MHz, respectively unless otherwise specified. Mass spectra were 
recorded on a Kratos MA890 mass spectrometer using electron impact (EI, 70 eV) ionization unless 
otherwise specified. Optical rotations were recorded in cells with 10 cm path length on a 
Perkin-Elmer 241 digital polarimeter.  
3.5.2 Preparation of Cyclic Imines 




2) 30%  NaOH
 
Pelletier’s procedure44 was followed: to a solution of 1,2,3,4-tetrahydroisoquinoline (3.48a, 5.4 
g, 40.6 mmol) in CH2Cl2 (100mL) was added NBS (7.95 g, 44.6 mmol) in portions. After the addition 
was complete, the mixture was stirred until TLC (CH2Cl2/MeOH = 9:1) indicated that the starting 
material was consumed (30 minutes). Sodium hydroxide (25 mL of a 30% aqueous solution) was 
added, and stirring was continued for 1 hour at 25 oC. The organic layer was separated and washed 
with water (50 mL), and the product was extracted with 10% HCl (2 x 50 mL). The combined acidic 
extracts were washed with CH2Cl2 (50 mL) and made basic with concentrated ammonia. The liberated 
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oil was extracted with CH2Cl2 (3 x 50 mL), dried over sodium sulfate, and evaporated in vacuo. The 
residue was subjected to bulb-to-bulb distillation [79-81 oC (2 mmHg)] to give 4.26 g (80%) of 3.49a 
as a colorless oil. 1H NMR (CDC13, 300 MHz): δ 2.64 (ArCH2CH2N, t, J = 7.6 Hz, 2H), 3.68 
(ArCH2CH2N, dt, J = 1.8 Hz, 7.6 Hz, 2H), 7.04-7.29 (HAr, m, 4H), 8.24 (Himine, d, J = 1.8 Hz, 1H). 











3,4-dimethoxyphenethylamine (5.0 g, 27.6 mmol) was mixed with ethyl formate (25 mL) and 
was heated to reflux for 12 hours. Volatiles were removed in vacuo and the residue was treated 
carefully at 0 oC with freshly distilled POCl3 (15 mL). When the vigorous initial reaction subsided, 
the mixture was warmed to room temperature over 10 minutes then heated to 40 oC for 10 minutes 
and finally kept at room temperature for 2 hours. The excess POCl3 was evaporated in vacuo, and the 
residue was made basic with concentrated aqueous ammonia. The mixture was extracted with CHCl3 
(5 x 50 mL) and the organic extracts were combined and dried over sodium sulfate. Evaporation of 
volatiles leaves a brown oily residue which was purified using flash column chromatography on silica 
gel (10:1 CH2Cl2/MeOH) to afford 3.49b (3.7 g) in 71 % yield. 1H NMR (CDC13, 300 MHz): δ 2.73 
(ArCH2CH2N, t, J = 7.5 Hz, 2H), 3.82 (ArCH2CH2N, t, J = 7.6 Hz, 2H), 3.93 (OMe, s, 3H), 3.95 
(OMe, s, 3H), 6.71 (HAr, s, 1H), 6.85 (HAr, s, 1H), 8.31 (Himine, s, 1H). 
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3.5.2.3 Preparation of 7,8-Dihydro-[1,3]dioxolo[4,5-g]isoquinoline (3.49c)45 
NH2
CHO 1) CH3NO2, AcOH
    NH4OAc (cat.)









Piperonal (5.4 g, 36.0 mmol) was heated in a 1:1 mixture of CH3NO2 and AcOH (30 mL) at 
100 oC in the presence of NH4OAc (1.3 g, 16.9 mmol) for 12 hours. The resulting dark yellow 
solution was cooled to room temperature and was extracted with diethyl ether (5 x 30 mL). The 
combined ethereal solutions were washed several times with saturated NaHCO3 and dried over 
Na2SO4. Solvents were removed under high vacuum. The residue was dissolved in 50 mL of THF and 
was added to a suspension of LAH (5.0 g, 131.8 mmol) in THF (200 mL) dropwise at 0 oC. The 
reaction was stirred at room temperature for 12 hours before quenching with saturated NH4Cl (10 mL) 
carefully. Solids were filtered off and were washed with EtOAc (5 x 100 mL). The filtrate was 
concentrated to give crude amine 3.46c (5.1 g) in 86% yield (2 steps). Amine 3.46c was converted to 
imine 3.49c using the same method for the preparation of 3.49b in 62% yield. 1H NMR (CDC13, 300 
MHz): δ 2.60 (ArCH2CH2N, t, J = 7.6 Hz, 2H), 3.64 (ArCH2CH2N, dt, J = 1.8 Hz, 7.6 Hz, 2H), 5.92 
(OCH2O, s, 2H), 6.59 (HAr, s, 1H), 6.70 (HAr, s, 1H), 8.10 (Himine, d, J = 1.8 Hz, 1H). 13C NMR 
(CDC13, 75 MHz): δ 159.2 (C=N), 149.2 (CAr), 146.3 (CAr), 131.6 (CAr), 122.6 (CAr), 107.9 (CAr), 
107.4 (CAr), 101.1 (OCH2O), 47.1 (ArCH2CH2N), 25.2 (ArCH2CH2N). 















    H2SO4, HOAc
3.46d  
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3,4-Dichlorophenethylamine (3.46d), which was prepared using the same method for the 
preparation of 3.46c, was converted to trifluoroacetamide 3.51 using Stokker’s procedure46 with 
minor modifications: to a solution of amine 3.46d (4.0 g, 21.0 mmol) in CH2Cl2 (5 mL) at 0 oC was 
added pyridine (10 mL) and trifluoroacetic anhydride (12 mL). The reaction was allowed to warm to 
room temperature for 6 hours before quenching with saturated NH4Cl. The organic layer was 
separated and the aqueous was washed with CH2Cl2 (3 x 50 ml). The combined organic solution was 
washed with water (3 x 50 ml), dried over Na2SO4 then concentrated to give an oily residue. This 
crude trifluoroacetamide (3.9g, 13.6 mmol) was treated with paraformaldehyde (0.67 g, 21.4 mmol) 
in H2SO4/AcOH (38 mL, 3:2) at room temperature. After stirring for 16 hours, the reaction mixture 
was poured into cold water (300 mL) and EtOAc (200 mL). The organic layer was washed with 
saturated NaHCO3 (300 mL), water (200 mL), dried over MgSO4 and evaporated to dryness. 1H NMR 
indicated that the crude material contained a 4:1 mixture of two regioisomers. The major isomer (3.51) 
could be isolated in 52% yield after flash column chromatography on silica gel (8:1 hexanes/EtOAc). 
To a solution of 3.51 (1.3 g, 4.36 mmol) in MeOH (30 mL) was added 3 M KOH (20 mL) and 
the solution was brought to reflux for 4 hours. The reaction was cooled to room temperature and was 
extracted with ether (3 x 20 mL). The combined organic layers were washed with brine, dried over 
Na2SO4, and then concentrated to dryness. The crude amine was converted to the desired imine 3.49d 
following the procedure for the preparation of 3,4-dihydroisoquinoline (3.49a). IR (neat): 1629 (C=N) 
cm-1; 1H NMR (CDC13, 300 MHz): δ 2.68 (ArCH2CH2N, t, J = 7.6 Hz, 2H), 3.76 (ArCH2CH2N, dt, J 
= 1.9 Hz, 7.6 Hz, 2H), 7.24 (HAr, s, 1H), 7.33 (HAr, s, 1H), 8.25 (Himine, d, J = 1.9 Hz, 1H). 13C NMR 
(CDC13, 75 MHz): δ 158.0 (C=N), 135.8 (CAr), 134.7 (CAr), 130.9 (CAr), 129.4 (CAr), 128.7 (CAr), 
 127 
127.6 (CAr), 46.9 (ArCH2CH2N), 24.1 (ArCH2CH2N); MS m/z (relative intensity): 199 (M+, 93), 198 
(M+-H, 100), 172 (M+-HCN, 18), 164 (M+-Cl, 29). 










1,2,3,4-Tetrahydroisoquinoline (11.6 g, 84.8 mmol) was added dropwise with care to stirred 
concentrated H2SO4 (42.0 mL) at 0 oC. Potassium nitrate (9.40 g, 93.0 mmol) was then added in small 
portions. After being stirred overnight at room temperature, the dark brown reaction mixture was 
added carefully to a stirred ice-cold concentrated NH4OH solution. The basic mixture was extracted 
with CHCl3 (3 x 100 mL), and the combined CHCl3 extracts were washed with brine and dried over 
Na2SO4. Evaporation of the organic solvent gave a dark brown oil which was taken up in EtOH (65 
mL) and cooled in an ice bath. Treatment of this reddish solution with concentrated HCl (11 mL) 
yielded a viscous yellow precipitate of the hydrochloride salt which was filtered and crystallized from 
methanol (250 mL) to yield 3.48e·HCl as an off-white solid (5.36 g, 30%).47,48 3.48e was oxidized 
using NBS/NaOH to afford imine 3.49e in 55% yield. IR (neat): 1652 (C=N) cm-1; 1H NMR (CDC13, 
300 MHz): δ 2.79 (ArCH2CH2N, t, J = 8.0 Hz, 2H), 3.77 (ArCH2CH2N, dt, J = 2.1 Hz, 8.0 Hz, 2H), 
7.28 (HAr, d, J = 8.2 Hz, 1H), 8.04 (HAr, d, J = 2.1 Hz, 1H), 8.12 (HAr, dd, J = 2.1 Hz, 8.2 Hz, 1H), 
8.34 (Himine, d, J = 2.1 Hz, 1H); 13C NMR (CDC13, 75 MHz): δ 158.1 (C=N), 147.1 (CAr), 143.5 (CAr), 
128.7 (CAr), 128.5 (CAr), 125.6 (CAr), 121.7 (CAr), 46.8 (ArCH2CH2N), 25.0 (ArCH2CH2N); MS m/z 
(relative intensity): 176 (M+, 100), 130 (M+-NO2, 44). 
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3.52 3.53  
Tryptamine (3.52, 10.0 g, 62.4 mmol) was dissolved in ethyl formate (100 ml) and the solution 
was brought to reflux for 12 hours. Volatiles were removed in vacuo to give an oily residue 
formamide. To this crude formamide was added phosphorus oxychloride (60 mL) at 0 oC and the 
stirring was continued for another 12 hours at room temperature. The bright yellow suspension was 
slowly poured into diethyl ether (250 mL) with rapid stirring. The hydrochloride salt of the 
dihydro-β-carboline which precipitated was then collected by filtration and washed several times with 
ether. The solid was then dissolved in water (300 mL) and the solution was made basic by slow 
addition of aqueous sodium hydroxide (1 M), leading to precipitation of the β-carboline 3.53. The 
mixture was extracted with ether (320 mL), the organic extracts were combined, washed with brine 
(200 mL), dried over sodium sulfate and the solvent removed under reduced pressure, leaving a pale 
yellow amorphous solid 3.53 (7.54 g) in 71% yield. 1H NMR (CDC13, 300 MHz): δ 2.88 
(ArCH2CH2N, s, br, 2H), 3.92 (ArCH2CH2N, s, br, 2H), 7.14 (HAr, t, J = 7.5 Hz, 1H), 7.26 (HAr, t, J = 
7.5 Hz, 1H), 7.35 (HAr, d, J = 7.5 Hz, 1H), 7.57 (HAr, d, J = 7.5 Hz, 1H), 8.38 (Himine or Hindole, s, br, 
1H), 8.47 (Himine or Hindole, s, br, 1H). 





MacLean’s procedure was followed with minor modifications.50 To a suspension of NaH (1.16 
g, 29.2 mmol) in DMF (40 mL) at -10 oC was added a solution of 3.53 (2.80g, 16.5 mmol) in DMF 
(10 mL). The mixture was stirred at that temperature for an hour before cooling down to - 45 oC. TsCl 
(6.3 g, 33.0 mmol) was added to the reaction quickly and the reaction was kept at -45 oC for another 
1.5 hours. The reaction was poured in to 100 mL of 2 M HCl and 100 mL diethyl ether. The aqueous 
layer was separated and the organic layer was washed with 2 M HCl (2 x 50 mL). The combined 
aqueous layers were basified with concentrated ammonia and were extracted with EtOAc (3 x 100 
mL). The Layers were separated and the aqueous phase was washed three times with EtOAc (50 mL). 
The combined organic solution was dried over sodium sulfate and was concentrated. Purification was 
done using flash column chromatography (1:1 EtOAc/hexanes) to produce the imine 3.54 (3.60 g) in 
67% yield. 1H NMR (CDC13, 300 MHz): δ 2.30 (ArCH3, s, 3H), 2.76 (ArCH2CH2N, t, J = 8.8 Hz, 
2H), 3.92 (ArCH2CH2N, dt, J = 2.1 Hz, 8.8 Hz, 2H), 7.04 (HAr, d, J = 8.6 Hz, 2H), 7.27 (HAr, t, J = 
7.6 Hz, 1H), 7.37-7.47 (HAr, m, 2H), 7.64 (HAr, d, J = 8.6 Hz, 2H), 8.17 (HAr, d, J = 7.6 Hz, 1H), 8.99 
(Himine, d, J = 2.1 Hz, 1H). 






To a suspension of iodosobenzene (275 mg, 1.25 mmol) and MS 4Å (100 mg) in 5 mL of 
CH2Cl2 was added pyrrolidine (85.2 mg, 0.10 mL, 1.20 mmol). The completion of the reaction was 
indicated by the disappearance of most solid (20 minutes). 1H NMR showed a 95:5 mixture of imine 
3.57 and its trimer 3.58 (100% NMR yield). This imine solution was used immediately without 
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further purification. 1H NMR (CH2Cl2 with D2O in a sealed tube, 300 MHz, imine-H was not 
detected): δ 1.25-1.45 (CH2CH2CH2-N=C, m, 2H), 1.97-2.02 (CH2CH2CH2-N=C, m, 2H), 3.21-3.23 
(CH2CH2CH2-N=C, m, 2H). 






3.59 3.60  
To a solution of N-chloropiperidine (109 mg, 1.28 mmol) and 18-crown-6 (10 mg) in diethyl 
ether (3 mL) was added KO2 (0.20 g, 2.82 mmol) quickly. The resulting pale yellow suspension was 
stirred at room temperature until TLC showed all starting material 3.59 was consumed (six hours). 
The solids were filtered off and the filtrate (3.60 in ether) was used immediately without further 
purification. Spectra data are identical to those reported in the literature. 
3.5.3 General Procedure for the Allylboration of Cyclic Imines 
To a solution of the appropriate 3,3′-disubstitutedbinaphthol 2.42 (0.35 mmol) in THF (5 mL) 
was added triallylborane (46 mg, 0.34 mmol) dropwise. The reaction was stirred at room temperature 
for 2 hours then brought to reflux for 1 hour (2 hours for 2.42e-j). The allylboronate solution was 
cooled to room temperature and concentrated under reduced pressure.  The resulting white solid was 
dissolved in toluene (5 mL) and THF (1 mL) and the solution was cooled to -78 oC.  A solution of 
the imine (0.21 mmol, 0.1 - 0.5 M) in THF was added dropwise over 2 minutes. The reaction was 
stirred at -78 oC for 24 hours and warmed to room temperature over an additional 24 hours. MeOH (5 
mL) and aqueous NH4Cl (5 mL) were used to quench the reaction. The organic phase was washed 
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with brine and dried over Na2SO4. Purification using flash column chromatography on silica gel 
(EtOAc/MeOH/NH4OH) gave the desired homoallylic amine and the chiral ligand in their pure forms. 
Alternatively, the reaction mixture could be extracted with 2 M HCl (5 x 5 mL). The chiral 
ligand was recovered from the organic phase. The aqueous phase was then basified using 1 M NaOH 
and extracted with diethyl ether (5 x 5 mL). The combined ethereal extracts were dried over Na2SO4 
and evaporation of the solvent gave the homoallylic amine. The enantiomeric purities of the products 
were determined by HPLC analysis (4.6 x 250 mm ChiralCel OD, hexanes/i-PrOH = 99.5/0.5-98/2) 
of their trifluoroacetamides unless otherwise specified. 









[α]25589 +91 (95% ee, c 0.51, THF) [lit.39 (S enantiomer): [α]25589 -98.1 (94.8% ee, c 0.93, THF)]; 
IR (neat): 3304, 3073, 3018, 1639,1583, 913, 742 cm-1; 1H NMR (300 MHz, CDCl3): δ 1.92 (NH, s, 
br, 1H), 2.43-3.02 (Hb, He, Hf , m, 5H), 3.22 (He, dt, J = 11.1 Hz, 5.4 Hz, 1H), 4.03 (Ha, dd, J = 3.3 Hz, 
9.0 Hz, 1H), 5.09-5.22 (Hd, m, 2H), 5.83 (Hc, m, 1H), 7.04-7.17 (HAr, m, 4H); 13C NMR (75 MHz, 
CDCl3): δ 138.6 (CAr), 135.5 (Cc), 135.3 (CAr), 129.2 (CAr), 125.9 (CAr), 125.9 (CAr), 125.7 (CAr), 
117.8 (Cd), 55.0 (Ca), 41.0 (Cb or Ce), 40.5 (Cb or Ce), 29.9 (Cf); The enantiomeric excess of the 
product was determined by HPLC analysis of its trifluoroacetamide: (hexanes/i-PrOH = 99/1, flow 










 [α]25589 -116.5 (95% ee, c 1.68, CHCl3)[lit.39 (S enantiomer): [α]27589 +121.24 (94.8% ee, c 
1.43, CHCl3)]; IR (neat): 3079, 2913, 1689, 1642, 1462, 1270, 1197, 1179, 1141, 921, 765 cm-1; 1H 
NMR (300 MHz, CDCl3, 5.7 : 1 mixture of rotamers): δ 2.50-3.18 (Hb and Hf, m, 4H), 3.36 (He, dt, J 
= 4.8 Hz, 11.4 Hz, 0.15H), 3.60 (He, dt, J = 3.9 Hz, 12.8 Hz, 0.85H), 3.95-4.60 (He, m, 1H), 4.99-5.22 
[Ha (0.15H) and Hd (2H), m, 2.15H] 5.48-6.02 [Ha (0.85H) and Hc (1H), m, 1.85H], 7.03-7.42 (HAr, m, 
4H); 13C NMR (75 MHz, CDCl3, 5.7 : 1 mixture of rotamers, signals for the minor isomer are in italic 
style): δ 156.2 (C=O, q, J = 35.3 Hz), 135.3 (CAr), 135.2 (CAr), 133.7 (Cc), 133.0 (Cc), 132.8 (CAr), 
132.5 (CAr), 129.2 (CAr), 128.8 (CAr), 127.5 (CAr), 127.1 (CAr), 126.6 (CAr), 126.3 (CAr), 118.4 (Cd), 
118.2 (Cd), 116.7 (CF3, q, J = 288.5 Hz), 56.4 (Ca), 53.3 (Ca), 41.6 (Cb), 40.9 (Cb), 39.6 (Ce), 37.3 (Ce), 
29.0 (Cf), 27.3 (Cf); MS m/z (relative intensity): 228 (M+-allyl, 100). 











[α]25589 +87.6 (98% ee, c 0.69, THF); IR (neat): 3333, 3072, 1639, 1610, 1515, 1261, 1224, 
1118, 915, 857, 780 cm-1; 1H NMR (300 MHz, CDCl3): δ 1.80 (NH, s, br, 1H), 2.30-3.15 (Hb, He and 
Hf, m, 6H), 3.72 (OMe, s, 6H), 3.85 (Ha, dd, J = 2.1 Hz, 8.4 Hz, 1H), 4.98-5.16 (Hd, m, 2H), 5.72 (Hc, 
m, 1H), 6.45 (HAr, s, 1H), 6.54 (HAr, s, 1H); 13C NMR (75 MHz, CDCl3): δ 147.1 (CAr), 146.9 (CAr), 
135.4 (Cc), 130.3 (CAr), 127.2 (CAr), 117.6 (Cd), 111.5 (CAr), 108.8 (CAr), 55.7 (OCH3), 55.5 (OCH3), 
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54.5 (Ca), 40.8 (Cb or Ce), 40.5 (Cb or Ce), 29.2 (Cf); MS m/z (relative intensity): 233 (M+, 0.5), 232, 
(M+-H, 2.5), 192 (M+-allyl, 100); The enantiomeric excess of the product was determined by HPLC 
analysis of its trifluoroacetamide: (hexanes/i-PrOH = 98/2, flow rate = 1 mL/min), tR = 17.6 min (S), 











 [α]25589 -113.8 (98% ee, c 0.65, CHCl3) [lit.39 (S enantiomer): [α]25589 +106.8 (95% ee, c 1.29, 
CHCl3)]; IR (neat): 3075, 2937, 2837, 1688, 1642, 1520, 1464, 1256, 1232, 1178, 1195, 1178, 1140, 
1118, 915, 857, 778, 754, 668, 654 cm-1; 1H NMR (300 MHz, CDCl3, 6.1:1 mixture of rotamers): δ 
2.48-2.78 (Hb and Hf, m, 3H), 2.86-3.02 (Hb or Hf, m, 1H), 3.29 (He, dt, J = 4.9 Hz, 12.6 Hz, 0.14H), 
3.56 (He, ddd, J = 4.2 Hz, 12.2 Hz, 14.1 Hz, 0.86H), 3.82 (OMe, s, 3H), 3.83 (OMe, s, 3H), 3.95-4.05 
(He, m, 0.86H), 4.53 (He, m, 0.14H), 4.88 (Ha, t, J = 7.1 Hz, 0.14H), 4.98-5.13 (Hd, m, 2H), 5.51 (Ha, 
dd, J = 5.2 Hz, 9.2 Hz, 0.86H), 5.69-5.88 (Hc, m, 1H), 6.54 (HAr, s, 0.14H), 6.56 (HAr, s, 0.86H), 6.59 
(HAr, s, 0.14H), 6.60 (HAr, s, 0.86H); 13C NMR (75 MHz, CDCl3, 6.1:1 mixture of rotamers, signals 
for the minor isomer are in italic style): δ 155.9 (C=O, q, J = 35.6 Hz), 148.4 (CAr), 148.1 (CAr), 147.8 
(CAr), 147.5 (CAr), 133.7 (Cc), 133.2 (Cc), 127.2 (CAr), 127.1 (CAr), 124.9 (CAr), 124.5 (CAr), 118.8 
(Cd), 118.2 (Cd), 116.5 (CF3, q, J = 287.9 Hz), 111.5 (CAr), 111.1 (CAr), 109.7 (CAr), 109.5 (CAr), 56.0 
(OCH3), 55.9 (OCH3), 53.0 (Ca), 41.7 (Cb), 40.9 (Cb), 39.6 (Ce), 37.2 (Ce), 28.7 (Cf), 27.0 (Cf); MS 
m/z (relative intensity): 228 (M+-allyl, 100). 
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[α]25589 +97.8 (98% ee, c 0.91, THF); IR (neat): 3305, 3073, 2910, 1638, 1503, 1484, 1248, 
1229, 1040, 936, 861, 805 cm-1; 1H NMR (300 MHz, CDCl3): δ 1.74 (NH, s, br, 1H), 2.31-3.22 (Hb, 
He and Hf, m, 6H), 3.89 (Ha, dd, J = 2.7 Hz, 8.4 Hz, 1H), 5.07-5.15 (Hd, m, 2H), 5.79 (Hc, m, 1H), 
5.84 (OCH2O, s, 2H), 6.50 (HAr, s, 1H), 6.60 (HAr, s, 1H); 13C NMR (75 MHz, CDCl3): δ 145.6 (CAr), 
145.5 (CAr), 135.4 (Cc), 131.6 (CAr), 128.4 (CAr), 117.8 (Cd), 108.7 (CAr), 105.9 (CAr), 100.5 (Cg), 55.0 
(Ca), 40.9 (Cb or Ce), 40.6 (Cb or Ce), 30.0 (Cf); MS m/z (relative intensity): 217 (M+, 0.3), 216, (M+-H, 
1.6), 176 (M+-allyl, 100); HRMS m/z Calcd for C13H14NO2 (M+-H): 216.1025. Found: 216.1027; The 
enantiomeric excess of the product was determined by HPLC analysis of its trifluoroacetamide: 












 [α]25589 -94.1 (98% ee, c 1.31, CHCl3); IR (neat): 2910, 1690, 1642, 1506, 1487, 1240, 1199, 
1140, 1040, 923, 864, 753, 668, 650 cm-1; 1H NMR (300 MHz, CDCl3, 6.3:1 mixture of rotamers): δ 
2.48-3.04 (Hb and Hf, m, 4H), 3.32 (He, dt, J = 4.6 Hz, 11.6 Hz, 0.14H), 3.55 (He, dt, J = 3.5 Hz, 11.3 
Hz, 0.86H), 3.91-4.52 (He, m, 1H), 4.82-5.54 (Ha and Hd, m, 3H), 5.70-5.86 (Hc, m, 1H), 5.89 (Hg, s, 
2H), 6.53-6.58 (HAr, m, 2H); 13C NMR (75 MHz, CDCl3, 6.3:1 mixture of rotamers, signals for the 
minor isomer are in italic style): δ 156.0 (C=O, q, J = 30.0 Hz), 149.0 (CAr), 146.8 (CAr), 146.6 (CAr), 
144.4 (CAr), 133.6 (Cc), 133.1 (Cc), 128.4 (CAr), 128.3 (CAr), 126.4 (CAr), 125.9 (CAr), 119.0 (Cd), 
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118.4 (Cd), 116.6 (CF3, q, J = 285 Hz), 108.9 (CAr), 108.4 (CAr), 106.9 (CAr), 106.7 (CAr), 101.1 (Cg), 
56.0 (Ca), 53.4 (Ca), 41.7 (Cb), 41.0 (Cb), 39.7 (Ce), 37.3 (Ce), 29.2 (Cf), 27.4 (Cf); MS m/z (relative 
intensity): 313 (M+, 1.5), 272 (M+-allyl, 100); HRMS m/z Calcd for C15H14F3NO3 (M+-H): 313.0926. 
Found: 313.0934. 











[α]25589 +117.6 (95% ee, c 0.91, THF); IR (neat): 3339, 3076, 2926, 1640, 1472, 1136, 917, 667 
cm-1; 1H NMR (300 MHz, CDCl3): δ 1.75 (NH, s, br, 1H), 2.31-3.33 (Hb, He and Hf, m, 6H), 3.90 (Ha, 
dd, J = 3.0 Hz, 8.7 Hz, 1H), 5.08-5.15 (Hc, m, 2H), 5.74 (Hd, m, 1H), 7.11 (HAr, s, 1H), 7.19 (HAr, s, 
1H); 13C NMR (75 MHz, CDCl3): δ 138.9 (CAr), 135.8 (CAr), 134.8 (Cc), 130.9 (CAr), 129.7 (CAr), 
129.5 (CAr), 127.9 (CAr), 118.6 (Cd), 54.6 (Ca), 40.7 (Cb or Ce), 40.4 (Cb or Ce), 29.3 (Cf); MS m/z 
(relative intensity): 241 (M+, 0.3), 240, (M+-H, 1.1), 200 (M+-allyl, 100); HRMS m/z Calcd for 
C12H12NCl2 (M+-H): 240.0347. Found: 240.0345; The enantiomeric excess of the product was 
determined by 19F NMR of its (R)-MTPA-amide [δ -69.55 (RR), -70.75 (SR)]. 













[α]25589 +144 (99% ee, c 3.4, CHCl3); IR (neat): 3344, 3074, 2927, 1640, 1587, 1518, 1345, 
1279, 1134, 903, 739 cm-1; 1H NMR (300 MHz, CDCl3): δ 2.03 (NH, s, br, 1H), 2.44-3.32 (Hb, He and 
Hf, m, 6H), 4.08 (Ha, dd, J = 3.1 Hz, 8.6 Hz, 1H), 5.14-5.24 (Hc, m, 2H), 5.81 (Hd, m, 1H), 7.23 (Hg, d, 
J = 8.0 Hz, 1H), 7.97 (Hh, dd, J = 2.1Hz, 8.0 Hz, 1H); 8.05 (Hi, d, J = 2.1 Hz, 1H); 13C NMR (75 
MHz, CDCl3): δ 146.2 (CAr), 143.4 (CAr), 140.0 (CAr), 134.4 (Cc), 130.2 (CAr), 121.3 (CAr), 121.0 (CAr), 
118.9 (Cd), 55.0 (Ca), 40.4 (Cb or Ce), 40.2 (Cb or Ce), 30.1 (Cf); MS m/z (relative intensity): 218 (M+, 
0.1), 217, (M+-H, 0.6), 177 (M+-allyl, 100), 131 (M+-NO2-allyl, 37); HRMS m/z Calcd for C9H9N2O2 
(M+-allyl): 177.0664. Found: 177.0662; The enantiomeric excess of the product was determined by 
HPLC analysis of its trifluoroacetamide: (hexanes/i-PrOH = 98/2, flow rate = 1 mL/min), tR = 28.0 












 [α]25589 -137 (99% ee, c 1.67, CHCl3); IR (neat): 2959, 1692, 1640, 1525, 1467, 1346, 1282, 
1260, 1195, 1158, 1141, 1045, 1000, 944, 928, 895, 834, 738 cm-1; 1H NMR (300 MHz, CDCl3, 5.6:1 
mixture of rotamers): δ 2.52-3.16 (Hb and Hf, m, 4H), 3.35 (He, ddd, J = 5.4 Hz, 11.1 Hz, 13.5 Hz, 
0.18H), 3.60 (He, ddd, J = 4.8 Hz, 11.1 Hz, 14.4 Hz, 0.82H), 4.02-4.65 (He, m, 1H), 4.99-5.85 (Ha, Hc 
and Hd, m, 4H), 7.25-7.36 (Hg, m, 1H), 7.95-8.07 (Hh and Hi, m, 2H); 13C NMR (75 MHz, CDCl3, 
5.6:1 mixture of rotamers, signals for the minor isomer are in italic style): δ 156.0 (C=O, q, J = 36.0 
Hz), 146.6 (CAr), 146.3 (CAr), 140.7 (CAr), 140.3 (CAr), 136.8 (CAr), 136.7 (CAr), 132.6 (Cc), 132.0 (cr), 
130.5 (CAr), 130.0 (CAr), 122.4 (CAr), 122.3 (CAr), 122.0 (CAr), 121.9 (CAr), 119.9 (Cd),119.1 (Cd), 
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116.3 (CF3, q, J = 288 Hz), 56.0 (Ca), 53.0 (Ca), 41.3 (Cb), 40.6 (Cb), 38.9 (Ce), 36.3 (Ce), 29.3 (Cf), 
27.5 (Cf); MS m/z (relative intensity): 314 (M+, 0.1), 273 (M+-allyl, 100); HRMS m/z Calcd for 
C11H8F3N2O3 (M+-allyl): 273.0487. Found: 273.0496. 









1H NMR (300 MHz, CDCl3): δ 2.25 (NH, s, br, 1H), 2.44-3.43 (Hb, He and Hf, m, 6H), 4.14 (Ha, t, 
J = 6.3 Hz, 1H), 5.16-5.30 (Hd, m, 2H), 5.87 (Hc, m, 1H), 7.08-7.22 (HAr, m, 2H), 7.27 (HAr, d, J = 7.2 
Hz, 1H), 7.51 (HAr, d, J = 7.2 Hz, 1H), 8.40 (indole-H, s, 1H); 13C NMR (75 MHz, CDCl3): δ 135.7 
(CAr), 135.6 (CAr), 134.9 (Cc), 127.3 (CAr), 121.5 (CAr), 119.2 (CAr), 118.5 (Cd), 118.1 (CAr), 110.8 
(CAr), 109.1 (CAr), 51.9 (Ca), 42.6 (Cb or Ce), 39.3 (Cb or Ce), 22.6 (Cf); 3.61f was derivatized  by 
sequential treatment with (CF3CO)2O/pyridine and TsCl/NaH. The enantiomeric excess of the product 
was then determined by chiral HPLC analysis of that derivative: (hexanes/i-PrOH = 98/2, flow rate = 












[α]25589 -173.2 (94% ee, c 0.50, CHCl3); IR (neat): 3074, 2959, 2925, 1692, 1643, 1598, 1452, 
1377, 1208, 1174, 1143, 1089, 1041, 1022, 800, 756, 666, 584, 572, 543 cm-1; 1H NMR (300 MHz, 
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CDCl3, 5:1 mixture of rotamers): δ 2.27 (CH3, s, 2.5H), 2.28 (CH3, s, 0.5H), 2.42-4.80 (Hb, He and Hf, 
m, 6H), 5.04-5.16 (Hd, m, 2H), 5.68-5.98 [Hc (1H) and Ha (0.17H), 1.17H), 6.39 (Hg, dd, J = 2.8 Hz, 
10.6 Hz, 0.83H), 7.14 (Hh, d, J = 8.3 Hz, 2H), 7.19-7.36 (HAr, m, 3H), 7.55 (Hh, d, J = 8.3 Hz, 0.34H), 
7.67 (Hg, d, J = 8.3 Hz, 1.66H), 8.09 (HAr, d, J = 8.1 Hz, 0.17H), 8.17 (HAr, d, J = 8.3 Hz, 0.83H); 13C 
NMR (75 MHz, CDCl3, 5:1 mixture of rotamers, signals for the minor isomer are in italic style): δ 
156.6 (C=O, q, J = 36.0 Hz), 145.3 (CAr), 145.2 (CAr), 136.9 (CAr), 136.7 (CAr), 134.7 (Cc), 134.3 (Cc), 
134.0 (CAr), 133.5 (CAr), 133.0 (CAr), 130.0 (CAr), 129.9 (CAr), 129.5 (CAr), 129.4 (CAr), 126.8 (CAr), 
126.5 (CAr), 125.5 (CAr), 125.3 (CAr), 124.3 (CAr), 119.0 (CAr), 118.8 (CAr),118.6 (CAr), 118.2 (Cd), 
117.2 (Cd), 115.6 (CAr), 115.4 (CAr), 116.5 (CF3, q, J = 269 Hz), 54.2 (Ca), 51.0 (Ca), 39.9 (Cb), 39.2 
(Cb), 38.2 (Ce), 36.0 (Ce), 22.7 (CH3), 22.2 (Cf), 21.6 (CH3), 20.4 (Cf); MS m/z (relative intensity): 
462 (M+, 1.2), 421 (M+-allyl, 100); HRMS m/z Calcd for C20H16F3N2O3S (M+-allyl): 421.0834. 
Found: 421.0831. 












[α]25589 -202.4 (94% ee, c 1.8, CHCl3); IR (neat): 3337, 3070, 2925, 1639, 1597, 1450, 1366, 1172, 
754, 667, 584, 573 cm-1; 1H NMR (300 MHz, CDCl3): δ 2.06 (NH, s, br, 1H), 2.26 (CH3, s, 3H), 
2.41-3.15 (Hb, He and Hf, m, 6H), 4.53 (Ha, d, J = 9.3 Hz, 1H), 5.14-5.20 (Hd, m, 2H), 5.94 (Hc, m, 
1H), 7.09 (Hh, d, J = 8.1 Hz, 2H), 7.19-7.34 (HAr, m, 3H), 7.51 (Hg, d, J = 8.1 Hz, 2H), 8.11 (HAr, J = 
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6.1 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 144.6 (CAr), 137.8 (CAr), 136.8 (CAr), 136.0 (CAr), 134.9 
(Cc), 130.7 (CAr), 129.6 (CAr), 126.4 (CAr), 124.5 (CAr), 123.8 (CAr), 119.3 (CAr), 118.3 (CAr), 117.7 
(Cd), 115.5 (CAr), 52.6 (Ca), 39.0 (Cb or Ce), 37.2 (Cb or Ce), 22.5 (CH3), 21.5 (Cf); MS(CI) m/e 
(relative intensity): 367 ([M+1]+, 100), 325(M+-allyl, 14), 192 (M+-allyl, 100); HRMS m/z Calcd for 
C18H17N2O2S (M+-allyl): 325.1011. Found: 325.1012; The enantiomeric excess of the product was 
determined by HPLC analysis of its trifluoroacetamide: (hexanes/i-PrOH = 98/2, flow rate = 1 
mL/min), tR = 8.7 min (S), tR = 19.7 min (R).  










The allylation of imine 3.57 (0.24 mmol) was accomplished according to the general procedure. 
To the crude reaction mixture was added TsCl (381 mg, 2 mmol) and DMAP (244 mg, 2 mmol). The 
reaction was stirred at room temperature overnight. Solvent was removed under reduced pressure. 
The residue was purified by column chromatography (1:1 hexanes/EtOAc) to give 43 mg of 3.62 
(65%). [α]25589 -42.2 (91% ee, c 2.22, CH2Cl2) [lit.39 (R enantiomer): [α]27589 +35.1 (89.4% ee, c 0.40, 
CH2Cl2)]; IR (neat): 3066, 2941, 2865, 1628, 1600, 1452, 1380, 1326, 1150, 926, 814, 658, 550 cm-1; 
1H NMR (300 MHz, CDCl3): δ 1.16-1.60 (He, m, 6H), 2.26 (Hb, t, J = 7.7 Hz, 2H), 2.38 (CH3, s, 3H), 
2.94 (Hf, dt, J = 2.6 Hz, 13.7 Hz, 1H), 3.73 (Hf, dd, J = 3.7 Hz, 13.7 Hz, 1H), 4.07 (Ha, m, 1H), 
4.97-5.02 (Hd, m, 2H), 5.65 (Hc, m, 1H), 7.24 (HAr, d, J = 8.0 Hz, 2H), 7.68 (HAr, d, J = 8.0 Hz, 2H); 
13C NMR (75 MHz, CDCl3): δ 142.7 (CAr), 138.7 (CAr), 134.9 (Cc), 129.5 (CAr), 126.9 (CAr), 117.0 
(Cd), 52.4 (Ca), 40.6 (Cf), 33.9 (Cb), 26.5 (Ce), 24.5 (Ce), 21.4 (CH3), 18.1 (Ce); MS (CI) m/z (relative 
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intensity): 280 ([M+1]+, 100), 238, (M+-allyl, 37); The enantiomeric excess of the N-tosylamide 3.62 
was determined by HPLC analysis: (hexanes/i-PrOH = 99.5/0.5, flow rate = 1 mL/min), tR = 47.5 min 
(R), tR =  51.2 min (S).  







The allylation of imine 3.60 (0.20 mmol) was accomplished according to the general procedure. 
To the crude reaction mixture was added (Boc)2O (436 mg, 2 mmol) and NEt3 (0.2 mL). The reaction 
was stirred at room temperature overnight. Solvent was removed under reduced pressure. The residue 
was purified by column chromatography (3:1 hexanes/EtOAc) to give 30 mg of 3.63 (71%).  [α]25589 
-45.4 (92% ee, c1.26, CHCl3) [lit.71 [α]25589 -32.4 (c 1.56, CHCl3)]; IR (neat): 3077, 2976, 1694, 1641, 
1394, 1366, 1173, 1114 cm-1; 1H NMR (300 MHz, CDCl3): δ 1.43 (CMe3, s, 9H), 1.54-1.84 (He, m, 
4H), 2.00-2.55 (Hb, m, 2H), 3.21-3.42 (Hf, m, 2H), 3.66-3.85 (Ha, m, 1H), 4.98-5.05 (Hd, m, 2H), 5.72 
(Hc, m, 1H); 13C NMR (75 MHz, CDCl3): δ 145.0 (C=O), 135.2 (Cc), 116.9 (Cd), 78.8 (OCMe3), 53.7 
(Ca), 45.6 (Cf), 38.1 (Cb), 30.0 (Ce), 28.5 [OC(CH3)3], 23.1 (Ce); MS m/z (relative intensity): 211 (M+, 
0.1), 170 (M+-allyl, 42), 114 (100); The enantiomeric excess of the product was determined by HPLC 
analysis: (hexanes/i-PrOH = 99.5/0.5, flow rate = 0.3 mL/min), tR = 30.0 min (R), tR = 32.3 min (S).  
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3.5.4 Total Synthesis of (+)-Crispine A 











To a solution of amine (R)-361b (110 mg, 0.47 mmol) in THF (10 mL) was added Hg(OAc)2. 
A white precipitate was formed in 30 minutes and TLC indicated that the starting material was all 
consumed. 10% NaOH (20 mL) was added followed by NaBH4 (300 mg) in portions. The grey 
suspension was stirred at room temperature over night and was extracted with diethyl ether (3 x 15 
mL). The combined organic extracts were washed with brine and water then concentrated. 
Purification was done by flash column chromatography (1:1 hexanes/EtOAc) to give the title 
compound (62 mg) in 58% yield. 1H NMR (300 MHz, CDCl3): δ 2.98 (Ha, t, J = 6.6 Hz, 2H), 3.86 
(OMe, s, 3H), 3.90 (OMe, s, 3H), 4.03 (Hb, t, J = 6.6 Hz), 6.18 (Hd, m, 1H), 6.37 (He, m, 1H), 6.62 
(Hc, m, 1H), 6.68 (Hf, s, 1H), 7.00 (Hg, s, 1H); 13C NMR (75 MHz, CDCl3): δ 29.0 (Ca), 44.2 (Cb), 
55.9 (OMe), 56.0 (OMe), 102.2 (Ca), 105.9 (Ca), 108.3 (Cd), 111.3 (Ce), 120.4 (Cc), 122.5 (CAr), 122.7 
(CAr), 129.9 (CAr), 147.2 (CAr), 148.2 (CAr).  











To a solution of amine (R)-3.61b (110 mg, 0.47 mmol) in THF (2 mL) was added 9-BBN (3 
mL, 0.5 M in THF) dropwise. The reaction was stirred at room temperature for 3 hours. A mixture of 
aqueous NaOH (3 M, 5 mL) and 30% H2O2 (5 mL) were added at room temperature. The exothermic 
reaction caused the temperature to quickly rise to 55 oC and this temperature was maintained for 25 
minutes with external heat. The reaction mixture was then cooled to room temperature and extracted 
with Et2O (3 x 5 mL). The combined ethereal extracts were washed with brine (10 mL) and dried over 
Na2SO4. Purification by flash column chromatography (10:1 CH2Cl2/MeOH, 0.5% NH4OH) gave the 
intermediate alcohol (96 mg, 81 %). IR (neat): 3303, 2934, 1611, 1515, 1257, 1223, 1115 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 1.62-2.00 (Hb and Hc, m, 4H), 2.56-2.81 (Hf, m, 2H), 2.95-3.22 (He, m, 
2H), 3.46-3.66 (Hd, m, 2H), 3.81 (OMe, s, 6H), 3.91 (Ha, dd, J = 4.5 Hz, 7.2 Hz, 1H), 4.72 (NH and 
OH, s, br, 2H), 6.52 (HAr, s, 1H), 6.55 (HAr, s, 1H); 13C NMR (75 MHz, CDCl3): δ 147.5 (CAr), 147.4 
(CAr), 130.2 (CAr), 126.6 (CAr), 111.6 (CAr), 109.3 (CAr), 62.8 (Cd), 56.0 (OCH3), 55.8 (OCH3), 55.4 
(Ca), 39.7 (Cb, Cc or Ce), 35.5 (Cb, Cc or Ce), 30.5 (Cb, Cc or Ce), 28.6 (Cf); MS m/z (relative intensity): 
251 (M+, 0.5), 250 (M+-H, 2.4), 232 (M+-H-H2O, 6.5), 192 (M+-CH2CH2CH2OH, 100). HRMS m/z 
Calcd for C14H20NO3 (M+-H): 250.1443. Found: 250.1444. 











The alcohol (96 mg) obtained from the hydroboration of (R)-361b was stirred with PPh3 (262 
mg, 1.0 mmol), CBr4 (331 mg, 1.0 mmol) and i-Pr2NEt (0.3 mL) in THF (10 mL) at room temperature 
for 2 hours, followed by removal of the solvent under reduced pressure. Flash column 
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chromatography (3:1 EtOAc/MeOH, 1% NH4OH) yielded the title compound (73 mg, 66% yield for 2 
steps). [α]25589 +96.9 (c 1.1, CHCl3) [lit.73 [α]23589 +100.4 (>99% ee, c 1, CHCl3)]; IR(neat): 3303, 
2934, 1611, 1515, 1257, 1223, 1115 cm-1; 1H NMR (300 MHz, CDCl3): δ 1.62-2.00 (Hb, m, 3H), 
2.23-2.37 (Hb, m, 1H), 2.48-2.77 (Hc, m, 3H), 2.92-3.21 (Hc, m, 3H), 3.41 (Ha, t, J = 8.4 Hz, 1H), 3.82 
(OMe, s, 6H), 6.54 (HAr, s, 1H), 6.58 (HAr, s, 1H); 13C NMR (75 MHz, CDCl3): δ 147.2 (CAr), 147.1 
(CAr), 130.9 (CAr), 126.2 (CAr), 111.2 (CAr), 108.8 (CAr), 62.9 (Cq), 55.9 (OCH3), 55.8 (OCH3), 53.0 
(Cc), 48.2 (Cc), 30.4 (Cb or Cc), 27.9 (Cb or Cc), 22.2 (Cb); MS m/z (relative intensity): 233 (M+, 43), 
232 (M+-H, 100), 205 (M+-C2H4, 43), 190 (M+-CH2CH2CH2OH, 33).  
3.5.5 Total Synthesis of R-(-)-Coniine·HCl 
NH.HCl
 
Allylation of imine 3.57 (0.32 mmol) was accomplished according to the general procedure. To 
the crude reaction mixture was added 10% Pd/C (5 mol%) and MeOH (3 mL). The suspension was 
stirred at room temperature under a H2 atmosphere balloon for 12 hours before the addition of 
HCl/Et2O (4 mL, 0.5 M). (R)-(-)-Coniine.HCl was obtained after column chromatography on silica 
gel (10:1-6:1 CH2Cl2/MeOH). [α]25589 -6.8 (c 0.34, EtOH) [lit. 74 [α]22589 -7.1 (c 1.0, EtOH)]; 1H NMR 
(300 MHz, CDCl3): δ 0.84 (t, J = 7.3 Hz, 3H), 1.20-1.95 (m, 10H), 2.65-2.94 (m, 2H), 3.23-3.42 (m, 
1H), 9.10 (s, br, 1H), 9.34 (s, br, 1H); 13C NMR (75 MHz, CDCl3): δ 57.0, 44.6, 35.2, 28.0, 22.3, 22.0, 
18.4, 13.6; The enantiomeric excess of the product was determined by HPLC analysis of its 





 [α]25589 -34.5 (c 1.0, benzene) [lit.75 (for S enantiomer): [α]24589 +39.6 (c 0.53, benzene)]; IR 
(neat): 3063, 3021, 2937, 2871, 1598, 1337, 1151, 1093, 932, 815, 712, 694, 653, 599, 552 cm-1. 1H 
NMR (300 MHz, CDCl3): δ 0.86 (t, J = 7.3 Hz, 3H), 1.10-1.65 (m, 10H), 2.39 (s, 3H), 2.96 (t, J = 
13.5 Hz, 1H), 3.71 (dd, J = 3.7 Hz, 13.5 Hz, 1H), 3.95-4.06 (m, 1H), 7.25 (d, J = 7.8 Hz, 2H), 7.69 (d, 
J = 7.8 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 143.2, 139.3, 129.5, 126.9, 52.7, 40.5, 31.6, 27.3, 
24.4, 21.4, 19.6, 18.4, 13.9; MS (CI) m/z (relative intensity): 282 (M+, 100), 238 (M+-CH2CH2CH3, 
31).  










2) OsO4, NaIO4, 

























To a solution of amine (R)-3.61b (300 mg, 1.29 mmol) in CH2Cl2 (5 mL) at 0 oC was added 
butyryl chloride (0.4 mL), triethylamine (0.80 mL) and DMAP (10 mg). The reaction mixture was 
stirred at room temperature overnight before quenching with NaHCO3 (sat.). The organic layer was 
separated and the aqueous phase was washed with CH2Cl2 (3 x 10 mL). The combined organic phases 
were washed with 1 M HCl (10 mL) and brine then dried over Na2SO4. Crude amide 3.75 was 
obtained in quantitative yield after evaporation of the solvent. 
Amide 3.75 (170 mg, 0.56 mmol) was dissolved in 6 mL of dioxane/H2O (3:1) and was treated 
with osmium tetroxide (0.55 mL, 0.012 mmol, 0.022 M in water, 2 mol%), NaIO4 (480 mg, 2.24 
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mmol) and 2,6-lutidine (120 mg, 1.12 mmol). Ethyl acetate (15 mL) was added after the suspension 
was stirred at room temperature for 3 hours. The organic phase was separated and was washed with 
Na2SO3 (sat., 3 x 15 mL) then dried over Na2SO4. Evaporation of volatiles left a pale yellow oil which 
was purified by flash column chromatography (2:1 EtOAc/hexanes) to give pure aldehyde 3.76 (140 
mg) in 82% yield. 1H NMR (300 MHz, CDCl3, 4.9:1 rotamers, signals for the minor isomer are in 
italic style): δ 0.83 (Ha, t, J = 7.1 Hz, 0.51H), 0.85 (Ha, t, J = 7.4 Hz, 2.49H), 1.40-1.68 (Hb, m, 2H), 
2.12-2.41 (Hc, m, 2H), 2.58-3.10 (He and Hi, m, 4H), 3.40 (Hd, ddd, J = 4.5 Hz, 10.3 Hz, 13.7 Hz, 
0.83H), 3.47-3.58 (Hd, m, 0.17H), 3.66-3.83 (2 x OMe and Hd, m, 6.83H), 4.50-4.64 (Hd, m, 0.17H), 
5.39 (Hh, t, J = 6.1 Hz, 0.17H), 5.94 (Hh, dd, J = 4.7 Hz, 9.2 Hz, 0.83H), 6.49 (HAr, s, 0.17H), 6.50 
(HAr, s, 0.17H), 6.51 (HAr, s, 0.83H), 6.58 (HAr, s, 0.83H). 13C NMR (75 MHz, CDCl3, 4.9:1 rotamers, 
signals for the minor isomer are in italic style): δ 200.0 (CHO), 199.3 (CHO), 172.0 (N-C=O), 171.7 
(N-C=O), 148.1 (CAr), 147.9 (CAr), 147.8 (CAr), 147.5 (CAr), 127.8 (CAr), 127.6 (CAr), 126.3 (CAr), 
125.5 (CAr), 111.6 (CAr), 111.2 (CAr), 109.6 (CAr), 108.9 (CAr), 55.9 (OMe), 55.7 (OMe), 51.5 (Ch), 
51.0 (Ch), 49.9 (Ci), 47.6 (Ci), 40.0 (Cd), 35.7 (Cd), 35.3 (Cc), 35.1 (Cc), 28.5 (Ce), 27.2 (Ce), 18.5 (Cb), 
18.3 (Cb), 14.0 (Ca), 13.7 (Ca); MS (EI) m/z (relative intensity): 305 (M+, 3), 287 (M+-H2O, 100). 
To a solution of aldehyde 3.76 (100 mg, 0.33 mmol) in CH2Cl2 (5 mL) was added 
Ph3P=CHCOOEt (150 mg, 0.431 mmol). The solution was stirred at room temperature for 2 hours. 
Evaporation of volatiles resulted in a pale yellow oil which was subjected to flash column 
chromatography (2:1 EtOAc/hexanes) to afford the title compound in quantitative yield. 1H NMR 
(300 MHz, CDCl3, 2.9:1 rotamers, signals for the minor isomer are in italic style): δ 0.83 (Ha, t, J = 
7.4 Hz, 0.78H), 0.87 (Ha, t, J = 7.4 Hz, 2.22H), 1.11-1.21 (Hm, m, 3H), 1.47-1.66 (Hb, m, 2H), 
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2.12-2.40 (Hc, m, 2H), 2.49-2.98 (He and Hi, m, 4H), 3.38 (Hd, ddd, J = 4.6 Hz, 10.3 Hz, 13.9 Hz, 
0.74H), 3.46-3.55 (Hd, m, 0.26H), 3.63-3.84 (2 x OMe and Hd, m, 6.74H), 3.94-4.14 (Hl, m, 2H), 
4.57-4.68 (Hd, m, 0.26H), 4.82 (Hh, dd, J = 6.1Hz, 7.9 Hz, 0.26H), 5.59 (Hh, t, J = 6.8 Hz, 0.74H), 
5.63-5.83 (Hk, m, 1H), 6.46-6.54  (HAr, m, 2H), 6.73-6.93 (Hj, m, 1H); 13C NMR (75 MHz, CDCl3, 
2.9:1 rotamers, signals for the minor isomer are in italic style): δ 171.8 (N-C=O), 171.7 (N-C=O), 
166.1 (O-C=O), 165.8 (O-C=O), 148.2 (CAr), 147.9 (CAr), 147.6 (CAr), 147.4 (CAr), 144.9 (Cj), 143.6 
(Cj), 128.1 (CAr), 127.5 (CAr), 126.7 (CAr), 125.6 (CAr), 124.7 (Ck), 123.6 (Ck), 111.7 (CAr), 111.2 (CAr), 
110.0 (CAr), 109.5 (CAr), 60.4 (Cl), 56.0 (OMe), 55.9 (OMe), 55.4 (Ch), 51.1 (Ch), 40.3 (Cd or Ci), 39.8 
(Cd or Ci), 39.2 (Cd or Ci), 35.6 (Cc), 35.4 (Cd or Ci or Cc), 35.2 (Cd or Ci or Cc), 28.8 (Ce), 27.6 (Ce), 
21.0 (Cb), 18.7 (Cb), 14.3 (Cm), 14.0 (Ca); MS (EI) m/z (relative intensity): 375 (M+, 2), 262 
(M+-CH2CH=CHCOOEt, 100). 





























Compound 3.79a was synthesized using a similar procedure to the preparation of compound 
3.77. To a solution of 3.79a (150 mg, 0.33 mol) in THF (40 mL) at -78 oC was added n-BuLi (0.27 
mL, 0.40 mmol, 1.5 M in hexane, 1.2 equiv.) dropwise. The clear solution was stirred at that 
temperature for 2 minutes before 1 mL of MeOH was added. Solvents were removed in vacuo and the 
1H NMR of the residue (crude 3.73) indicated the existence of two diastereomers (~ 4:1).  
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The crude δ-lactam 3.73 was then taken up in 5 mL of THF and LAH (120 mg, 3.16 mmol) was 
added in one portion at 0 oC. The suspension was brought to reflux for 2 hours before cooling down to 
0 oC again. Saturated NH4Cl solution (0.5 mL) was added very slowly to quench the reaction. Solids 
were filtered off and filtrate was concentrated to leave an oily residue. Purification of this oily residue 
by flash column chromatography (EtOAc) gave the title compound in 68% yield (from 3.79a). 1H 
NMR (300 MHz, CDCl3): δ 0.89 (Ha, t, J = 7.3 Hz, 3H), 1.16-1.35 (Hb and Hf, m, 2H), 1.42 (Hc, m, 
1H), 1.50-1.68 (Hb and Hj, m, 3H), 1.86 (Hi, m, 1H), 1.98 (Hh, m, 1H), 2.25 (Hd, dd, J = 1.6 Hz, 11.1 
Hz, 1H), 2.40  (He, dt, J = 3.5 Hz, 11.7 Hz, 1H), 2.54 (Hf, dd, J = 3.5 Hz, 16.0 Hz, 1H), 2.81 (He, dd, 
J = 6.0 Hz, 11.7 Hz, 1H), 2.90-3.13 (Hc, He and Hg, m, 3H), 3.71 (Hk, t,  J = 6.7 Hz, 2H), 3.81 (OMe, 
s, 3H), 3.82 (OMe, s, 3H), 6.54 (HAr, s, 1H), 6.66 (HAr, s, 1H); 13C NMR (75 MHz, CDCl3): δ 147.3 
(CAr), 147.0 (CAr), 130.6 (CAr), 127.0 (CAr), 111.5 (CAr), 108.1 (CAr), 63.3 (Ca), 60.7 (Ca), 59.0 (Ca), 
56.1 (OMe), 55.8 (OMe), 53.0 (Cg), 39.0 (Cf), 36.6 (Ce), 36.3 (Cl), 33.8 (Ch), 29.3 (Cf), 17.5 (Cb), 12.5 
(Ca). 








A solution of amine 3.61g (220 mg, 0.60 mmol) in CH2Cl2 (20 mL) was treated with DCC 
(1.18 g, 5.72 mmol), 2-bromobutyric acid (957 mg, 5.73 mmol) and DMAP (20 mg) at -10 oC. The 
reaction was allowed to warm to room temperature for 2 hours. Solid material was filtered off and the 
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filtrate was washed with 10% NaHCO3 (aq.). Removal of the volatiles gave the crude amide 3.98 in 
quantitative yield. This crude material was used without further purification. 
















Amide 3.98 was dissolved in dioxane/H2O (3:1, 15 mL). 2,6-Lutidine (0.15 mL), OsO4 (0.6 mL, 
0.022 M in water) and NaIO4 (510 mg, 4.68 mmol) were added and the mixture was stirred at room 
temperature for 4 hours. The reaction mixture was then diluted with EtOAc (10 mL) and water (10 
mL). The organic phase was separated and the aqueous phase was washed with EtOAc (3 x 10 mL). 
The combined organic phases were washed with saturated Na2SO3 and brine then dried over Na2SO4. 
Following removal of the solvent, the crude aldehyde was taken up in CH2Cl2 (10 mL) and treated 
with Ph3P=CHCOOEt (0.28 g, 0.8 mmol) at room temperature for 2 hours. Solvent was then removed 
under reduced pressure. Flash column chromatography (2:1 EtOAc/hexanes) afforded the title 
compound (288 mg, 82% yield for three steps). 1H NMR (300 MHz, DMSO, mixture of 
diastereomers and rotamers) δ 0.75-0.89 (Ha, m, 3H), 1.15 (COOCH2CH3, t, J = 7.1 Hz, 3H), 
1.79-2.26 (Hb and ArCH3, m, 5H), 2.57-3.23 (He and Hg, m, 4H), 3.43-3.61 (Hd, m, 1H), 3.94-4.68 
(COOCH2CH3 and Hd, m, 3H), 4.76-5.64 (Hc, m, 1H), 5.81-7.08 (Hf, Hh and Hi, m, 3H), 7.15-7.48 
(HAr, m, 5H), 7.55-7.69 (HAr, m, 1.74H), 7.74-7.81 (HAr, m, 0.26H), 7.94 (HAr, d, J = 8.4 Hz, 0.13H), 
8.01 (HAr, d, J = 8.2 Hz, 0.87H); 13C NMR (75 MHz, CHCl3, signals for the major isomer): δ 167.8 
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(N-C=O), 165.9 (O-C=O), 144.9 (Ch), 144.0 (CAr), 136.7 (CAr), 134.8 (CAr), 133.9 (CAr), 129.7 (CAr), 
129.6 (CAr), 129.3 (CAr), 126.7 (CAr), 125.0 (Ci or CAr), 124.1 (Ci or CAr), 118.5 (CAr), 118.0 (CAr), 
115.4 (CAr), 60.1 (COOCH2CH3), 48.8 (Cc), 44.7 (Cf), 37.4 (Cd), 36.9 (Ce), 28.8 (Cg), 21.5 (ArCH3), 
20.4 (Hb), 14.2 (COOCH2CH3), 12.1 (Ca); MS (ESI) m/z (relative intensity): 558 (M++H, 100), 238 
(M+-CH2CH2CH3, 31); HRMS m/z Calcd for C28H32BrN2O5S (M++H): 587.1215. Found: 587.1207. 















To a solution of compound 3.99 (220 mg, 0.375 mmol) in THF (35 mL) at -78 oC was added 
n-BuLi (0.414 mmol, 0.28 mL, 1.48 M in hexane) dropwise. The resulting clear solution was stirred 
at that temperature for an additional 2 minutes. The reaction was quenched with a minimum amount 
of saturated NH4Cl solution. Evaporation of the solvent gave an oily residue that was purified by flash 
column chromatography (2:1 EtOAc/hexanes) to afford the title compound (3.100) as a single 
diastereomer (119 mg, 63%). 1H NMR (300 MHz, CDCl3): δ 0.98 (Ha, t, J = 7.4 Hz, 3H), 1.18 
(COOCH2CH3, t, J = 7.1 Hz, 3H), 1.45-1.81 [Hb and Hg (1H), m, 3H], 2.12 (Hi, dd, J = 9.4 Hz, 15.5 
Hz, 1H), 2.23 (ArCH3, s, 3H), 2.38 (Hi, dd, J = 5.7 Hz, 15.5 Hz, 1H), 2.45-2.81 [Hc, Hd (1H) and He, 
Hh, m, 5H], 3.05 (Hg, dt, J = 13.5 Hz, 5.2 Hz, 1H), 4.01-4.12 (COOCH2CH3, m, 2H), 4.96-5.11 [Hd 
(1H) and Hf, m, 2H], 7.04 (HTs, d, J = 8.2 Hz, 2H), 7.15-7.32 (HAr, m, 3H), 7.41 (HTs, d, J = 8.2 Hz, 
2H),  8.06 (HAr, d, J = 9.0 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 172.5 (O-C=O), 172.0 (N-C=O), 
144.9 (CTs), 138.1 (CAr), 135.7 (CAr), 133.2 (CTs), 130.2 (CAr), 129.2 (CTs), 126.4 (CTs), 125.2 (CAr), 
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124.5 (CAr), 123.1 (CAr), 118.6 (CAr), 116.3 (CAr), 60.5 (COOCH2CH3), 53.7 (Cf), 45.3 (Cc), 38.5 (Cd), 
36.9 (Ci), 35.6 (Cg), 31.1 (Ch), 21.7 (Ce), 21.4 (ArCH3), 20.7 (Cb), 14.1 (COOCH2CH3), 12.8 (Ca). 











Ester 3.100 (110 mg, 0.216 mmol) was dissolved in THF (35 mL) and LAH (130 mg, 15 equiv.) 
was added in 4 portions over 2 hours. The suspension was stirred at ambient temperature over night. 
The reaction was then cooled to 0 oC and the unreacted LAH quenched carefully with saturated 
NH4Cl. Removal of solid by filtration resulted in a clear solution that was concentrated to an oily 
residue. Purification by flash column chromatography (12:1 CH2Cl2/MeOH, 0.5% NH4OH) gave the 
desired compound ent-corynantheidol as a white solid (57 mg, 88%), which has identical 
spectroscopic properties to those reported in the literature. [α]D20 +93.2 (c 0.65, pyridine) [lit.68 for 
corynantheidol: [α]D20 -93.0 (c 0.52, pyridine)]; 1H NMR (300 MHz, CDCl3): δ 0.92 (Ha, t, J = 7.3 Hz, 
3H), 1.17-1.94 (Hb, Hc, Hh, Hi and Hk, m, 8H), 2.24 (OH, s, br, 1H), 2.32 (dd, J = 2.2 Hz, 11.5 Hz, 
1H), 2.46-2.75 (Hd, m, 2H), 2.86-3.15 (He, Hf and Hg, m, 4H), 3.71 (Hj, dt, J = 2.5 Hz, 6.5 Hz, 2H), 
7.04-7.15 (HAr, m, 2H), 7.28 (HAr, d, J = 7.4 Hz, 1H), 7.45 (HAr, d, J = 7.3 Hz, 1H), 8.05 (NH, s, br, 
1H); 13C NMR (75 MHz, CDCl3): δ 136.0 (CAr), 135.4 (CAr), 127.4 (CAr), 121.0 (CAr), 119.2 (CAr), 
118.0 (CAr), 110.8 (CAr), 107.9 (CAr), 60.7 (Cj). 60.4 (Cg), 57.9 (Cd or Ce), 53.5 (Cd or Ce), 39.6 (Cc), 
36.5 (Ci), 36.0 (Ch), 31.9 (Cf), 21.7 (Ck), 17.7 (Cb), 12.6 (Ca);MS (EI) m/z (relative intensity): 298 (M+, 
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Chapter 4. Asymmetric Syntheses of Propargylamides via 
3,3′-Disubstituted Binaphthol-modified Alkynylboronates 
 
4.1 Introduction 
Optically active propargyl amines may be encountered within bioactive natural products such as 
dynemicin A, a potent antibiotic and antitumour agent isolated from Micromonospora chersina.1 
They are also present in various synthetic medicinal agents such as (S)-γ-acetylenic GABA 
(γ-aminobutyric acid), which has been shown to be responsible for the inhibition of mammalian 












Dynemicin A  
Figure 4.1 Examples of naturally occurring or bioactive chiral propargyl amines. 
Although there are some interesting targets bearing propargyl amine subunits, the main 
significance of these compounds is from a broader synthetic perspective: Optically active propargyl 
amines serve as versatile synthetic intermediates in the total synthesis of natural products. They can 
be easily converted into various nitrogen-containing compounds such as amino alcohols, amino acids, 




























Not surprisingly, the preparation of optically active propargyl amines has been an important 
topic of organic synthesis. Great efforts have been made in the past two decades to develop new 
methodologies for generating these optically active propargyl amines. These methodologies in general 
can be divided into three categories: (1) chiral pool and stereospecific reactions; (2) chiral auxiliary 
controlled reactions and (3) asymmetric catalytic reactions. Some typical examples are discussed 
below. 
4.1.1 Chiral Pool and Stereospecific Reactions 
A decade ago, when there were not many asymmetric reactions available, the synthesis of 
optically active propargyl amines relied to a great extent on chiral pool chemistry and stereospecific 
functional group transformations.12-18 For instance, propargyl amines 4.2 could be obtained from 














1) Zn, PPh3, CBr4, rt
2) BuLi (3 equiv.)
    THF, -78 oC




Chiral propargyl alcohols, which could be obtained easily from the asymmetric reduction of 
alkynyl ketones or asymmetric alkynylation of aldehydes, are also good starting materials for the 
preparation of optically active propargyl amines.  For example, Holmes and coworkers reported that 
chiral propargyl phthalimide 4.4 could be obtained from propargyl alcohol 4.3 using Mitsunobu 
chemistry.5,16 Compound 4.4 was the key intermediate for the synthesis of (S)-γ-acetylenic GABA 













(S)-γ-acetylenic GABA  
Scheme 4.3 
Similarly, propargyl alcohols could be converted to the corresponding propargyl amines 4.6 
under palladium catalysis (Scheme 4.4). The reaction is believed to go through an allenyl-Pd 










4.5 4.6  
Scheme 4.4 
4.1.2 Enzyme Chemistry 
The important role of enzymes in organic synthesis has been well-documented,20 and the 
advantages include minimal byproducts and mild reaction conditions. In 1999, Botta reported an 
enzymatic resolution of racemic propargyl amine rac-4.7. Racemic propargyl amine 4.7 was mixed 
with lipase B from Candida antarctica in organic solvents such as ether and EtOAc to give both of 
the two enantiomers with >98% ee.13,21 The produced optically active propargyl amine (R)-4.7 was 
the key intermediate for the synthesis of 4.9, which is a potent aromatase inhibitor (IC50 5.3 nM in 
























Another enzymatic desymmetrization of propargyl amine 4.10 was later developed by Halcomb 
in 2003. Amine 4.11 could be obtained from the diacetate 4.10 with moderate ee’s (76-80%) in the 
presence of pig liver esterase (PLE).25 Syntheses of constrained glycopeptides 4.12 and 4.13 were 





























4.1.3 Chiral Auxiliary Controlled Reactions 
4.1.3.1 Alkynylation of Chiral 1,3-Oxazolidines  
Chiral 1,3-oxazolidines 4.14, which can be easily synthesized by the condensation of chiral 
1,2-amino alcohols and aldehydes, are known to react with various organometallic reagents in a 
highly diastereoselective manner to give chiral amines in high chemical and optical yields.26-32 
Husson and coworkers found that 4.14 reacted with aluminum acetylides to give the desired 
propargylamines with excellent yields and diastereoselectivities (Scheme 4.7).33-36  
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4.15R = Ph, C5H11 ...
R' = Me, CH2CH2Ph, 2-furyl, 3-pyridyl ... 75-87% yield
91-97% de  
Scheme 4.7 
Alkynyl Grignard reagents could also be applied in this type of reaction. Thus chiral 
1,3-oxazolidine 4.17 was treated with 1-propynyl magnesium bromide to give a cyclic 
propargylamine 4.18 in diastereomerically pure form. This resulting propargylamine was then treated 


























4.1.3.2 Alkynylation of Chiral Imino Compounds  
The diastereoselective addition of organometallic reagents to the C=N bond of chiral imines or 
their derivatives has proven to be very efficient.38 However, this strategy often gives unsatisfactory 
results for the preparation of propargylamines. Enders and coworkers described a general method for 
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the alkynylation of chiral imines in 1995. However, the reaction involved a 1,2-addition of 
organocerium reagents to aldimines bearing chiral auxiliaries which had to be performed at -100 oC 
and the cleavage of the chiral auxiliaries was sometimes problematic.39,40 The nucleophilic addition of 
alkynyl Grignard reagents on chiral acyliminiums has recently been reported to proceed at more 
elevated temperature (35 °C) but with moderate diastereoselectivities (ca 65 % de) in most cases.41,42 
Recently, Ellman’s auxiliary has been found to be very efficient in inducing high 
diastereoselectivities in the metal acetylides addition to imines.43-45 However, the stereoselectivity of 
this reaction is highly dependent on the metal that is connected with the acetylene (Table 4.1).43 













4.19 4.20  
Met dr (R:S) Yield 
MgEt 1:3 74% 
Li 1:7 99% 
K 2:1 30% 
Si(OEt)3a 20:1 95% 
a Activated with 20 mol% of KOEt and 18-crown-6.  
In 2002, Carreira reported a highly diastereoselective addition of terminal alkynes to chiral 
nitrones 4.21. The method prescribes the use of nitrones which are conveniently prepared through 
condensation of the corresponding aldehydes and a mannose-derived glycosidic N-hydroxylamine. 
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The chiral nitrones were treated with a variety of terminal acetylenes in the presence of Zn (II) triflate, 



















R = Me, i-Pr, c-C6H11, t-Bu, Ph ...






After the reaction was completed, the produced diastereomers 4.22 were treated with 
N-hydroxylamine hydrochloride to give enantiomerically enriched propargylhydroxylamines 4.24 and 





















4.22 4.23 4.24  
Scheme 4.10 
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4.1.3.3 Miscellaneous Reactions  
Chiral propargylamines could also be prepared from a Mannich-type reaction between an achiral 
alkynylimine 4.25 and an enolate 4.26 bearing a chiral auxiliary. The resulting β-amino esters could 




















4.1.4 Asymmetric Catalysis 
Although chiral auxiliary controlled approaches have proven useful, the requirement of the 
attachment and the removal of the chiral auxiliaries is a cumbersome feature. Also, another major 
drawback is that stoichiometric amounts of enantiomerically pure compounds (auxiliaries) are 
required in these processes. Throughout the last decades, numerous efforts have been made to avoid 
these problems. An important development in recent years has been the application of chiral catalysts 
to induce the formation of chiral propargyl amines from achiral starting materials. 
4.1.4.1 Imine Alkynylation 
A pioneering work in the area of imine alkynylation was done by Huffman and coworkers in 
1995. They found that lithium acetylides could add to imino compounds 4.28 in the presence of 
stoichiometric amounts of the lithium salt of quinine to afford enantiomerically enriched products 
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4.29 (Scheme 4.12).2 However the enantioselectivity of this reaction is very sensitive to the structures 
of substrates and lithium acetylides. Although a stoichiometric amount of chiral inducer has to be 





















(up to 94% ee)
 
Scheme 4.12 
In 2002, Li and coworkers developed a highly enantioselective copper(I)-catalyzed direct 
alkyne-imine addition. The process is simple and provides a diverse range of propargylamines in high 
ee’s and good yields. The reaction could be carried out in various solvents (even in water!).  
However, aliphatic acetylenes gave lower enantioselectivities (60-85% ee) and the reaction seemed to 

















up to 93% yield and 96% ee
 
Scheme 4.13 
In 2003, Traverse, Hoveyda and Snapper reported a zirconium-catalyzed method for the 
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enantioselective addition of alkynylzinc reagents to arylimines to afford optically enriched 
propargylamines 4.33 in up to 90% ee. In addition, this study extends the utility of amino acid-based 

















0.6 equiv. Zn TMS
2










Almost at the same time, Knochel reported a copper-mediated three-component synthesis of 
chiral propargylamines. Aliphatic aldehydes, acetylenes and amines are compatible in this reaction 








O CuBr (5 mol%)













4.1.4.2 Alkynylimine Alkylation and Mannich-type Reaction  
Chiral propargylamines can be prepared not only from asymmetric alkynylation of imines, but 
also from the asymmetric alkylation of alkynylimines. Recently, Hoveyda and Snapper disclosed an 
efficient zirconium-mediated process for alkylation of alkynylimines that lead to a wide range of 
enantiomerically enriched propargylamines.53 Once again, the fact that chiral catalyst 4.36 can be 
prepared easily from commercially available and inexpensive amino acids in large quantities makes 





















R = Ph, n-C5H11, TBSO ,




4.37[(R1)2Zn], 0-22 oC, PhMe
 
Scheme 4.16 
Later on, Hoveyda developed the first silver-catalyzed Mannich reaction for the enantioselective 
synthesis of β-alkynyl-β-aminoacids, a class of compounds that is very difficult to access by other 
catalytic protocols. The optically enriched (84-94% ee) products obtained can be further 













PPh2 (4.38, 5 mol%)













4.1.4.3 Enamine Alkynylation 
Another methodology developed by Knochel and coworkers is a type of reaction that is not very 
commonly seen in literature, namely the alkynylation of enamines. Enamines 4.40 reacted with 
terminal alkynes in the presence of a catalytic amount of CuBr and (+)-quinap to give chiral 















R2, R3 = Allyl, Bn, PMB ...






A careful mechanistic study showed that the acetylenic deuterium atom of the 
[D]phenylacetylene is transferred to the β-position of enamine 4.40 leading to the formation of the 
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Very similar to chiral propargylamines, stereochemically defined propargylamides are also 
present in many bioactive compounds (such as FR184764)57 and are important as synthetic 









Figure 4.2 Structure of a bioactive compound FR184764. 
Typical routes to prepare chiral propargylamides include metal complexes (Cu, Zn, and Zr) 
catalyzed terminal alkyne addition to achiral imines or the addition of alkynylmetallics to imino 
compounds or 1,3-oxazolidines bearing chiral auxiliaries. Protecting groups or auxiliaries are then 
removed, and the intermediate chiral propargylamines are acylated to provide the desired 
propargylamides. These procedures are sometimes tedious and possibly problematic. For example, in 
one of the chiral auxiliary-controlled alkynylation reactions mentioned above, diastereomerically pure 
propargylamines 4.15 could be obtained in good yields. However, to convert 4.15 to propargylamides 


















R1 = Me, (CH2)2Ph, 2-fur
R2 = C5H11, Ph
 
Scheme 4.20 
To our knowledge, a general method that provides reliable and direct access to enantiomerically 
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enriched propargylamides via asymmetric synthesis has not been reported. Therefore, it seemed 
worthwhile to look for an efficient method for the synthesis of these compounds. 
Recently, our group found that 3,3′-disubstitutedbinaphthol-modified alkynylboronates 2.11 
could deliver alkynyl groups onto enones in a conjugate fashion with excellent yields (up to 99%) and 














up to >99% ee
X = Ar, CF3, Halo...




If the α-carbon of enone 4.43 is replaced by a nitrogen, the resulting structure will be an 
N-acylimine (4.44) which also bears a carbonyl group conjugated with a double bond (C=N instead of 
C=C). It is reasonable to believe that N-acylimines, being structurally similar to enones, may also 



















4.3 Results and Discussions 
4.3.1 Preparation of N-Acylimines 
In order to examine our idea, N-acylimines needed to be synthesized. It was reported by Kupfer 
that N-acylimines 4.44 could be obtained from the reaction of N-TMS protected imines 4.46 and acyl 
chlorides in excellent yields and that N-TMS imines 4.46 were easily prepared from the 
corresponding aldehydes (Scheme 4.23).63,64 Since N-acylimines are very sensitive to moisture, they 













4.3.2 Optimization of Reaction Conditions 
Binaphthol-modified alkynylboronates 4.47 were prepared according to a previous procedure 
(Scheme 4.24).62 Upon treatment of boronate 4.47a (X = H, R = n-C6H13) with 
N-benzoylbenzaldimine (4.44a) in various common organic solvents, the desired propargylamide 
4.45a was obtained in excellent chemical yields and moderate enantioselectivities. Dichloromethane, 











4.47 (R = n-C6H13, Ar)
2.27-2.37







Oi-PrLi BF3•OEt2 (1.33 equiv.)

























entry solvent yield (%) ee (%)c 
1a CH2Cl2 86 59 
2b CH2Cl2 84 64 
3a PhMe 92 48 
4a CH3CN 80 35 
5a Et2O 90 48 
a the reaction was run at rt for 12 h. b reactants were mixed at 78 oC then warmed 
to rt for 12 h. c Determined by HPLC analysis with a Chiralcel OD column 
4.3.3 Ligand Screening 
When 3,3′-disubstitutedbinaphthols were used in place of the parent binaphthol, additions to 
N-benzoylbenzaldimine (4.44a) were considerably more selective (Table 4.3, entries 2-7). Among a 
variety of boronates (4.47a-g), 3,3′-diarylbinaphthol-modified boronates (4.47f and 4.47g) gave the 
best results in terms of both yield and enantioselectivity (Table 4.3, entries 6 and 7). Boronates 
bearing electron-withdrawing groups on the binaphthol rings gave poor yields (Table 4.3, entries 3-5) 
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and possible reasons for this will be discussed later in this section. 
Table 4.3 Alkynylation of N-benzoylbenzaldimine (4.44a) with 3,3′-disubstituted 

















entry X yielda (%) eeb (%) 
1 H (4.47a) 84 64 
2 Me (4.47b) 85 67 
3 I (4.47c) 30 80 
4 CF3 (4.47d) <20 75 
5 COOi-Pr (4.47e) <20 N. D.c 
6 Ph (4.47f) 82 80 
7 4-MeOC6H4 (4.47g) 84 80 
a Isolated yields of purified products based on chiral boronates 
(acylimines were generated in situ without isolation). b Determined by 
HPLC analysis with a Chiralcel OD column. c Not determined. 
Reactions of imines bearing different N-acyl groups were also examined (Table 4.4). The best 
result (in terms of both enantioselectivity and yield) was obtained from the reaction of N-acetylimine 
4.44c and boronate 4.47f (Table 4.4, entry 8). 
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CH2Cl2, -78 oC  to  rt, 24 h
R = Ph (4.44a)
      OBn (4.44b)
      CH3 (4.44c)
4.47
R = Ph (4.45a)
      OBn (4.45b)
      CH3 (4.45c)  
entry R X yield (%)a ee (%)b 
1 Ph I (4.47c) 30 80 
2 Ph Ph (4.47f) 82 80 
3 OBn I (4.47c) 40 80 
4 OBn Ph (4.47f) 90 40 
5 OBn 3,5-(Me)2-phenyl (4.47h) 86 15 
6 OBn 3,5-(CF3)2-phenyl (4.47i) 83 14 
7 CH3 I (4.47c) 33 94 
8 CH3 Ph (4.47f) 75 92 
9 CH3 4-MeOC6H4 (4.47g) 74 90 
a Isolated yields of purified products based on chiral boronates (acylimines were generated in situ 
without isolation). b Determined by HPLC analysis with a Chiralcel OD column.  
As noted above, it was found that all boronates with relatively strong electron-withdrawing 
groups at the 3 and 3′ positions of the binaphthol rings gave poor yields (Table 4.4, entries 1, 3 and 7). 
This result may be rationalized by proposing that, to deliver the alkynyl group in a 1,4-fashion, 
alkynylboronates must coordinate with the oxygen atom of the N-acylimines (Scheme 4.25). 
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Electron-withdrawing groups (I, CF3, COOi-Pr) increase the Lewis acidity of boronates and thus 
increase the possibility of boron coordinating with the nitrogen atom of the N-acylimine, leading to 
poor yields. We have no experimental evidence for this coordination, but it is offered as a speculation 
as to why electron-withdrawing groups have a major negative impact on reactions of 
























when X = CF3, I, COOi-Pr
A
B










4.3.4 Scope and Limitations 
The alkynylation of other N-acetylimines using 4.47f and 4.47j were studied. All reactions 
proceeded smoothly to give products 4.45c-k in high yields (Table 4.5). Excellent enantioselectivities 
(>90% ee) were observed for all of the aromatic imines examined (Table 4.5, entries 1-6, 8 and 9) 
with highest selectivities (99% ee) noted for aromatic groups that are ortho substituted (Table 4.5, 
entries 5 and 6). Similar to the results from our previous study on allylboration, high yield but lower 
selectivity were found with an alkenylimine (67% ee, Table 4.5, entry 7). However, with a larger 
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alkenyl group, excellent selectivity was obtained (92% ee, Table 4.5, entry 10). Aliphatic acylimines 
were not examined as the method of preparation used is applicable only to non-enolizable aldehydes. 
The adduct 4.45k was prepared particularly to determine the absolute configuration of the addition 
products. (S)-Boronate 4.47j produced propargylamide 4.45k with S stereochemistry which has been 
proven by X-ray crystallographic analysis (Figure 4.3). 
 
Figure 4.3 X-ray crystal structure of (S)-4.45k. 
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CH2Cl2, -78 oC  to  rt, 24 hR H
O 1) LiHMDS
2) CH3COCl R H
N CH3
O
4.45c-jR' = C6H13 (4.47f)
        Ph (4.47j)  
entry R R′ compd no. yield (%)a ee (%)b 
1 Ph n-C6H13 4.45c 75 92 
2 4-ClC6H4 n-C6H13 4.45d 72 91 
3 4-MeOC6H4 n-C6H13 4.45e 81 92 
4 4-MeC6H4 n-C6H13 4.45f 76 92 
5 2-MeC6H4 n-C6H13 4.45g 78 99 
6 1-naphthyl n-C6H13 4.45h 70 >99c 
7 PhCH=CH n-C6H13 4.45i 75 67 
8 Ph Ph 4.45j 85 92 
9 4-BrC6H4 Ph 4.45k 75 91 
10 PhCH=C(CH3) Ph 4.45l 80 93 
a Isolated yields of purified products based on chiral boronates (acylimines were 
generated in situ without isolation). b Determined by HPLC analysis with a 
Chiralcel OD column. c The minor enantiomer was not detected by HPLC 
analysis. 
4.3.5 Proposed Model 
Given the fact that S boronates produce (S)-propargylamides, we were able to propose a working 
model for the transition state of the alkynylation. The stereochemical result could be explained using 
a cyclic six-membered chair transition state model similar to that proposed for additions of the same 
alkynylboronate reagents to enones (Figure 4.4).62 In this model, the larger or aryl group occupies an 
 178
equatorial position in either of two possible transition states. The 3- and 3′-substituents on the 
binaphthol play an important role in destabilizing one of the possible transition states. The nonbonded 
interactions between the 3-substituent (phenyl) and the axial imine hydrogen presumably favour B 






















Figure 4.4 Proposed transition state model of the asymmetric alkynylation of N-acylimines. 
4.3.6 Synthesis of (-)-N-Acetylcolchinol (ZD6126 Phenol) 
With this general methodology in hand, we were able to look into one of its potential 
applications in total synthesis: ZD6126 phenol.  
ZD6126 is a novel vascular targeting agent that was developed for its tubulin-binding properties 
and its ability to induce vascular damage in tumors. It is a phosphate prodrug of the tubulin binding 
agent N-acetylcolchinol (ZD6126 Phenol) that inhibits microtubule polymerization (Figure 4.5). 
Release of ZD6126 Phenol by phosphatases in vivo leads to the selective disruption of the 
cytoskeleton of tumor endothelial cells. This results in selective occlusion of tumor blood vessels, 



















4.49: (-)-N-acetylcolchinol  
Figure 4.5 Structures of ZD-6126 and (-)-N-acetylcolchinol. 
A retrosynthetic analysis indicated that the B ring of the final product could be formed by an 
intramolecular oxidative biaryl coupling of compound 4.50. This acetamide could be obtained from a 


































The total synthesis started with the commercially available methyl 3,4,5-trihydroxybenzoate 
(4.54). Protection of all three hydroxyl groups followed by the reduction of the ester gave aldehyde 
4.56 which was easily converted to the corresponding aryl acetylene using Corey-Fuchs chemistry.70 
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Treatment of acetylene 4.53 with n-butyllithium and triisopropylborate sequentially gave an “ate” 













1) LAH / THF
























Mixing the “ate” complex with (R)-3,3′-diphenyl binaphthol (2.32), followed by the treatment 
with dry HCl in Et2O, gave the chiral alkynylboronate 4.47k (C ring precursor) which is moisture 













Ph4.57 4.47k  
Scheme 4.28 
To prepare the requisite substrate, TBS protected 3-hydroxybenzaldehyde 4.52 was converted to 
the corresponding N-acetylimine which was then treated in situ with boronate 4.47k to afford 
(R)-propargylacetamide 4.51 in 72% yield and 94% ee. (On the basis of the reaction model proposed, 
(R)-diphenylbinaphthol should give the natural enantiomer of the final product, whereas 
(S)-diphenylbinaphthol would give the other enantiomer). After hydrogenation over Pd/C, the 
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saturated compound (S)-4.50 was obtained in quantitative yield. Finally, following Sawyer’s 
procedure,71 (S)-4.50 was transformed into (-)-N-acetylcolchinol 4.50 by treatment with (CF3COO)3Tl 
in the presence of freshly distilled BF3·OEt2, trifluoroacetic acid and trifluoroacetic anhydride in an 
unoptimized yield of 53% (Scheme 4.29). This material exhibited an optical rotation of [α]25D -45.2 (c 
0.6, CHCl3), which is comparable to the literature value for (-)-N-acetylcolchinol obtained from 
degradation of (-)-colchicine ([α]D20 -51.6 (c 1.23, CHCl3)).72 The biaryl coupling has also been 
attempted with other oxidizing reagents (such as PhI(OAc)2, PhI(O2CCF3)2, RuO2, RuCl3/NaIO4), but 




































4.3.7 Recent Advances in the Asymmetric Alkynylation of N-Acylimines 
It needs to be mentioned that, during the preparation of this thesis, Soderquist also reported a 
very similar asymmetric alkynylation of N-acetylimines using chiral alkynylborane 4.58.73 A number 
















R2 = Ar, t-Bu
R1 = alkyl, alkenyl
50-82% yield




4.4 Summary and Future Work  
 In summary, we have shown that 3,3′-disubstituted binaphthol-modified alkynylboronates can be 
used to prepare chiral propargylamides in high yields (70-85%) and enantioselectivities (up to >99% 
ee). This represents the first direct enantioselective synthesis of chiral propargylamides and this 
methodology was also applied to the first enantioselective total synthesis of the antitubulin reagent 
(-)-N-acetylcolchinol (or ZD6126 phenol, Scheme 4.31). Part of this work has been published in 











CH2Cl2, -78 oC  to  rt, 24 hR H
O 1) LiHMDS
2) CH3COCl R H
N CH3
O
R = Ar, Alkenyl ...








up to >99% ee  
Scheme 4.31 
In order to obtain high enantioselectivity in the alkynylation, an acetyl group needs to be present 
on the imine nitrogen. Acyl groups other than acetyl lead to low enantioselectivities (<80% ee). 
However, an acetyl group is not a very “handy” protecting group as taking it off can be problematic 
sometimes. For instance, in an effort to replace the acetyl group with a Boc group using a reported 




























In the future, a mild method that removes the acetyl group on these chiral propargylamides 
should be investigated. On the other hand, in order to broaden the scope of this methodology, efforts 
could be directed toward the discovery of chiral alkynylboronates that can induce high 















R1 = Ar, Alkenyl ...
R2 = Alkyl, Aryl, Alkoxy ...





It is known that internal alkynes could be oxidized to afford carboxylic acids. The oxidation of 
chiral propargylamides might give arylglycines which are valuable precursors to many natural 
products. For example, an aldehyde 4.63 was prepared easily from commercially available methyl 
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3,4,5-trihydroxybenzoate (4.62). Aldehyde 4.63 was converted to the corresponding chiral 
propargylamide 4.64 in good yield (61%) and excellent enantioselectivity (>99% ee). Oxidation of 
4.64 would give carboxylic acid 4.66 which may serve as the central-arylglycine synthon in the total 
synthesis of vancomycin. However, several attempts (such as KMnO4 or O3) to oxidize 
propargylamide 4.64 failed to give the desired product 4.66. Instead, it seemed that the electron-rich 
aromatic ring of propargylamide 4.64 was oxidized in these cases. Therefore, reaction conditions that 






























Another application of our methodology would be the synthesis of chiral piperidines and 
pyrrolidines which are encountered in many natural products. A model reaction suggested that a 
chiral pyrrolidine 4.69 may be obtained in two steps from propargylamide 4.67. This method may be 




















4.5.1 General Experimental 
All reactions were performed using flame-dried glassware under an argon atmosphere. 
Dichloromethane was freshly distilled from CaH2. THF and diethyl ether was freshly distilled from 
Na/benzophenone. CHCl3 was freshly distilled from P2O5 then passed through a basic alumina 
column. Acetyl chloride was distilled prior to use. Chiral 3,3′-disubstituted binaphthols were 
synthesized using procedures from a previous report.1 Lithium triisopropyl-B-1-alkynylborate was 
prepared according to a literature procedure.2 1H and 13C NMR spectra were recorded in CDCl3 at 300 
MHz and 75 MHz , respectively. Elemental analyses were conducted by M-H-W Laboratories, 
Phoenix, Arizona. Mass spectra were recorded on a Kratos MA890 mass spectrometer using electron 
impact (EI, 70 eV) ionization. Optical rotations were recorded in cells with 10 cm path length on a 
Perkin-Elmer 241 digital polarimeter. 





To 4.59 mL (28.4 mmol) of 1,1,1,3,3,3-hexamethyldisilazane (HMDS) was added 16.1 mL 
(25.8 mmol) of a 1.6 M hexane solution of n-butyllithium over a 5-min period. Solvents were 
removed in vacuo until a white precipitate appeared. The resulting slurry was cooled in an ice bath, 
and 2.74 g (25.8 mmol) of benzaldehyde was added over a 10-min period. Direct fractional 
distillation of the resulting solution gave 3.7 g (89%) of imine 4.46 as a pale yellow liquid: bp 45-46 
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oC (0.15 mmHg); 1H NMR (CDC13): δ 0.26 (SiMe3, s, 9H), 7.39-7.47 (HAr, m, 3 H), 7.77-7.83 (HAr, 
m, 2 H), 8.98 (CH=N, s, 1 H). 
4.5.3 General Procedure for the Preparation of 3,3′-Disubstituted Binaphthol-modified 
Alkynylboronates (4.47a-i)62 
A literature procedure was followed with minor modifications: to a mixture of 
3,3′-disubstitutedbinaphthol (0.51 mmol) and lithium triisopropyl-B-1-alkynylborate (0.50 mmol) was 
added 5 mL of THF at 0 oC. The resulting clear solution was stirred at room temperature for 6 h. 
Solvent was removed under reduced pressure. The residue was suspended in 5 mL of Et2O before 
anhydrous HCl/Et2O (1.0 mL, 0.50 M) was added dropwise at -78 oC. The solution was allowed to 
warm to room temperature for 0.5 h. Evaporation of volatiles gave the desired product as a white 
foam. Compounds 4.47a-i are moisture sensitive and thus were used directly without isolation and 
further purification. 
4.5.4 General Procedure for the Alkynylation of N-Acylimines 
To a solution of lithium hexamethyldisilazide (1.1 mmol) in 1 mL of hexane was added 
aldehyde (1.0 mmol) at 0 oC. The resulting solution was stirred at room temperature for 30 minutes 
before TMSCl (1.1 mmol) in 1 mL of THF was added. The suspension was stirred at room 
temperature for another 0.5 h. Solvent was removed under high vacuum. To the oily residue was 
added 6 mL of CHCl3 then acetyl chloride (1.5 mmol, 1.1 mmol for all other acyl chlorides) at 0 oC. 
The reaction was kept at 0 oC for 3 h (for other acetyl chlorides, the reaction was brought to reflux for 
3 h). Volatiles were removed under high vacuum to give the acylimine as a pale yellow oil. To the 
crude material was added CH2Cl2 then the chiral alkynylboronate (0.5 mmol) in CH2Cl2 at -78 oC. 
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The reaction was allowed to warm to room temperature slowly for 24 h. Workup was done by 
quenching the reaction with saturated aqueous NH4Cl. The organic phase was separated, and the 
aqueous phase was extracted with CH2Cl2 for three times. The organic layers were combined and 
dried over Na2SO4. Column chromatography (hexanes/EtOAc 2:1) gave the desired chiral propargyl 
amide and 3,3'-disubstitutedbinaphthol in pure form. The enantiomeric excesses of products were 
determined by the HPLC (4.6 x 250 mm Chiralcel OD) analysis. 








IR (KBr): 3295 (N-H), 1638 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.88 (Hd, t, J = 6.9 Hz, 
3H), 1.27-1.56 (Hc, m, 8H), 2.25 (Hb, dt, J = 1.8 Hz, 6.9 Hz, 2H), 6.21 (Ha, d, br, J = 8.4 Hz, 1H), 
6.82 (NH, d, J = 8.4 Hz, 1H), 7.27-7.78 (HAr, m, 10H); 13C NMR (75 MHz, CDCl3): δ 166.0 (C=O), 
139.6 (CAr), 133.8 (CAr), 131.5 (CAr), 128.5 (CAr), 128.4 (CAr), 127.8 (CAr), 127.0 (CAr), 127.0 (CAr), 
85.7 (C≡C), 77.8 (C≡C), 45.2 (Ca), 31.2 (Cc), 28.5 (Cc), 22.4 (Cc), 18.7 (Cb), 13.9 (Cd); MS m/e 
(relative intensity): 319 (M+, 11), 290 (M+-C2H5, 8), 248 (M+-C5H11, 100); Anal. Calcd for C22H25NO: 
C, 82.72; H, 7.89; N, 4.38. Found: C, 82.53; H, 8.03; N, 4.53. The enantiomeric excess of the product 
was determined by HPLC (hexanes/i-PrOH = 98/2, flow rate = 1 mL/min), tR = 14.3 min (S), tR = 
19.6 min (R). [α]D25 +8.9 (80% ee, c 0.9, CHCl3). 
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IR (KBr): 3325 (N-H), 1702 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.88 (Hd, t, J = 6.9 Hz, 
3H), 1.28-1.60 (Hc, m, 8H), 2.20-2.25 (Hb, m, 2H), 5.06-5.23 (Ha and He, m, 3H), 5.68 (NH, d, br, J = 
7.2 Hz, 1H), 7.28-7.50 (HAr, m, 10H); 13C NMR (75 MHz, CDCl3): δ 155.5 (C=O), 139.8 (CAr), 136.4 
(CAr), 128.7 (CAr), 128.6 (CAr), 128.3 (CAr), 128.1 (CAr), 128.0 (CAr), 127.0 (CAr), 86.1 (C≡C), 78.0 
(C≡C), 67.1 (Ce), 47.2 (Ca), 31.4 (Cc), 28.7 (Cc), 22.7 (Cc), 18.8 (Cb), 14.2 (Cd); MS m/e (relative 
intensity): 349 (M+, 0.8), 258 (M+-Bn, 100); Anal. Calcd for C23H27NO2: C, 79.05; H, 7.79; N, 4.01. 
Found:  C, 79.25; H, 7.79; N, 4.02. The enantiomeric excess of the product was determined by 
HPLC (hexanes/i-PrOH = 98/2, flow rate = 1.0 mL/min), tR = 19.1 min (R), tR = 26.3 min (S). [α]D25 
-6.2 (80% ee, c 1.29, CHCl3). 









IR (KBr): 3269 (N-H), 1651 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.86 (Hd, t, J = 6.9 Hz, 
3H), 1.27-1.52 (Hc, m, 8H), 1.92 (COCH3, s, 3H), 2.20 (Cb, t, J = 6.9 Hz, 2H), 5.94 (1H, d, J = 8.4 Hz, 
1H), 6.45 (NH, d, br, J = 8.4 Hz, 1H), 7.23-7.47 (HAr, m, 5H); 13C NMR (75 MHz, CDCl3): δ 168.8 
(C=O), 139.7 (CAr), 128.4 (CAr), 127.7 (CAr), 126.9 (CAr), 85.3 (C≡C), 77.9 (C≡C), 44.7 (Ca), 31.2 
(Ca), 28.5 (Cc), 28.5 (Cc), 22.9 (COCH3), 22.4 (Cc), 18.6 (Cb), 13.9 (Cd); MS m/e (relative intensity): 
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257 (M+, 6), 186 (M+-C5H11, 100); Anal. Calcd for C17H23NO: C, 79.33; H, 9.01; N, 5.44. Found:  C, 
79.24; H, 8.97; N, 5.53. The enantiomeric excess of the product was determined by HPLC 
(hexanes/i-PrOH = 95/5, flow rate = 1.0 mL/min), tR = 11.1 min (R), tR = 17.4 min (S). [α]D25 +12 
(92% ee, c 2.28, CHCl3). 












IR (KBr): 3268 (N-H), 1651 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.84 (Hd, t, J = 6.9 Hz, 
3H), 1.23-1.50 (Hc, m, 8H), 1.92 (COCH3, s, 3H), 2.18 (Hb, dt, J = 1.8 Hz, 6.9 Hz, 2H), 5.87 (Ha, d, br, 
J = 8.4 Hz, 1H), 6.55 (NH, d, br, J = 8.4 Hz, 1H), 7.23 (He, d, J = 8.4 Hz, 2H), 7.37 (Hf, d, J = 8.4 Hz, 
2H); 13C NMR (75 MHz, CDCl3): δ 169.1 (C=O), 138.5 (CAr), 133.7 (CAr), 128.6 (CAr), 128.5 (CAr), 
86.0 (C≡C), 77.6 (C≡C), 44.3 (Ca), 31.3 (Cc), 28.6 (Cc), 28.6 (Cc), 23.1 (COCH3), 22.6 (Cc), 18.8 (Cb), 
14.1 (Ca); MS m/e (relative intensity): 291 (M+, 4), 220 (M+-C5H11, 100); Anal. Calcd for 
C17H22ClNO: C, 69.97; H, 7.60; N, 4.80. Found:  C, 70.00; H, 7.42; N, 4.82. The enantiomeric 
excess of the product was determined by HPLC (hexanes/i-PrOH = 95/5, flow rate = 1.0 mL/min), tR 
= 9.2 min (R), tR = 10.2 min (S). [α]D25 +28.2 (91% ee, c 4.0, CHCl3). 












IR (KBr): 3272 (N-H), 1652 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.85 (Hd, t, J = 6.9 Hz, 
3H), 1.25-1.53 (Hc, m, 8H), 1.92 (COCH3, s, 3H), 2.19 (Hb, dt, J = 1.8 Hz, 6.9 Hz, 2H), 3.74 (OMe, s, 
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3H), 5.87 (Ha, d, br, J = 8.4 Hz, 1H), 6.27 (NH, d, br, J = 8.4 Hz, 1H), 6.81 (Hf, d, J = 8.5 Hz, 2H), 
7.37 (He, d, J = 8.5 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 168.7 (C=O), 159.1 (CAr), 131.9 (CAr), 
128.2 (CAr), 113.7 (CAr), 85.1 (C≡C), 78.1 (C≡C), 55.2 (OCH3), 44.2 (Ca), 31.2 (Cc), 28.5 (Cc), 28.4 
(Cc), 23.0 (COCH3), 22.4 (Cc), 18.6 (Cb), 13.9 (Cd); MS m/e (relative intensity): 287 (M+, 8), 216 
(M+-C5H11, 100); Anal. Calcd for C18H25NO2: C, 75.22; H, 8.77; N, 4.87. Found:  C, 75.30; H, 8.64; 
N, 4.86. The enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 
94.8/5.2, flow rate = 1.0 mL/min), tR = 14.0 min (R), tR = 14.9 min (S). [α]D25 +22.8 (92% ee, c 1.80, 
CHCl3). 












IR (KBr): 3271 (N-H), 1651 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.87 (Hd, t, J = 6.9 Hz, 
3H), 1.25-1.53 (Hc, m, 8H), 1.94 (COCH3, s, 3H), 2.20 (Hb, dt, J = 2.0 Hz, 6.9 Hz, 2H), 2.31 (ArCH3, 
s, 3H), 5.90 (Ha, d, br, J = 8.5 Hz, 1H), 6.16 (NH, d, br, J = 8.5 Hz, 1H), 7.11 (Hf, d, J = 7.9 Hz, 2H), 
7.36 (He, d, J = 7.9 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 168.6 (C=O), 137.5 (CAr), 136.8 (CAr), 
129.1 (CAr), 126.9 (CAr), 85.2 (C≡C), 78.0 (C≡C), 44.5 (Ca), 31.2 (Cc), 28.5 (Cc), 28.5 (Cc), 23.1 
(COCH3), 22.4 (Cc), 21.0 (ArCH3), 18.7 (Cb), 13.9 (Cd); MS m/e (relative intensity): 271 (M+, 6), 200 
(M+-C5H11, 100); Anal. Calcd for C18H25NO: C, 79.66; H, 9.28; N, 5.16. Found: C, 79.53; H, 9.22; N, 
5.18. The enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 98/2, flow 
rate = 1.0 mL/min), tR = 20.3min (R), tR = 22.6 min (S). [α]D25 +29.9 (92% ee, c 0.94, CHCl3). 
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IR (KBr): 3265 (N-H), 1651 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.86 (Hd, t, J = 6.8 Hz, 
3H), 1.24-1.53 (Hc, m, 8H), 1.95 (COCH3, s, 3H), 2.20 (Hb, dt, J = 2.0 Hz, 6.9 Hz, 2H), 2.35 (ArCH3, 
s, 3H), 5.80 (NH, d, br, J = 8.1 Hz, 1H), 5.99 (Ha, d, br, J = 8.1 Hz, 1H), 7.12-7.60 (HAr, m, 4H); 13C 
NMR (75 MHz, CDCl3): δ 168.1 (C=O), 137.2 (CAr), 135.8 (CAr), 130.6 (CAr), 127.8 (CAr), 126.7 
(CAr), 126.0 (CAr), 84.8 (C≡C), 78.0 (C≡C), 42.5 (Ca), 31.1 (Cc), 28.3 (Cc), 22.9 (COCH3) , 22.3 (Cc), 
18.8 (ArCH3), 18.6 (Cb), 13.8 (Cd); MS m/e (relative intensity): 271 (M+, 6), 200 (M+-C5H11, 100); 
Anal. Calcd for C18H25NO: C, 79.66; H, 9.28; N, 5.16. Found: C, 79.50; H, 9.25; N, 5.06. The 
enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 95/5, flow rate = 1.0 
mL/min), tR = 10.2 min (R), tR = 11.9 min (S). [α]D25 -7.10 (99% ee, c 0.67, CHCl3). 









IR (KBr): 3269 (N-H), 3050 (CAr-H), 1649 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.87 
(Hd, t, J = 6.9 Hz, 3H), 1.24-1.56 (Hc, m, 8H), 1.95 (COCH3, s, 3H), 2.25 (Hb, dt, J = 1.7 Hz, 6.9 Hz, 
2H), 6.05 (NH, d, br, J = 8.5 Hz, 1H), 6.62 (Ha, d, br, J = 8.5 Hz, 1H), 7.41-8.11 (HAr, m, 7H); 13C 
NMR (75 MHz, CDCl3): δ 168.5 (C=O), 134.5 (CAr), 133.8 (CAr), 130.4 (CAr), 129.0 (CAr), 128.6 
(CAr), 127.1 (CAr), 126.6 (CAr), 125.3 (CAr), 125.1 (CAr), 123.4 (CAr), 85.8 (C≡C), 78.0 (C≡C), 42.5 
(Ca), 31.2 (Cc), 28.5 (Cc), 23.0 (COCH3), 22.4 (Cc), 18.6 (Cb), 13.9 (Cd); MS m/e (relative intensity): 
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307 (M+, 18), 236 (M+-C5H11, 100); Anal. Calcd for C21H25NO: C, 82.04; H, 8.20; N, 4.56. Found: C, 
82.10; H, 8.21; N, 4.63. The enantiomeric excess of the product was determined by HPLC 
(hexanes/i-PrOH = 95/5, flow rate = 1.0 mL/min), tR = 13.4 min (R), tR = 39.0 min (S). [α]D25 +31.3 
(>99% ee, c 0.78, CHCl3). 












IR (KBr): 3270 (N-H), 1652 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.87 (Hd, t, J = 6.8 Hz, 
3H), 1.28-1.55 (Hc, m, 8H), 1.99 (COCH3, s, 3H), 2.23 (Hb, dt, J = 1.5 Hz, 7.0 Hz, 2H), 5.51-5.52 (Ha, 
m, 1H), 5.87 (NH, d, J = 8.2 Hz, 1H), 6.14 (He, dd, J = 5.2 Hz, 15.7 Hz, 1H), 6.77 (Hf, d, J = 15.7 Hz, 
1H), 7.19-7.36 (HAr, m, 5H); 13C NMR (75 MHz, CDCl3): δ 168.7 (C=O), 136.2 (CAr), 131.5 (CAr), 
128.5 (Cf), 127.8 (CAr), 126.7 (CAr), 126.6 (Ce), 85.9 (C≡C), 76.8 (C≡C), 42.9 (Ca), 31.3 (Cc), 28.6 
(Cc), 28.5 (Cc), 23.2 (COCH3), 22.5 (Cc), 18.7 (Cb), 14.0 (Cd); MS m/e (relative intensity): 283 (M+, 
15), 212 (M+-C5H11, 100); Anal. Calcd for C19H25NO: C, 80.52; H, 8.89; N, 4.94. Found: C, 80.30; H, 
9.03; N, 5.13. The enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 
95/5, flow rate = 1.0 mL/min), tR = 16.7 min (R), tR = 20.6 min (S). [α]D25 +55.4 (67% ee, c 1.0, 
CHCl3). 




IR (KBr): 3264 (N-H), 1648 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 2.01 (CH3, s, 3H), 
6.22-6.24 (ArCH and NH, m, 2H), 7.30-7.85 (HAr, m, 10H); 13C NMR (75 MHz, CDCl3): δ 168.9 
(C=O), 139.1 (CAr), 131.9 (CAr), 128.8 (CAr), 128.7 (CAr), 128.4 (CAr), 128.2 (CAr), 127.2 (CAr), 122.5 
(CAr), 87.1 (C≡C), 84.8 (C≡C), 45.2 (ArCH), 23.3 (CH3); MS m/e (relative intensity): 249 (M+, 15), 
207 (M+-C2H2O, 100); The enantiomeric excess of the product was determined by HPLC 
(hexanes/i-PrOH = 94.8/5.2, flow rate = 1.0 mL/min), tR = 19.5 min (R), tR = 22.4 min (S). [α]D25 
-29.1 (92% ee, c 0.67, CHCl3). 




IR (KBr): 3270 (N-H), 1634 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 2.03 (CH3, s, 3H), 
6.08 (NH, d, br, J = 8.4 Hz, 1H), 6.19 (ArCH, d, J = 8.4 Hz, 1H), 7.27-7.49 (HAr, m, 9H); 13C NMR 
(75 MHz, CDCl3): δ 168.9 (C=O), 138.3 (CAr), 131.9 (CAr), 128.9 (CAr), 128.9 (CAr), 128.5 (CAr), 
122.2 (CAr), 86.4 (C≡C), 85.3 (C≡C), 44.8 (ArCH), 23.3 (CH3); MS m/e (relative intensity): 327 (M+, 
9), 206 (M+-C2H2O-Br, 100); Anal. Calcd for C17H14BrNO: C, 62.21; H, 4.30; N, 4.27. Found: C, 
62.14; H, 4.27; N, 4.17. The enantiomeric excess of the product was determined by HPLC 
(hexanes/i-PrOH = 95/5, flow rate = 1.0 mL/min), tR = 24.5 min (R), tR = 28.6 min (S). [α]D25 -6.7 
(91% ee, c 0.67, CHCl3). 
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4.5.4.12 (S,E)-N-(2-Methyl-1,5-diphenylpent-1-en-4-yn-3-yl)acetamide (4.45l) 
NHAc
 
IR (KBr): 3264 (N-H), 1651 (C=O) cm-1; 1H NMR (300 MHz, CDCl3): δ 1.96 (COCH3, s, 3H), 
2.06 (C=C-CH3, s, 3H), 5.68 (C≡C-CH, d, J = 8.8 Hz, 1H), 6.08 (NH, d, J = 8.8 Hz, 1H), 6.83 
(HC=C, s, 1H), 7.21-7.45 (HAr, m, 10H); 13C NMR (75 MHz, CDCl3): δ 169.0 (C=O), 137.1, 134.5, 
131.7, 128.9, 128.4, 128.2, 128.0, 127.4, 126.7, 122.4, 86.6 (C≡C), 84.8 (C≡C), 48.4(C≡C-CH), 23.2 
(COCH3), 15.2 (C=C-CH3); MS m/e (relative intensity): 289 (M+, 21), 247 (M+-C2H2O, 100); Anal. 
Calcd for C20H19NO: C, 83.01; H, 6.62; N, 4.84. Found: C, 83.14; H, 6.57; N, 4.86. The enantiomeric 
excess of the product was determined by HPLC (hexanes/i-PrOH = 95/5, flow rate = 1.0 mL/min), tR 
= 24.9 min (R), tR = 29.2 min (S). [α]D25 -2.0 (93% ee, c 0.75, CHCl3). 












A literature procedure70 was followed: Triphenylphosphine (23.0 g, 88 mmol) was added to 
CBr4 (14.5 g, 44 mmol) in CH2Cl2 (270 mL) at 0 °C and the mixture was stirred at that temperature 
for 5 minutes. 3,4,5-Trimethoxybenzaldehyde (5.70 g, 29 mmol) was added and the resulting mixture 
was stirred at 0 °C for 10 minutes before the addition of H2O (75 mL). The organic phase was 
separated, dried (MgSO4) and concentrated in vacuo. The yellow slurry obtained was triturated with 
hexanes and then Et2O to remove Ph3P=O. The organic washings were dried (MgSO4) and 
 196
concentrated in vacuo to give the dibromoalkene (9.3 g, 91%) as a yellow solid. 1H NMR (300 MHz, 
CDCl3): δ 3.83 (OCH3, s, 6H), 3.84 (OCH3, s, 3H), 6.77 (HAr, s, 2H), 7.64 (Br2C=CH, s, 1H); 13C 
NMR (75 MHz, CDCl3): δ 153.1 (CAr), 138.4 (CAr), 136.7 (CH=CBr2), 130.6 (CAr), 105.8 (CAr), 88.8 
(CH=CBr2), 60.9 (OCH3), 56.2 (OCH3). 
To a solution of the dibromoalkene (9.3 g, 26.4 mmol) in 180 mL of THF at -78 oC was added 
n-BuLi (34.3 mL, 55 mmol, 1.6 M in hexane) slowly over 30 minutes. The resulting solution was 
stirred at -78 oC for 1 h then warmed to room temperature for 2 hours. Saturated NH4Cl (100 mL) was 
added and the mixture was extracted with ether (3 x 100 mL). The combined ethereal extracts were 
dried (MgSO4) and concentrated in vacuo to afford a yellow solid. Flash column chromatography on 
silica gel (2:1 hexanes/EtOAc) gave the alkyne 4.53 (4.8 g, 93%) as a white solid. 1H NMR (300 
MHz, CDCl3): δ 2.89 (C≡CH, s, 1H), 3.75 (OCH3, s, 6H), 3.76 (OCH3, s, 3H), 6.64 (HAr, s, 2H); 13C 
NMR (75 MHz, CDCl3): δ 153.1 (CAr), 139.2 (CAr), 117.1 (CAr), 109.3 (CAr), 83.7 (C≡CH), 76.4 
(C≡CH), 60.9 (OCH3), 56.1 (OCH3). 







To a solution of alkyne 4.53 (384 mg, 2.0 mmol) in THF (10 mL) at -78 oC was added n-BuLi 
(1.6 M in hexane). After stirring at that temperature for 30 minutes, the resulting solution was added 
slowly to a solution of triisopropyl borate (395 mg, 2.1 mmol) in THF (10 mL) at -78 oC. The reaction 
mixture was allowed to warm to room temperature for 6 hours. Volatiles were removed in vacuo and 
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the crude product 4.57 was obtained as an off-white powder in quantitative yield. This product was 
used without further purification and identification. 








The title compound was prepared in 72% yield and 94% ee from TBS protected 
3-hydroxybenzaldehyde75 and borate 4.57 using the general procedure for the alkynylation of 
acylimines. IR (KBr): 3272 (N-H), 1655 (C=O), 1130 (C-O) cm-1; 1H NMR (300 MHz, CDCl3): δ 
0.17 [Si(CH3)2, s, 6H], 0.94 [Si-C(CH3)3, s, 9H], 1.99 (COCH3, s, 3H), 3.79 (2 x MeO, s, 6H), 3.80 
(MeO, s, 3H), 6.15 (Ar-CH, d, J = 8.6 Hz, 1H), 6.28 (NH, d, br, J = 8.6 Hz, 1H), 6.65 (HAr, s, 2H), 
6.75-7.22 (HAr, m, 4H); 13C NMR (75 MHz, CDCl3): δ 168.8 (C=O), 155.8 (CAr), 152.9 (CAr), 140.3 
(CAr), 138.8 (CAr), 129.6 (CAr), 119.9 (CAr), 119.7 (CAr), 118.7 (CAr), 117.4 (CAr), 108.9 (CAr), 86.0 
(C≡C), 84.4 (C≡C), 60.8 (OCH3), 56.0 (OCH3), 44.8 (ArCH), 25.6 [C(CH3)3], 23.1 (COCH3), 18.1 
[C(CH3)3], -4.5 [Si(CH3)2]; HRMS m/z Calcd for C26H35NO5Si (M+): 469.2285. Found: 469.2293. ee 
was determined by HPLC (hexanes/i-PrOH = 95.6/4.4, flow rate = 1.0 mL/min), tR = 35 min (R), tR = 
39 min (S). [α]D25 +18.7 (94% ee, c 1.4, CHCl3). 
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4.5.8 Preparation of (S)-N-(1-(3-(tert-Butyldimethylsilyloxy)phenyl)-3-(3,4,5-trimethoxy 







Compound 4.51 (1 mmol) was taken up in 5 mL of MeOH and 10% Pd/C (20 mg) was added. 
The reaction was stirred at room temperature under 1 atm of H2 for 24 h. Compound 4.50 was 
obtained as a colorless oil in quantitative yield after column chromatography (EtOAc/hexanes: 2/1). 
IR (KBr): 3285 (N-H), 1649 (C=O), 1129 (C-O) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.05 [Si(CH3)2, 
s, 6H], 0.95 [Si-C(CH3)3, s, 9H], 1.93-2.17 (ArCH2CH2 and COCH3, m, 5H), 2.45-2.54 (ArCH2CH2, 
m, 2H), 3.78 (2 x MeO, s, 6H), 3.79 (MeO, m, 3H), 4.93 (ArCHNH, q, J = 8.3 Hz, 1H), 5.88 (NH, d, 
J = 8.3 Hz, 1H), 6.33 (HAr, s, 2H), 6.71-7.19 (HAr, m, 4H); 13C NMR (75 MHz, CDCl3): δ 169.1 
(C=O), 155.9 (CAr), 153.0 (CAr), 143.3 (CAr), 137.1 (CAr), 136.0 (CAr), 129.6 (CAr), 119.5 (CAr), 119.0 
(CAr), 118.4 (CAr), 105.2 (CAr), 60.7 (MeO), 56.0 (MeO), 53.0 (ArCHNH), 37.4 (ArCH2CH2), 32.8 
(ArCH2CH2), 25.6 [Si-C(CH3)3], 23.3 (COCH3), 18.1 [C(CH3)3], -4.5 [Si(CH3)2]; HRMS m/z Calcd 
for C26H39NO5Si (M+): 473.2598. Found: 473.2591. [α]D25 -35 (c 1.1, CHCl3). 














Sawyer’s procedure71 was followed with minor modifications: Tl(O2CCF3)3 (65 mg, 0.121 
mmol) and 1.0 mL of freshly distilled BF3.OEt2 were dissolved in 23 mL of trifluoroacetic acid 
(contains 5% trifluoroacetic anhydride) in the presence of 4Å molecular sieves (0.5 g). A solution of 
compound 4.50 (55 mg, 0.115 mmol) in 5 mL of trifluoroacetic acid was then added at 0 oC and the 
resulting brown solution was stirred at ambient temperature for 4 h. 30 mL of CHCl3 was added 
before the reaction was quenched with 20 mL of water. The organic layer was separated and the 
aqueous layer was extracted with 3 x 15 mL CHCl3. The organic layers were combined and dried over 
Na2SO4. After evaporating the volatiles, the residual brown oil was purified by column 
chromatography (EtOAc) to give 22 mg (53%) of 4.49 as an off-white powder. 1H NMR spectrum of 
compound 4.49 in CDCl3 showed 2.5:1 mixture of conformational isomers (doubled resonances for 
all protons). In d6-DMSO, only one set of peaks was observed due to either fast equilibration between 
the two diastereomers or the presence of a single diastereomer. 1H NMR (300 MHz, d6-DMSO): δ 
1.78-1.90 (COCH3 and Hb, m), 2.00-2.15 (Ha and Hb, m, 2H), 2.38-2.52 (Ha, m, 1H), 3.45 (OMe, s, 
3H), 3.75 (OMe, s, 3H), 3.80 (OMe, s, 3H), 4.40-4.47 (Hc, m, 1H), 6.67 (He, dd, J = 2.4 Hz, 8.3 Hz, 
1H), 6.73 (Hg, s, 1H), 6.74 (Hd, d, J = 2.4 Hz, 1H), 7.09(Hf, d, J = 8.3 Hz, 1H), 8.31(NH, d, J = 8.4 Hz, 
1H), 9.36(OH, s, 1H); 13C NMR (75 MHz, d6-DMSO): δ 168.2 (C=O), 156.4 (CAr), 151.8 (CAr), 150.3 
(CAr), 141.7 (CAr), 140.5 (CAr), 134.7 (CAr), 130.4 (CAr), 124.7 (CAr), 124.4 (CAr), 112.9 (CAr), 110.2 
(CAr), 107.9 (CAr), 60.5 (OMe), 60.4 (OMe), 55.8 (OMe), 48.1 (Cc), 38.4 (Hb), 30.1 (Ha), 22.6 
(COCH3); HRMS m/z Calcd for C20H23NO5 (M+): 357.1576. Found: 357.1579. [α]D25 -45.2 (c 0.6, 
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Catalytic Asymmetric Conjugate Alkynylation of Enones 
 
5.1  Introduction: Boron in Asymmetric Catalysis 
Asymmetric catalysis has received explosive interest in the past few decades since the use of only 
catalytic amounts of chiral catalysts has obvious economic and practical advantages. Some famous 
catalytic reactions such as the Sharpless asymmetric epoxidation1 and Noyori’s hydrogenation2 have 
been widely applied in the pharmaceutical and agricultural industries. Boron reagents also play an 
important role in asymmetric catalysis as various chirally modified boron reagents have been applied 
in catalytic processes such as the reduction of carbonyls and C=N bonds, Diels-Alder reactions, aldol 
and alkylation reactions, etc.3,4 This section discusses some typical examples of catalytic reactions 
involving chiral boron reagents.  
5.1.1 Catalytic Reductions 
5.1.1.1 Ketone Reductions 
The stereoselective reduction of ketones has been one of the most studied transformations 
because the resulting chiral alcohols are present in numerous natural products and are key 
intermediates for many complex molecule syntheses.5 In the past 50 years, the asymmetric reduction 
of carbonyl compounds with stoichiometric quantities of chiral-modified boron or aluminum reagents 
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has been studied.6 However, the asymmetric reduction of carbonyls induced by a catalytic amount of 
chiral boron reagents remained unexploited until the early 1980’s.  
In 1981, Itsuno reported that mixtures of chiral amino alcohols such as alcohol 5.1 and BH3·THF 
in a ratio of 1:2 in THF could reduce achiral ketones enantioselectively to chiral secondary alcohols in 
nearly quantitative yield and up to 94% ee (Scheme 5.1).7-10 It was noted that at least two equivalents 















Later, a mechanistic study on this stoichiometric reaction was conducted by Corey and 
co-workers.11,12 It was found that when tertiary alcohol 5.1 was treated with one equivalent of 
BH3·THF, an oxazaborolidine 5.3 was generated. Surprisingly, this oxazaborolidine 5.3 did not 
reduce ketones even after several hours at room temperature. However, a mixture of compound 5.3 
and BH3·THF (0.6 equiv.) effected the rapid reduction of acetophenone at 23 oC to afford secondary 
alcohol 5.2 in 94.7% ee which is comparable to the results obtained by Itsuno. More interestingly, 
they soon realized that only a catalytic amount of compound 5.3 was required in this reaction to 



















Since the initial report, many variations and improvements of the original catalyst 5.3 have been 
published (Figure 5.1). These oxazaborolidines, which were later named CBS catalysts (after the 
developers Corey, Bakshi and Shibata), exhibited high enantioselectivities toward a wide range of 






R1 = Ph, 2-naphthyl ...





















Figure 5.1 Variations of the original oxazaborolidine catalyst 5.3. 
A general mechanistic model was proposed to rationalize the selectivity of the CBS reduction 
(Scheme 5.3). The initial step in the pathway is the rapid coordination of BH3 to the Lewis-basic 
nitrogen atom on oxazaborolidine 5.3 to form oxazaborolidine-BH3 complex 5.4. The strongly 
Lewis-acidic complex 5.4 then readily binds to the ketone substrate at the more sterically accessible 
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electron lone pair. Facially-selective hydride transfer via a six-membered transition state forms the 














































Similar to oxazaborolidines, chiral oxazaphospholidine-borane complexes are also capable of 
catalyzing the reduction of ketones enantioselectively. Buono has reported that catalyst 5.7 could 
reduce a range of aryl alkyl ketones in up to 94% ee.13,14 Interestingly, in contrast to CBS catalysts, 
































5.1.1.2 C=N Double Bond Reductions 
Although effective catalytic asymmetric reduction of carbonyl compounds has been extensively 
studied, the catalytic reduction of imine derivatives to chiral amines has been relatively neglected. 
Consequently, less success has been achieved. The first catalytic asymmetric reduction of imino 
compounds was realized by Itsuno in the late 1980’s.15 It was found that oxazaborolidine·BH3 
complex 5.8 could reduce oxime ether 5.9 to give chiral secondary amines in good chemical and 
optical yields. Compared to the catalytic reduction of ketones, the reduction of oxime ether 5.9 
requires much higher catalyst loading (25 mol%). Lower catalyst loadings (10 mol%) resulted in 













NH2 90% ee (25 mol% of 5.8)





Results of several other catalytic asymmetric reductions of imino compounds are summarized in 
Table 5.1.  
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Table 5.1 Catalytic asymmetric reduction of imino compounds. 






































Ph BH3  
BH3·SMe2 59 63 
5.1.2 Boron Reagents as Chiral Lewis Acids 
Chiral Lewis acids are very versatile mediators of a variety of stereoselective organic 
transformations. Boron reagents are potentially excellent Lewis acids due to the electron deficient 
nature of boron atom (Figure 5.2). To date, numerous asymmetric reactions induced by chiral boron 








Nucleophilic Addition Cycloaddtion  
Figure 5.2 Examples of boron-based Lewis acid catalyzed reactions. 
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5.1.2.1 Diels-Alder Reactions 
The first highly enantioselective Diels-Alder reaction induced by a chiral boron complex was 
reported by Kelly in 1986.20 Complex 5.10 was prepared from juglone (a peri-hydroxyquinone which 
is the dienophile for the Diels-Alder reaction) and a 3,3'-diphenyl-l,1'-binaphthol. It reacted with 
various dienes to give the desired Diels-Alder adducts in excellent optical yields (Scheme 5.6). 
However, since this reaction proceeds via the binding of the boron to the dienophile, the use of a 

























A “propeller-shaped” complex 2.43 was obtained by Kaufmann and co-workers when they were 
trying to synthesize compound 5.11. This complex dramatically accelerated the Diels-Alder reaction 
between cyclopentadiene and methacrolein. 21 The exo-selectivity (97%) of the reaction is outstanding, 
as is the observed enantioselectivity (90% ee). In contrast to Kelly’s reaction, only 3 mol% of chiral 































Another example is Yamamoto’s CAB catalysts (Chiral Acy1oxyBorane).22 They are very 
effective Lewis acids for the Diels-Alder reactions between a wide range of dienes and dienophiles 


















Moreover, this CAB catalyst could also induce high enantioselectivities in intramolecular-23 and 
hetero-Diels-Alder reactions (Scheme 5.9).24 
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R = H, Me
R' = Ph, CH3CH=CH-, PhCH=CH-
55-86% yield






5.1.2.2 1,3-Dipolar Cycloaddtions 
Boron-based chiral Lewis acids are also able to catalyze other type of cyclization reactions such 
as the 1,3-dipolar cycloaddition reaction between nitrones and electron-rich alkenes.25 Although only 























up to 74% ee





5.1.2.3 Aldol and Allylation Reactions 
Enantioselective Mukaiyama aldol and Sakurai-Hosomi allylation reactions catalyzed by chiral 
Lewis acids are of great interest since the products of these reactions are valuable building blocks for 
total syntheses of complex molecules. Yamamoto and coworkers have reported CAB catalyst 5.21 to 
be an excellent catalyst for the enantioselective Mukaiyama condensation of enol silyl ethers with 





1) 5.21 (10-20 mol%)













up to 97% ee and 98% de  
Scheme 5.11 
They also found that CAB catalysts 5.21 are powerful catalyst in the Sakurai-Hosomi allylation 
reactions of aldehydes.27 Crotylation catalyzed by 5.21 exhibits the same level of high 
enantioselectivity as that of the allylation. Regardless of the geometry of the starting allylsilane, the 
syn-isomer is always the major product (Scheme 5.12). 
R1CHO  + TMSR
2
R3 1) 5.21 (10-20 mol%)
    EtCN, -78 oC















5.1.2.4 Other Catalytic Processes 
In addition to the catalytic reactions mentioned above, boron-based chiral Lewis acids are also 
involved in many other asymmetric catalytic reactions such as the asymmetric cyanation of 
aldehydes,28 the catalytic addition of dialkylzinc to aldehydes29 and asymmetric cyclopropanation 
reactions.30 Details of those reactions have appeared in several review papers.3-5,13,28 
5.1.3 Miscellaneous Reactions 
In 1994, Corey reported an asymmetric alkynylation of aldehydes catalyzed by chiral 
oxazaborolidines 5.24.31 Alkynylborane 5.26 was prepared in situ from the corresponding 
alkynylstananne 5.25. In the presence of a stoichiometric amount of catalyst 5.24a, alkynylborane 
5.26 added to aldehydes to afford the desired propargyl alcohols in excellent yields (up to 96%) and 
enantioselectivities (85-97% ee, Table 5.2, entries 1-5), while oxazaborolidine 5.24b (R = Ph) 
efficiently promotes the same alkynylation reactions in substoichiometric quantities (25 mol%, Table 
5.2, entries 6 and 7). 
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5.24a (R = Bu)
5.24b (R = Ph)




5.265.25 5.27  
entry R1 R2 catalyst (equiv.) yield (%) ee (%) 
1 c-C6H11 Ph 5.24a (1.0) 96 90 
2 c-C6H11 n-C5H11 5.24a (1.0) 82 95 
3 Ph Ph 5.24a (1.0) 78 96 
4 n-C5H11 Ph 5.24a (1.0) 90 96 
5 t-Bu Ph 5.24a (1.0) 71 93 
6 Ph Ph 5.24b (0.25) 72 97 
7 n-C5H11 Ph 5.24b (0.25) 71 93 
 
The rationale for this enantioselective alkynylation process is outlined in Scheme 5.13. The first 
step of the reaction is the coordination of alkynylborane 5.26 with the basic nitrogen on 
oxazaborolidine 5.24 to form a complex 5.27. The coordination of the alkynylborane 5.26 to the 
nitrogen atom of 5.24 serves to activate 5.26 as an alkynyl group donor and also to increase the Lewis 
acidity of the endocyclic boron atom. The strongly Lewis acidic complex 5.27 then binds with 
aldehydic oxygen and transfers the alkynyl group to the aldehyde through a six-membered transition 
























































As was discussed previously in Chapter 4, 3,3′-disubstituted binaphthol-modified 
alkynylboronates 4.47 are able to deliver alkynyl groups to acylimines or enones in a highly 











CH2Cl2, -78 oC  to  rt, 24 hR H
O 1) LiHMDS
2) CH3COCl R H
N CH3
O
4.45c-jR' = C6H13 (4.47f)














up to >99% ee
X = Ar, CF3, Halo...
R1, R2, R3 = Ar, Alkyl...
 
Scheme 5.14 
Regardless of the fact that these alkynylation reactions are very effective, the enantioselectivities 
of these reactions are sensitive to impurities that are introduced during the preparation of chiral 
alkynylboronates 4.47. As illustrated in Scheme 5.15, alkynylboronates 4.47 were prepared from 
“ate” complexes 4.60 which were obtained from the ligand exchange reaction between the 
corresponding binaphthols and achiral alkynylborates 4.59.33,34 It was found that if “aged” BF3·OEt2 
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was used, the alkynylations suffered lower enantioselectivities. In addition, an excess amount of 


















Oi-PrLi BF3•OEt2 (1.33 equiv.)





To explain the observation that “aged” BF3·OEt2 induces low enantioselectivity, we proposed that 
the free fluoride anion (F-), which is present in unpurified or aged BF3·OEt2, can readily replace the 
chiral ligands on alkynylboronates 4.47 in a reversible fashion and the resulting boronates 5.30 are 
still active enough to react with electrophiles (acylimines or enones) to give alkynylation products but 
with a different sense of enantioselectivity (Scheme 5.16). In addition, if an excess amount of HCl is 
















low enantioselectivity  
Scheme 5.16 
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Besides, previously, Suzuki and co-workers found that alkenyl or alkynyl boronates 5.35 could 
readily undergo a reversible ligand exchange with BF3·OEt2 (via a four-membered transition state, 
Scheme 5.17).35,36 This implies that an excess amount of BF3·OEt2 might also react with chiral 
































These problems, however, prompted us to think about the alkynylation chemistry from a different 
angle. Given the fact that the “stereoselective” chiral alkynylboronates 4.47 and the 
“non-stereoselective” alkynylboronates such as 5.30 and 5.36 are interconvertible, we envisaged a 
scenario wherein an achiral (non-stereoselective) alkynylboronate 5.31 is mixed with chiral 
binaphthols and electrophiles (enones or N-acylimines). Achiral alkynylboronate 5.31 may undergo 
ligand exchange with chiral binaphthols to form chiral boronates 4.47 in situ which then immediately 
induce the asymmetric alkynylation reaction with electrophiles. The alkynylation reaction will be 
highly enantioselective as long as chiral boronates 4.47 are far more reactive than the starting achiral 
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alkynylboronate 5.31. This would allow us to carry out the asymmetric alkynylation without 


















































Moreover, if the chiral ligand could be freed from the intermediate borate 5.32, it could react 
with more of 5.31 to generate more chiral boronate 4.47 and hence render a catalytic reaction. As is 
depicted in Scheme 5.19, borate 5.32 might undergo a ligand exchange with achiral alkynylboronate 
5.31 to yield alkynylation product 5.33 and regenerate the active chiral alkynylboronate 4.47 (Path B). 
Alternatively, 5.32 might also react with alcohol 5.34 which is released in the initial step to complete 























































The use of catalytic amounts of chiral catalysts has obvious economic and practical advantages. 
While various boron complexes, especially CBS and CAB reagents, have been used as catalysts in 
asymmetric reactions, a catalytic asymmetric reaction that is promoted by a catalytic amount of an 
“exchangeable” chiral ligand on the boron has not been reported. It seemed worthwhile to develop an 
asymmetric reaction based on the catalytic cycle demonstrated above.  
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5.3 Results and Discussions 
5.3.1 Initial Studies on the Catalytic Alkynylation of Enones 
In order to examine the proposed catalytic cycle, achiral alkynylboronates that do not react with 
electrophiles (enones or N-acylimines) are required. It was reported by Suzuki that diisopropyl 
alkynylboronate 5.38 is inert toward enones in the absence of BF3·OEt2.36 Therefore, 5.38 was 









  then HCl/Et2O  
Scheme 5.20 
1H NMR studies have shown that when alkynylboronate 5.38 was mixed with substituted 
binaphthols, an equilibrium between boronates 5.38 and 4.47 was established rapidly at room 
temperature and it seemed that the equilibrium predominantly favours 5.38 over 4.47. It could be 
explained by proposing that since binaphthol-modified boronate 4.47 is a much stronger Lewis acid 
than the starting dialkyl boronate 5.38, the stronger Lewis acid 4.47 is more likely to react with 
isopropanol to form the weaker Lewis acid 5.38 according to the acid-base theory. Nonetheless, it 



















2.28 (X = I)
2.32 (X = Ph)
4.47c (X = I)
4.47f (X = Ph)  
Scheme 5.21 
To examine whether binaphthols can induce the alkynylation of enone, various substituted 
binaphthols were tested. The results are summarized in Table 5.3. When chiral ligands were not 
present in the reaction (Table 5.3, entry 1), alkynylboronate 5.38 indeed did not react with chalcone 
(5.41a, an α,β-unsaturated ketone). However, 20 mol% of the parent binaphthol could induce the 
alkynylation giving more than 20% but less than 50% conversion. This indicated that a catalytic cycle 
was running but not very smoothly. The sluggish catalytic cycle might be the result of the formation 
of the thermodynamically stable compound 2.43 (Scheme 5.22) which prevents the chiral ligand from 


























When substituted binaphthol 2.32 (X = Ph) was used, an increased yield of 60% was obtained 
after the reaction was run for 5 days at room temperature (Table 5.3, entry 2). The enantioselectivity 
obtained in this catalytic reaction is very close to the result obtained using a stoichiometric amount of 
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diphenyl binaphthol-modified alkynylboronates 4.47f (Table 5.3, entry 3). Electron deficient ligands 
gave excellent conversions and identical enantioselectivities as those of the corresponding 
stoichiometric reactions (Table 5.3, entry 4-6). Since diiodo binaphthol (2.28) gave the best chemical 
and optical yields in this reaction, it was chosen for further investigation. 

















entry X (ligand no., mol%) time (h) yield (%)b ee (%)c 
1 - (0) 96 0 -- 




3 Ph(2.32, 20) 120 60
d
 83 (85) 
4 3,5-(CF3)2-C6H3(2.36, 20) 96 80 83 (82) 
5 CF3(2.31, 20) 96 90 83 (83) 
6 I(2.28, 20) 96 95 87 (86) 
a Reactions were carried out in CH2Cl2 at 25 °C unless otherwise noted. b % isolated 
yields of chromatographed products. c Determined by HPLC analysis on a Chiralcel OD 
column; values in parentheses are for reactions using stoichiometric amounts of 
binaphthol-modified alkynylboronates. d Estimated conversion based on 1H NMR 
analysis. e Not determined. 
Although diiodo binaphthol 2.28 could induce the alkynylation of chalcone in excellent yield 
and enantioselectivity, the fact that the reaction takes 4 days to complete at room temperature is not 
very practical (Table 5.4, entry 2). Further probing of this reaction revealed that warming to 40 oC 
(reflux CH2Cl2) decreased the reaction time substantially, with essentially negligible change in yield 
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and enantioselectivity (Table 5.4, entry 2). Decreasing the amount of ligand 2.28 to 10 mol% or 5 
mol% affected the reaction rate but not the yield or enantioselectivity (Table 5.4, entry 3 and 4). A 
further decrease to 2 mol% resulted in incomplete reaction after 72 h but the enantioselectivity still 
remained high (Table 5.4, entry 5). 



















entry catalyst loading (mol%) time (h) yield (%) ee (%) 
1 20 96a 95 87 
2 20 24b 94 86  
3 10 48 b 91 85  
4 5 72 b 90 85  
5 2 72 b 70c 85  
a The reaction was carried out at room temperature. b Reaction warmed to reflux. c Estimated conversion 
based on 1H NMR analysis.  
5.3.2 Scope of the Catalytic Reaction 
Use of 3,3′-diiodo binaphthol 2.28 in catalytic alkynylations of other enones gave consistently 
excellent results (Table 5.5). High yields of products were obtained in all cases, and the 
enantioselectivities were essentially the same as those obtained in stoichiometric reactions. Other than 
the obvious advantage of using less ligand, this new catalytic alkynylation has other benefits. For 
example, it is no longer necessary to pre-make chiral alkynyl boronate 4.47, as it can be generated in 
situ. In addition, a one-pot procedure (Scheme 5.23) starting with 1-alkynes can be used to effect 
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5.38: R3 = n-C6H13
5.39: R3 = Ph
5.40: R3 = CH2OBn
5.42a-h5.41a: R1 = R2 = Ph
5.41b: R1 = 1-Np, R2 = Ph
5.41c: R1 = 2-furyl, R2 = Ph
5.41d: R1 = Ph, R2 = Me  
Entry R1 R2 R3 Product no. time (h) yield (%)b ee (%)c 
1 Ph Ph n-C6H13 5.42a 24 94 86 (86) 
2 1-Np Ph n-C6H13 5.42b 12 93 96 (96) 
3 2-furyl Ph n-C6H13 5.42c 36 78 88 (88) 
4 Ph Me n-C6H13 5.42d 48 89 94 (96) 
5 Ph Ph Ph 5.42e 24 95d 82 (84) 
6 1-Np Ph Ph 5.42f 24 97d 90 (92) 
7 Ph Ph CH2OBn 5.42g 24 91d 86 (87) 
8 1-Np Ph CH2OBn 5.42h 24 94d 95 (96) 
a 3 equiv. of B-1-alkynyldiisopropylboronate was used. b isolated yields of chromatographed products. 
c Determined by HPLC analysis on Chiralcel OD column; values in parentheses are for reactions using 
stoichiometric amounts of binaphthol-modified alkynyl boronates. d A one-pot procedure starting from 
a 1-alkyne was used. See text for details. 
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5.3.3 Catalytic Cycle 
The results obtained from the catalytic asymmetric alkynylation reaction suggest that this 
reaction represents an example of ligand-accelerated asymmetric processes. Given the fact that the 
enantioselectivities obtained in all catalytic reactions are identical to those obtained from the 
corresponding stoichiometric reactions, it is reasonable to believe that binaphthol-modified 
alkynylboronates 4.47 are the key intermediates in this catalytic asymmetric induction. Hence, a 
catalytic cycle is proposed (Scheme 5.23). The reaction is initiated by the transesterification of achiral 
boronate 5.38 and binaphthol 2.28 to give an active species 4.47 which undergoes conjugate addition 
to the enone producing a boron enolate 5.43. At this stage, there are two possible pathways (Path A 
and B) for the regeneration of chiral boronate 4.47 as was purposed earlier (Scheme 5.18). It was 
noticed by Brown that isopropanol could react with alkynylboronate 5.38 slowly at room temperature 
to form the corresponding terminal alkyne and triisopropyl borate.37 Therefore, under the catalytic 
reaction conditions, there should not be any isopropanol left to react with 5.38 to regenerate the chiral 
binaphthol (Path A). Accordingly, this pathway (Path A) is ruled out and the catalytic cycle therefore 


















































In order to figure out which step is the rate-determining step, the conjugate addition or the 
ligand exchange, results from Table 5.5 are reviewed. It was observed that the overall reaction rate is 
dependent on the β-substituent of the enone (Table 5.5, entry 1-3). The same trend was also observed 
in the alkynylation of those substrates using stoichiometric amounts of chiral alkynylboronates 4.47.33 
Since the rate of ligand exchange should not be affected by this remote substituent, it is very likely 
that the rate-determining step is the nucleophilic addition step.  
5.3.4 Examination of Other Bidentate Ligands 
Diols other than binaphthols were also examined. Simple aliphatic diols such as ethylene glycol 
and pinacol gave no product, while diisopropyl tartrate, an electron deficient diol used very 
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effectively in allylborations,38 catalyzed the reaction (88% yield of 7a) but gave racemic product. 
Other bidentate ligands, such as amino alcohols 5.46 and 5.47, amino acid 5.48 or an activated chiral 
diamine 5.50, did not induce the catalytic alkynylation. However chiral N-tosyl-amino acids were 






ligand (30 mol%) 





























N.R. N.R. N.R. N.R.      100% conversion
(S)-5.49a: R = i-Pr, 26% ee
(R)-5.49b: R = Ph, 15% ee
(S)-5.49c: R = Bn, 45% ee
5.45 5.46 5.47 5.48 5.49 5.50
 
Scheme 5.25 
5.3.5 Alkynylation of Other 1,4-Addition Acceptors 
Other types of substrates such as ester 5.51 and amide 5.52 were subjected to the catalytic 
alkynylation. Unfortunately, the desired products were not observed in these cases (Scheme 5.25). We 
reasoned that the electron donating nature of alkoxy and amino group makes those substrates less 
reactive toward nucleophilic attack. Introduction of electron withdrawing groups on the amide 
nitrogen (substrate 5.53) did not bring any positive result either.  
 230
It was reported that α,β-unsaturated carboxylic acid imidazolides (such as 5.54) behaved 
similarly to enones in reactions such as a lanthanum catalyzed asymmetric α,β-epoxidation.39,40 











5.51 5.52 5.53 5.54  
Figure 5.3 Selected 1,4-addition acceptors for the catalytic alkynylation. 
An enone bearing β-alkoxy substituent 5.55 was examined.41 Instead of the desired product 
β-alkynyl-β-methoxy ketone, a β,β-dialkynyl ketone 5.58 was isolated. It can be explained by 
proposing that the alkynylation of substrate 5.55 gives a cis-enolate 5.56 which undergoes a 
retro-Michael addition (subsequent loss of (RO)2BOMe) to form a new enone 5.57. This enone 5.57 is 


























Chiral propargyl stannanes and silanes are potentially useful precursors for the synthesis of chiral 
propargyl and allenyl alcohols.42,43 Therefore, a β-tributylstannyl enone 5.59 was subjected to the 
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catalytic alkynylboration. However, only the decomposition of starting materials was observed. A 
β-trimethylsilyl enone 5.60 could be alkynylated under elevated temperature (81 oC), but the 
































In Chapter 4, we reported that substituted binaphthol-modified alkynylboronates 4.47 are 
excellent reagents for the asymmetric alkynylation of N-acylimines. Hence N-acetylbenzaldimine 
4.43c was tested in the catalytic reactions. However, the “background” reaction is too rapid and some 




















5.3.6 Comparison with Other Catalytic Reactions Involving Boron Reagents 
Compared to other boron-reagent catalyzed reactions, the catalytic asymmetric alkynylation 
reaction seems to be unique. For instance, in CBS reductions or CAB catalyzed Diels-Alder reactions, 
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bonds between chiral ligands and the central boron atom are not broken during the entire catalytic 
reactions (Figure 5.4). Breaking of these bonds would diminish the impact of chiral ligands on the 
transition states and lead to non-stereoselective inductions. On the contrary, in the catalytic 
alkynylation reactions, the breaking of the bonds between chiral ligand and the central boron atom is 















































Figure 5.4 Working models for different boron-induced catalytic asymmetric reactions. 
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5.4 Summary and Future Work 
In summary, we have shown that the asymmetric alkynylation of enones can be carried out very 
efficiently using catalytic amounts of binaphthol ligands (Scheme 5.29). This constitutes a major 






































More importantly, we have demonstrated a proof of principle that ligand exchange with 
boronates can be sufficiently fast that catalytic amounts of chiral ligands can be used to effect high 
levels of stereoselectivity. This catalytic protocol can potentially be applied to other asymmetric 
reactions providing the follow three requirements are met: (1) the starting achiral boronate does not 
react with the electrophile (no background reaction); (2) the chiral boronate reacts with the 
electrophile and (3) ligand exchange or transesterification occurs under the reaction conditions 
(Scheme 5.30). Some results from this chapter have been published in Journal of the American 

































Some prospective ligand-accelerated asymmetric reactions are illustrated in Scheme 5.31. 
These include asymmetric allylboration, hydroboration, and aldol reaction, just to name a few. Efforts 




































































Another potential variation of this catalytic process is to bind chiral ligands onto solid support 







Figure 5.5 Solid-support chiral binaphthols. 
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5.5 Experimental 
5.5.1 General Experimental 
All reactions were performed using flame-dried glassware under an argon atmosphere. 
Dichloromethane was freshly distilled from CaH2. Diethyl ether was freshly distilled from 
Na/benzophenone. Diisopropyl octynylboronate 5.38 was prepared according to Brown’s procedure.37 
Chiral 3,3′-disubstituted binaphthols were synthesized using procedures described previously.45 1H 
NMR and 13C NMR spectra were recorded in CDCl3 at 300 MHz and 75 MHz, respectively. 
5.5.2 General Procedure for the Stoichiometric Alkynylation of Enones 
Alkynylations of enones using stoichiometric amounts of binaphthol-modified 
alkynylboronates were carried out according to a previous procedure:34 (S)-3,3′-diiodo-2,2′- 
dihydroxy-1,1′-binaphthyl (2.28) (127 mg, 0.236 mmol) and lithium triisopropyl B-1-alkynylborate 
4.59 (0.232 mmol) were placed in a 25 mL round-bottomed flask under argon. THF (5 mL) was 
added slowly to the mixture at 0 oC. The solution was stirred at 0 oC for 1 h then warmed up to room 
temperature for 5 h. Solvent was evaporated under high vacuum. The enone (0.154 mmol) and 
CH2Cl2 (15 mL) were added followed by BF3·OEt2 (58 µL, 0.461 mmol). The reaction was stirred at 
room temperature for 3 h. After the reaction was complete, saturated NH4Cl (aq.) was added to 
quench the reaction. The organic layer was separated and the aqueous layer was washed with CH2Cl2 
(2 x 5 mL). The combined organic phase was washed with water and dried over Na2SO4. Most of the 
binaphthol was collected by crystallization from CH2Cl2/hexanes and the mother liquid was purified 
by column chromatography (acetone/hexanes 1:10) to give the 1,4-addition product. Enantiomeric 
excesses of all products were determined by HPLC with a Chiralcel OD column. Absolute 
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configurations for phenylacetylene and 1-octyne adducts to 1,3-bis(4-bromophenyl)-2-propen-1-one 
were determined by X-ray crystallography.33,34 The absolute configurations of other adducts have 
been assigned based on these known absolute configurations and the assumption that the enones are 
sufficiently similar in structure (all with β-aryl substituents) that the sense of asymmetric induction 
should be invariant. 
5.5.3 General Procedure for the Catalytic Alkynylation of Enones (Procedure A) 
A mixture of diisopropyl B-1-octynylboronate 5.38 (215 mg, 0.9 mmol), enone (0.3 mmol) and 
(S)-3,3′-diiodo-2,2′-dihydroxy-1,1′-binaphthyl (2.28) (32 mg, 0.06 mmol) were stirred in CH2Cl2 (4 
mL) under argon at room temperature for 6 h, then brought to reflux for 24 h. The reaction was 
quenched with saturated aqueous NH4Cl. The organic phase was washed with brine and dried over 
Na2SO4. Purification was done by column chromatography (acetone/hexanes 1:10) on silica gel. The 
chiral ligand was recovered in quantitative yield.  
5.5.4 One-pot Procedure for Catalytic Alkynylation of Enones from 1-Alkyne 
(Procedure B) 
To a solution of 1-alkyne (1.0 mmol) in Et2O (5 mL) was added 0.63 mL of n-BuLi (1.0 mmol, 
1.6 M) dropwise at -78 oC. The resulting solution was stirred at that temperature for 20 min then 
added dropwise to a mixture of (i-PrO)3B in 5 mL Et2O at -78oC. The suspension was stirred at -78 oC 
for 2 h and warmed up to room temperature for 1 h. The reaction was again cooled to -78 oC, and 0.5 
mL anhydrous HCl in Et2O (2 M, 1 mmol) was added slowly. The reaction was allowed to warm to 
room temperature and volatiles were removed in vacuo. To the yellowish oily residue was added 
CH2Cl2 (4 mL), enone (0.3 mmol) and catalyst (0.06 mmol) at room temperature. The mixture was 
 238
stirred at ambient temperature for 6 h then brought to reflux for 24 h. Workup was the same as in 
procedure A. 















[α]D25 +31.4 (c 2.04, CHCl3, 85% ee); IR (neat): C=O 1684 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 0.86 (Ha, 3H, t, J = 6.7 Hz), 1.15-1.48 (Hb, 8H, m), 2.14 (Hc, 2H, dt, J = 2.2 Hz, 6.8 Hz), 3.26 (Hg, 
1H, dd, J = 16.4 Hz, 6.0 Hz), 3.52 (Hg, 1H, dd, J = 16.4 Hz, 8.3 Hz), 4.38 (Hf, 1H, ddd, J = 8.3 Hz, 
6.0 Hz, 2.2 Hz), 7.18-7.94 (HAr, 10H, m); 13C NMR (75 MHz, CDCl3): δ 197.3 (C=O), 141.9 (CAr), 
136.9 (CAr), 132.9 (CAr), 128.4 (CAr), 128.0 (CAr), 127.4 (CAr), 126.6 (CAr), 83.5 (Cd or Ce), 80.9 (Cd or 
Ce), 47.6 (Cj), 33.3 (Cb), 31.2 (Cf), 28.7 (Cb), 28.4 (Cb), 22.4 (Cb), 18.7 (Cc), 13.9 (Ca); MS (EI), m/e 
(relative intensity) 318 (1, M+), 247 (13), 233 (33), 128 (20), 105 (100), 91 (27), 77 (53). Anal. Calcd 
for C23H26O: C, 86.75; H, 8.23. Found C, 86.55; H, 8.20. The enantiomeric excess of the product was 
determined by HPLC (hexanes/i-PrOH = 99.9/0.1, flow rate = 0.5 mL/min), tR = 55 min (S), tR = 61 
min (R). 















[α]D25 -13.1 (c 1.39, CHCl3, 96% ee); IR (neat): C=O 1684 cm-1; 1H NMR (300 MHz, CDCl3): δ 
0.87 (Ha, 3H, t, J = 6.9 Hz), 1.12-1.47 (Hb, 8H, m), 2.17 (Hc, 2H, dt, J = 2.2 Hz, 6.8 Hz), 3.32 (Hg, 1H, 
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dd, J = 16.8 Hz, 3.9 Hz), 3.65 (Hg, 1H, dd, J = 16.8 Hz, 9.6 Hz), 5.20 (Hf, 1H, ddd, J = 9.6 Hz, 3.9 Hz, 
2.2 Hz), 7.43-8.18 (HAr, 12H, m); 13C NMR (75 MHz, CDCl3): δ 197.6 (C=O), 137.4 (CAr), 137.0 
(CAr), 134.0 (CAr), 133.0 (CAr), 130.3 (CAr), 129.0 (CAr), 128.5 (CAr), 128.2 (CAr), 127.6 (CAr), 126.2 
(CAr), 125.5 (CAr), 125.4 (CAr), 125.2 (CAr), 123.0 (CAr), 84.1 (Cd or Ce), 80.8 (Cd or Ce), 46.5 (Cg), 
31.2 (Cb), 30.0 (Cf), 28.7 (Cb), 28.4 (Cb), 22.4 (Cb), 18.8 (Cc), 14.0 (Ca); MS (EI), m/e (relative 
intensity) 368 (3, M+), 284 (23), 283 (83), 179 (48), 178 (32), 165 (30), 105 (100). Anal. Calcd for 
C27H28O: C, 88.00; H, 7.66. Found C, 88.10; H, 7.58. The enantiomeric excess of the product was 
determined by HPLC (hexanes/i-PrOH = 99.5/0.5, flow rate = 1 mL/min), tR = 17 min (S), tR = 24 min 
(R). Note that the difference in absolute configuration between 5.42a and 5.42b is due to differences 
in CIP priorities: 1-naphthyl > 1-octynyl > phenyl. 


















[α]D25 -10.4 (c 2.0, CHCl3, 88% ee); IR (neat): C=O 1689 cm-1; 1H NMR (300 MHz, CDCl3): δ 
0.84 (Ha, 3H, t, J = 6.9 Hz), 1.10-1.50 (Hb, 8H, m), 2.09-2.15 (Hc, 2H, dt, J = 2.4 Hz, 6.9 Hz), 
3.43-3.46 (Hg, 2H, m), 4.43-4.49 (Hf, 1H, m), 6.22 (Hi, 1H, dd, J = 3.3 Hz, 0.9 Hz), 6.27 (Hj, 1H, dd, 
J = 3.3 Hz, 1.9 Hz), 7.30 (Hk, 1H, dd, J = 0.9 Hz, 1.9 Hz), 7.39-7.60 (HAr, 3H, m), 7.90-8.02 (HAr, 2H, 
m); 13C NMR (75 MHz, CDCl3): δ 196.9 (C=O), 154.1 (Cl), 141.6 (Ck), 136.9 (CAr), 133.1 (CAr), 
128.5 (CAr), 128.2 (CAr), 110.3 (Ci or Cj), 105.9 (Ci or Cj), 82.9 (Cd or Ce), 78.3 (Cd or Ce), 43.8 (Cg), 
31.3 (Cb), 28.7 (Cb), 28.4 (Cb), 27.2 (Cf), 22.5 (Cb), 18.7 (Cc), 14.0 (Ca); MS (EI), m/e (relative 
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intensity) 308 (1, M+), 105 (100), 77 (43). Anal. Calcd for C21H24O2: C, 81.78; H, 7.84. Found C, 
81.90; H, 7.76. The enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 
99.8/0.2, flow rate = 0.5 mL/min), tR = 34 min (R), tR = 36 min (S). 
















[α]D25 +2.4 (c 1.4, CHCl3, 94% ee); IR (neat): C=O 1706 cm-1; 1H NMR (300 MHz, CDCl3): δ 
0.87 (Ha, 3H, t, J = 6.9 Hz), 1.26-1.49 (Hb, 8H, m), 2.11 (Hi, 3H, s), 2.15-2.19 (Hc, 2H, dt, J = 2.1Hz, 
6.9Hz), 2.69 (Hg, 1H, dd, J = 16.1 Hz, 6.1 Hz), 2.86 (Hg, 1H, dd, J = 16.1 Hz, 8.5 Hz), 4.13 (Hf, 1H, 
ddd, J = 8.5 Hz, 6.1 Hz, 2.1 Hz), 7.17-7.40 (HAr, 5H, m); 13C NMR (75 MHz, CDCl3): δ 206.1 (C=O), 
141.6 (CAr), 128.5 (CAr), 127.3 (CAr), 126.8 (CAr), 83.6 (Cd or Ce), 80.6 (Cd or Ce), 52.3 (Cg), 33.2 (Ci), 
31.3 (Cb), 30.6 (Cf), 28.9 (Cb), 28.5 (Cb), 22.5 (Cb), 18.8 (Cc), 14.0 (Ca); MS (EI), m/e (relative 
intensity) 256 (1, M+), 185 (52), 171 (49), 129 (39), 128 (41), 43 (100). Anal. Calcd for C18H24O: C, 
84.32; H, 9.44. Found C, 84.26; H, 9.32. The enantiomeric excess of the product was determined by 
HPLC (hexanes/i-PrOH = 99.9/0.1, flow rate = 0.5 mL/min), tR = 54 min (R), tR = 60 min (S). 
 









[α]D25 +30.1 (c 1.44, CHCl3, 82% ee); IR (KBr): C=O 1680 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 3.39 (Hd, 1H, dd, J = 16.5 Hz, 6.2 Hz), 3.65 (Hd, 1H, dd, J = 16.5 Hz, 7.8 Hz), 4.63 (Hc, 1H, dd, J = 
6.2 Hz, 7.8 Hz), 7.31-8.05 (HAr, 15 H, m); 13C NMR (75 MHz, CDCl3): δ 197.0 (C=O), 141.2 (CAr), 
136.8 (CAr), 133.1 (CAr), 131.6 (CAr), 128.6 (CAr), 128.5 (CAr), 128.1 (CAr), 127.8 (CAr), 127.5 (CAr), 
127.0 (CAr), 123.3 (CAr), 90.7 (Cb), 83.3 (Ca), 47.2 (Cd), 33.7 (Cc); MS (EI), m/e (relative intensity) 
310 (10, M+), 205 (100), 191 (44), 105 (71), 77 (57). Anal. Calcd for C23H18O: C, 89.00; H, 5.84. 
Found C, 89.13; H, 5.83. The enantiomeric excess of the product was determined by HPLC 
(hexanes/i-PrOH = 99.8/0.2, flow rate = 0.5 mL/min), tR = 100 min (R), tR = 115 min (S). 








[α]D25 +37.3 (c 1.01, CHCl3, 90% ee); IR (KBr): C=O 1686 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 3.45 (Hd, 1H, dd, J = 16.8 Hz, 4.2 Hz), 3.81 (Hd, 1H, dd, J = 16.8 Hz, 9.6 Hz), 5.42 (Hc, 1H, dd, J = 
9.6 Hz, 4.2 Hz), 7.33-8.30 (HAr, 17H, m); 13C NMR (75 MHz, CDCl3): δ 197.2 (C=O), 136.8 (CAr), 
136.7 (CAr), 134.1 (CAr), 133.2 (CAr), 131.6 (CAr), 130.3 (CAr), 129.0 (CAr), 128.6 (CAr), 128.2 (CAr), 
128.1 (CAr), 127.9 (CAr), 127.8 (CAr), 126.4 (CAr), 125.7 (CAr), 125.5 (CAr), 125.4 (CAr), 123.4 (CAr,), 
122.9 (CAr), 90.6 (Cb), 83.8 (Ca), 46.2 (Cd), 30.4 (Cc); MS (EI), m/e (relative intensity) 360 (11, M+), 
255 (35), 207 (100). Anal. Calcd for C27H20O: C, 89.97; H, 5.59. Found C, 90.05; H, 5.58. The 
enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 99/1, flow rate = 1 
mL/min), tR = 17 min (S), tR = 22 min (R). Note that the difference in absolute configuration between 
5.42e and 5.42f is due to differences in CIP priorities: 1-naphthyl > phenylethynyl > phenyl. 
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[α]D25 -1.5 (c 1.6, CHCl3, 86% ee); IR (neat): 3062, 3030, 2232, 1684, 1598, 1495, 1450, 1352, 
1255, 1205, 1072, 1035 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.33 (Hf, 1H, dd, J = 16.8 Hz, 6 Hz), 
3.58 (Hf, 1H, dd, J = 16.8 Hz, 7.8 Hz), 4.17 (Hb, 2H, d, J = 2.0 Hz), 4.48 (He, 1H, ddt, J = 7.8 Hz, 6.0 
Hz, 2.0 Hz), 4.53 (Ha, 2H, s), 7.26-7.99 (HAr, 15H, m); 13C NMR (75 MHz, CDCl3): δ 196.8 (C=O), 
140.9 (CAr), 137.5 (CAr), 136.7 (CAr), 133.2 (CAr), 128.6 (CAr), 128.5 (CAr), 128.3 (CAr), 128.1 (CAr), 
128.0 (CAr), 127.7 (CAr), 127.5 (CAr), 127.0 (CAr), 87.9 (Cd), 78.7 (Cc), 71.2 (Ca), 57.5 (Cb), 47.0 (Cf), 
33.0 (Ce); MS (EI), m/e (relative intensity) 354 (1, M+), 105 (100), 77 (31). Anal. Calcd for C25H22O2: 
C, 84.72; H, 6.26. Found C, 84.98; H, 6.17. The enantiomeric excess of the product was determined 
by HPLC (hexanes/i-PrOH = 97/3, flow rate = 1 mL/min), tR = 16 min (R), tR = 26 min (S). 
 






[α]D25 +10.5 (c 0.84, CHCl3, 95% ee); IR (neat): C=O 1683 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 3.41(Hd, 1H, dd, J = 17.1 Hz, 4.2 Hz), 3.75 (Hd, 1H, dd, J = 17.1 Hz, 6.6 Hz), 4.18 (Hb, 2H, d, J = 
2.0 Hz), 4.52 (Ha, 2H, s), 5.27-5.32 (Hc, 1H, ddd, J = 2.0 Hz, 4.2 Hz, 6.6 Hz), 7.26-8.24 (17H, m); 13C 
NMR (75 MHz, CDCl3): δ 197.1 (C=O), 137.5 (CAr), 136.7 (CAr), 136.4 (CAr), 134.1 (CAr), 133.3 
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(CAr), 130.3 (CAr), 129.1 (CAr), 128.6 (CAr), 128.3 (CAr), 128.2 (CAr), 128.1 (CAr), 128.0 (CAr), 127.7 
(CAr), 126.4 (CAr), 125.7 (CAr), 125.5 (CAr), 125.3 (CAr), 122.9 (CAr), 87.9 (C≡C), 79.4 (C≡C), 71.2 
(Ca), 57.5 (Cb), 46.0 (Cd), 29.8 (Cc); MS (EI), m/e (relative intensity) 404 (1, M+), 296 (17), 105 (100), 
91 (33), 77 (33). Anal. Calcd for C29H24O2: C, 86.11; H, 5.98. Found C, 85.99; H, 5.91. The 
enantiomeric excess of the product was determined by HPLC (hexanes/i-PrOH = 99/1, flow rate = 1 
mL/min), tR = 58 min (R), tR = 63 min (S). 
 





Meyers’ procedure was followed:46 to a mixture of 3.88 g (103 mmol) sodium borohydride and 
100 mL of THF was added L-valine (5 g, 42.7 mmol) in one portion and the reaction flask was cooled 
to 0 "C in an ice bath. A solution of 10.84 g (42.7 mmol ) of iodine dissolved in 50 mL of THF was 
added slowly over 30 min. After addition of the iodine was complete and gas evolution had ceased, 
the reaction was heated to reflux for 18 h and then cooled to room temperature, and methanol was 
added cautiously until the mixture became clear. After stirring 30 min, the solvent was removed by 
rotary evaporation leaving a white paste which was dissolved by addition of 150 mL of 20% aqueous 
KOH. The solution was stirred for 4 h and extracted with 3 x 150 mL of methylene chloride. The 
organic extracts were dried over sodium sulfate and concentrated in vacuo, affording a white 
semisolid (100%) which was subjected to a bulb-to-bulb distillation to afford 5.46 (3.9 g) in 89% 
yield. bp 75-77 oC/7 mm. The 1H NMR data of the product was identical to reported values.47 
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To a solution of amino alcohol 5.46 (0.912 g, 8.84 mmol) in 8 mL of CH2Cl2 at 0 oC were 
added triethylamine (0.895 g, 8.84 mmol), tosyl chloride (1.69 g, 8.84 mmol) and DMAP (98 mmol, 
0.8 mmol). The reaction was stirred at 0 oC for 2 h then warmed to room temperature over night. 
Volatiles were removed in vacuo and the residue was purified by flash column chromatography on 
silica gel (EtOAc) to give the desired product (2.2 g) in 97 % yield. 1H NMR (300 MHz, CDCl3): δ 
7.76 (Ha, d, J = 6.8 Hz, 3H), 7.77 (Ha, d, J = 6.9 Hz, 3H), 1.74 (Hb, m, 1H), 1.98 (OH, s, br, 1H), 2.40 
(ArCH3, s, 3H), 3.02 (Hc, m, 1H), 3.49-3.58 (Hd, m, 2H), 4.92 (NH, d, br, J = 8.4 Hz, 1H), 7.27 (Hf, d, 
J = 8.1 Hz, 2H), 7.65 (He, d, J = 8.1 Hz, 2H). 











McChesney’s method was followed.49 An amino acid (10 mmol) was dissolved in 20 mL of 1 N 
sodium hydroxide. An ethereal solution of p-toluenesulfonyl chloride (2.0 g, 10 mmol) was added, 
and the mixture is stirred at room temperature overnight. The ethereal solution is then separated and 
the aqueous solution is acidified with hydrochloric acid. The derivative begins to crystallize at once. 
The crystals are collected through filtration and are recrystallized from 60% Ethanol.  
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1H NMR (300 MHz, d4-MeOH): δ 0.86 (Ha, d, J = 6.9 Hz, 3H), 0.91 (Ha, d, J = 6.9 Hz, 3H), 
2.04 (Hb, m, 1H), 2.44 (Hf, s, 3H), 3.62 (Hc, d, J = 7.5 Hz, 1H), 7.33 (He, d, J = 8.1 Hz, 2H), 7.73 (Hd, 
d, J = 8.1 Hz, 2H).  
5.5.15.2 (R)-N-Tosyl-phenylglycine (5.49b)51 
NHTs
OHO  
1H NMR (300 MHz, d6-DMSO): δ 2.34 (ArCH3, s, 3H), 5.06 (ArCHN, d, J = 7.5 Hz, 1H), 5.62 
(NH, d, br, J = 7.5 Hz, 1H), 7.08-7.60 (HAr, m, 9H). 













1H NMR (300 MHz, D6-DMSO): δ 2.36 (He, s, 3H), 2.97 (Ha, dd, J = 13.8 Hz, 6.3 Hz, 1H), 
3.06 (Ha, dd, J = 13.8 Hz, 5.5 Hz, 1H), 4.14 (Hb, ddd, J = 8.5 Hz, 6.3 Hz, 5.5 Hz, 1H), 5.25 (NH, d, br, 
J = 8.5 Hz, 1H), 7.04-7.23 (HAr, m, 7H), 7.58 (Hc, d, J = 8.2 Hz, 2H). 




NHTs   
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To a solution of (1R,2R)-1,2-diphenylethane-1,2-diamine53 (531 mg, 2.5 mmol) in 12 mL of 
CH2Cl2 at 0 oC were added triethylamine (759 mg, 7.5 mmol), p-toluenesulfonyl chloride (1.14g, 6 
mmol) and DMAP (6.1 mg). The reaction mixture was allowed to warm to room temperature for 12 h. 
Volatiles were removed in vacuo and the residue was purified by flash column chromatography on 
silica gel (EtOAc/hexanes = 1:1) to give the desired product in quantitative yield. 1H NMR (300 MHz, 
CDCl3): δ 2.30 (ArCH3, s, 6H), 4.44 (ArCHN, m, 2H), 5.48 (NH, m, 2H), 6.64 (HAr, d, J = 7.5 Hz, 
4H), 6.93 (HAr, t, J = 7.4 Hz, 4H), 6.98-7.07 (HAr, m, 6H), 7.46 (HAr, d, J = 7.5 Hz, 4H). 





N-tosyl aniline (531 mg, 2.15 mmol) and cinnamoyl chloride (0.43 g, 2.58 mmol) were mixed 
in 15 mL of THF. Finely ground potassium carbonate (1.48 g, 10.8 mmol) was added to the solution 
and the resulting suspension was stirred at room temperature over night. The solid was filtered off and 
the filtrate was concentrated in vacuo. The residue was purified by flash column chromatography on 
silica gel (EtOAc/hexanes = 4:1) to give the desired product (800 mg) in 98% yield. 1H NMR (300 
MHz, CDCl3): δ 2.43 (ArCH3, s, 3H), 6.03 (ArCH=CH, d, J = 15.6 Hz, 1H), 7.17-7.36 (HAr, m, 9H), 
7.48-7.52 (HAr, m, 3H), 7.65 (ArCH=CH, d, J = 15.6 Hz, 1H), 7.95 (HAr, d, J = 8.3 Hz, 2H);13C NMR 
(75 MHz, CDCl3): δ 165.4 (C=O), 145.7 (ArCH=CH), 144.9 (CAr), 136.2 (CAr), 136.0 (CAr), 134.0 
(CAr), 130.6 (CAr), 130.4 (CAr), 130.0 (CAr), 129.8 (CAr), 129.4 (CAr), 129.3 (CAr), 128.8 (CAr), 128.2 
(CAr), 117.7 (ArCH=CH), 21.7 (CH3); MS (EI), m/e (relative intensity): 377 (0.1, M+), 313 (5, 
 247
M+-SO2), 131 (100, M+-PhNTs); HRMS m/z Calcd for C22H19NO (M+-SO2): 313.1467. Found: 
313.1463. 









Cinnamoyl chloride (0.366 g, 2.2 mmol) and imidazole (0.350 g, 5.1 mmol) were mixed in 5 
mL of CH2Cl2. The mixture was stirred at room temperature for 1 h. The white precipitate was filtered 
off and the filtrate was purified by passing through a short silica column (EtOAc). Solvents were 
removed in vacuo to give the title compound (0.435 g) in quantitative yield. 1H NMR (300 MHz, 
CDCl3): δ 7.05 (Hb, d, J = 15.4 Hz, 1H), 7.14 (Hd, s, 1H), 7.39-7.50 (HAr, m, 3H), 7.59-7.65 (HAr and 
He, m, 3H), 8.05 (Ha, d, J = 15.4 Hz, 1H), 8.30 (Hc, s, 1H). 









The unstable 3-oxo-3-phenylpropanal was prepared from acetophenone and DMF using 
standard Claisen condensation techniques (with NaOMe in THF). This compound stays 
predominantly in its enol form (<10% aldehyde). 1H NMR (300 MHz, CDCl3): δ 2.14 (OH, s, 1H), 
6.02 (COCH=CH, d, J = 4.2 Hz, 1H), 7.24 (HAr, dd, J = 7.0 Hz, 8.2 Hz, 2H), 7.33 (HAr, t, J = 7.0 Hz, 
1H), 7.79 (HAr, d, J = 8.2 Hz, 2H), 8.05 (COCH=CH, d, J = 4.2 Hz, 1H); 13C NMR (75 MHz, CDCl3): 
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δ 188.0 (C=O), 178.8 (COCH=CH), 135.0 (CAr), 133.0 (CAr), 128.8 (CAr), 127.5 (CAr), 98.4 
(COCH=CH,). 
3-Oxo-3-phenylpropanal (1.48 g, 10 mmol) was dissolved in 20 mL of MeOH. To the stirred 
solution, at room temperature, was added 0.1 mL (0.1 mmol, 1 mol%) of a 1.0 M TiCl4 solution in 
CH2Cl2. After 10 min, the reaction was quenched with 5 mL of H2O and was then extracted with 
diethyl ether (3 x 10 mL). The combined organic layers were washed with water and dried over 
sodium sulfate. Evaporation of the solvent afforded the crude product in 90% yield. This crude 
material is pure enough to use without further purification. 1H NMR (300 MHz, CDCl3): δ 3.80 (OMe, 
s, 3H), 6.29 (CH=CHOMe, d, J = 12.2 Hz, 1H), 7.40-7.53 (HAr, m, 3H), 7.76 (CH=CHOMe, d, J = 
12.2 Hz, 1H), 7.87 (HAr, d, J = 7.1 Hz, 2H). 
 















A mixture of diisopropyl B-1-octynylboronate (5.38) (300 mg, 1.26 mmol), enone 5.55 (0.3 
mmol) and (S)-3,3′-diiodo-2,2′-dihydroxy-1,1-binaphthyl (2.28) (32 mg, 0.06 mmol) were stirred in 
CH2Cl2 (4 mL) under argon at room temperature for 6 h, then brought to reflux for 24 h. The reaction 
was quenched with saturated aqueous NH4Cl. The organic phase was washed with brine and dried 
over Na2SO4. Purification was done by column chromatography (acetone/hexanes 1:10) on silica gel 
to afford the title compound in 71% yield. 1H NMR (300 MHz, CDCl3): δ 0.83 (Ha, t, J = 7.0 Hz, 6H), 
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1.16-1.48 [Hb, m, 16H], 2.09 (Hc, dt, J = 2.2 Hz, 6.9 Hz, 4H), 3.32 (Hg, d, J = 7.2 Hz, 2H), 4.02 (Hf, 
m, 1H), 7.43 (Hk, t, J = 7.7 Hz, 2H), 7.54 (Hl, tt, J = 7.7 Hz, 1.2 Hz, 1H), 7.95 (Hj, dd, J = 7.7 Hz, 1.2 
Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 196.6 (C=O), 136.8 (Ci), 133.2 (Cl), 128.5 (Ck or Cj), 128.2 
(Ck or Cj), 81.3 (Ce), 78.2 (Cd), 45.3 (Cg), 31.3 (Cb), 28.6 (Cb), 28.4 (Cb), 22.5 (Cb), 19.3 (Cf), 18.7 
(Cc), 14.0 (Ca). MS (EI), m/e (relative intensity): 350(14, M+), 349 (15, M+-H), 279 (62 M+-C5H11), 
265 (46, M+-C6H13), 105 [100, (O≡C-Ph)+]; HRMS m/z Calcd for C25H34O (M+): 350.2610. Found: 
350.2602. 
 




Anhydrous aluminum chloride (0.1330 g, 1 mmol) was added to a solution of 
trans-1,2-bis(tributylstannyl)ethylene (0.61 g, 1.0 mmol) and benzoyl chloride (0.155 g, 1.1 mmol) in 
dichloromethane (5 mL) at -78 "C under an argon atmosphere. The reaction mixture was stirred for 1 
h at that temperature and was allowed to warm to 0 oC slowly. The reaction mixture was poured into 
20 mL of water containing KF (1 g) and stirred vigorously for 5 min. The mixture was extracted with 
diethyl ether (3 x 20 mL). The combined organic extracts were dried over anhydrous MgSO4, filtered, 
and concentrated. Flash chromatography using 30:l hexanes/EtOAc gave the title compound (0.262 g) 
in 62% yield. 1H NMR (300 MHz, CDCl3): δ 0.84-1.59 (SnBu3, m, 27H), 7.29 (COCH=CH, d, J = 
19.3 Hz, 1H), 7.39-7.54 (HAr, m, 3H), 7.78 (COCH=CH, d, J = 19.3 Hz, 1H), 7.90 (HAr, d, J = 7.6 Hz, 
2H). 
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A literature procedure56 was followed with some modifications. n-BuLi (6.7 mL, 10 mmol, 1.50 
M solution in hexane) was added to a solution of (trimethylsilyl)acetylene (1.0 g, 10.2 mmol) in THF 
(30 mL) at -50 oC and the mixture was stirred for 20 min. Benzaldehyde (977 mg, 9.18 mmol) was 
then added and the resulting solution was stirred for 1 h at room temperature. The reaction was 
quenched with water, poured into NaCl (aqueous, saturated), and extracted with Et2O. The organic 
layer was dried over MgSO4, filtered, and concentrated in vacuo. The crude propargyl alcohol 
(quantitative yield) was used in the next step without further purification. 1H NMR (300 MHz, CDCl3): 
δ 0.188 (SiMe3, s, 9H), 2.43 (OH, d, J = 6.0 Hz, 1H), 5.43 (ArCH, d, J = 6.0 Hz, 1H), 7.30-7.55 (HAr, 
m, 5H). 
A solution of this propargyl alcohol (1.80 g, 8.8 mmol) in THF (5 mL) was added to a 
suspension of LiAlH4 (237 mg, 6.25 mmol) in 30 mL of THF at 0 °C, and the mixture was stirred for 
2 days at 30 °C. After quenching with NH4Cl, the precipitate was removed by filtration and the 
resulting solution was dried over MgSO4, filtered, and concentrated under vacuum to afford a mixture 
of E- and Z-1-phenyl-3-trimethylsilyl-2-propen-1-ol57 as a colorless oil in a ratio of 2.85:1 (by 1H 
NMR). 1H NMR (for the E-alcohol, 300 MHz, CDCl3): δ 0.15 (SiMe3, s, 9H), 3.32 (OH, s, br, 1H), 
5.13 (ArCH, d, J = 4.9 Hz, 1H), 6.02 (TMSCH=CH, d, J = 18.6 Hz, 1H), 6.24 (TMSCH=CH, dd, J = 
18.6 Hz, 4.9 Hz, 1H), 7.26-7.55 (HAr, m, 5H). 
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The Z/E-alcohol mixture (0.208g, 0.99 mmol) was dissolved in dichloromethane (7 mL) and 
activated MnO2 (0.606 g, 6.97 mmol) was added at 0 oC. After stirring for 12 h at room temperature, 
the mixture was filtered through celite. The resulting solution was dried over MgSO4, filtered, and 
concentrated under vacuum. The residue was chromatographed on silica gel with EtOAc/hexanes = 
1/30 to afford (E)-enone 5.60 as a pale yellow oil (184 mg, 60% yield). 1H NMR (300 MHz, CDCl3): 
δ 0.22 (SiMe3, s, 9H), 7.22 (TMSCH=CH, d, J = 18.7 Hz, 1H), 7.30 (TMSCH=CH, d, J = 18.7 Hz, 
1H), 7.42-7.93 (HAr, m, 5H); 13C NMR (75 MHz, CDCl3): δ 190.4 (C=O), 149.5 (TMSCH=CH), 
138.0 (TMSCH=CH), 137.5 (CAr), 132.7 (CAr), 128.6 (CAr), 128.5 (CAr), -1.8 (SiMe3). 
 















A mixture of diisopropyl B-1-octynylboronate 5.38 (215 mg, 0.9 mmol), enone 5.60 (64 mg, 
0.3 mmol) and (S)-3,3′-diiodo-2,2′-dihydroxy-1,1-binaphthyl (2.28) (32 mg, 0.06 mmol) were stirred 
in CH3CN (5 mL) under argon at room temperature for 6 h, then brought to reflux for 24 h. The 
reaction was quenched with saturated aqueous NH4Cl. The organic phase was washed with brine and 
dried over Na2SO4. Purification was done by column chromatography (acetone/hexanes 1:10) on 
silica gel to afford the title compound in 93% yield. 1H NMR (300 MHz, CDCl3): δ 0.10 (SiMe3, s, 
9H), 0.84 (Ha, t, J = 7.0 Hz, 3H), 1.20-1.44 (Hb, m, 8H), 2.05 (Hc, dt, J = 2.5 Hz, 6.8 Hz, 2H), 2.30 (Hf, 
m, 1H), 2.87 (Hg, dd, J = 4.4 Hz, 16.2 Hz, 1H), 3.11 (Hg, dd, J = 6.3 Hz, 16.2 Hz, 1H), 7.40-7.96 (HAr, 
m, 5H); 13C NMR (75 MHz, CDCl3): δ 199.2 (C=O), 137.1 (CAr), 132.8 (CAr), 128.4 (CAr), 128.2 
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(CAr), 81.0 (Ce), 80.6 (Cd), 38.9 (Cg), 31.3 (Cb), 29.2 (Cb), 28.4 (Cb), 22.5 (Cb), 18.9 (Cc), 15.3 (Cf), 
14.0 (Ca), -3.2 (SiMe3). The enantiomeric excess of the product was determined by HPLC 
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Appendix. X-ray Crystallographic Data of 4.45k 
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